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Summary
1. The literature concerning the mechanism of action of steroid 
hormones, has been reviewed. In particular that relating to steroid 
receptor proteins and their interaction with the cell nucleus and nuclear 
material has been stressed.
2. r Nuclei have been isolated from human myometrium and their
purity assessed using standard criteria. The isolated nuclei have been 
extracted using either 2M NaCl or 0.1M I^SO^. The resultant extracts 
have been immobilised on sepharose 4B and assayed for the ability to 
specifically bind activated, labelled oestrogen receptor complexes.
3. Both nuclear fractions have shown significant ability to 
specifically bind activated, labelled oestrogen receptor complexes.
4. The relative abilities of oestrogen receptor from a variety of 
sources to bind to the 2M NaCl soluble nuclear extract/sepharose resin has 
been assessed. Receptor from immature rat uterus was found to bind in a 
reproducible, saturable manner to the myometrial nuclear extract and was 
used as the source of oestrogen receptor for all subsequent studies.
5. The effect of assay conditions on the binding activity at 4°C 
has been assessed. The presence or absence of EDTA or DTT in the assay 
buffer had no significant effect. A KC1 concentration in the range of
0.12-0.15M was necessary to observe the maximum amount of specific 
saturable binding. When oestrogen receptor was prepared in the presence 
of sodium molybdate, no decrease in binding activity was observed, 
indicating the presence of molybdate did not interfere with the interaction 
of the oestrogen receptor complex and the immobilised components.
6 . The effect of digestive enzymes on the ability of both nuclear 
fraction/sepharose resins to bind activated, labelled oestrogen receptor 
has been assessed. Only proteolytic enzymes were observed to reduce the 
binding activity indicating that the immobilised nuclear component involved
in binding activated, labelled oestrogen receptor in proteinaceous.
(xix)
7. Saturation analysis of the binding of activated,labelled
oestrogen receptor to both nuclear extract/sepharose resins revealed a
-11single class of high affinity, saturable binding site (Kd 3-4x10 M) 
with other non-specific lower affinity binding sites being present.
8 . Both nuclear extract/sepharose resins have been analysed 
for specific binding sites for androgen, glucocorticoid and progesterone 
receptor complexes. The nuclear material solubilised from human 
myometrium by mild acid treatment contained specific binding sites for all 
three classes of steroid-receptor complex. The nuclear material soluble 
in 2M NaCl only contained specific binding sites for androgen and 
glucocorticoid receptor complexes. In all cases the number of binding sites 
were lower than the number available to activated, labelled oestrogen 
receptor.. Both nuclear extract/sepharose resins contained binding sites 
for tamoxifen-oestrogen receptor complexes. The number of sites available 
for the tamoxifen-oestrogen receptor complex was much less than those 
available to bind oestradiol-oestrogen receptor complex.
9. Competition between the various steroid-receptor complexes for
binding sites available on both the nuclear extract/sepharose resins has 
been assessed. Competition between anti-oestrogen oestrogen receptor 
complexes and oestradiol-oestrogen receptor complexes has also been 
assessed. The data suggest there are both unique binding sites for each 
steroid-receptor complex and a population of common binding sites.
10. Nuclei have been isolated from immature female rat kidney, liver,
spleen and uterus. The 2M NaCl soluble nuclear fraction was then isolated 
in each case and analysed for the ability to specifically bind activated, 
labelled oestrogen receptor complex. The ability of the various 
preparations to bind activated, labelled oestrogen receptor was uterus >, 
liver >, spleen >, kidney.
(xx)
11. Protein blotting techniques have been used in an attempt to
identify the nuclear protein(s) which are involved in the binding activity.
125Both oestrogen receptor labelled with I-oestradiol and rabbit antiserum
raised against human myometrial oestrogen receptor in conjunction with 
125I-protein A, have been used in a search for a discreet protein
fraction(s) involved in binding oestrogen receptor. The use of the latter
technique revealed a faint signal around approximately 15,000 which
is worthy of further investigation.
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1. Introduction
1.1 Control and Regulatory Mechanisms in Higher Organisms
The human body has two major control systems to regulate both
the way in which it perceives and reacts to its surrounding environment 
and to regulate its biochemical function. These are (1) the nervous 
system and (2 ) the endocrine system which involves the ductless or 
endocrine glands. There is interaction between both systems at various 
levels but in general the nervous system is involved in the rapid 
transmission of information within the body. This is achieved by 
electrical impulses which pass along the nerve fibres of the body.
The endocrine system is concerned with the regulation of metabolism, 
including aspects of cellular metabolism, growth and differentiation. 
Communication in this system uses hormones. The effects of hormones 
can take place in seconds, (e.g. the catecholamines) or can extend over 
a much longer period of time (e.g. steroid hormones).
The endocrine glands are ductless tissues which secrete the 
hormones directly into the blood stream. Thus, hormonal responses are 
relatively slow compared with nervous transmissions.
A hormone is a chemical substance that is secreted into the 
blood stream at one location in the body and has its physiological 
effects at another, distant site. These distant sites have come to 
be known as target tissues. One hormone can effect more than one 
target tissue and it is possible for target tissues to be responsive 
to more than one hormone. The tissues which are affected by a 
hormone are defined by the presence of a chemical receptor (usually 
protein in nature) on or within the target cell. These receptor 
molecules enable a target tissue to perceive a hormonal signal and this 
is the initiation point for the further events which are induced by 
the interaction with the hormone. These events may include 
changes in enzyme activity (e.g. phosphorylation and/or dephosphoryl at ion) 5
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transport activity and longer term responses leading to modulation of 
gene expression, growth and cell division.
Endocrine glands involved in the synthesis and release of 
hormones may be influenced by environmental factors which may, 
through neuronal sectetions, increase or decrease their activity.
There is a close relationship between the neuronal and endocrine 
system. The complex control mechanism of the endocrine system may 
involve both a neural control loop and a feedback chemical control 
via the blood supply.
In terms of chemical structure, hormones can be divided into 
the following classes
1. Steroid Hormones e.g. oestradiol-17/S
2. Amino Acid Derivatives e.g. the catecholamines
3. Peptide Hormones e.g. Insulin
Classically these hormones can be divided into two groups:
(1) those which act via a receptor present on the cell surface or
(2 ) those which combine with a receptor which is located within the 
cell. Recently this separation has become clouded.
It is generally agreed (Holleriberg, 1979; Catt et al., 1980) 
that the primary site of action of catecholamines and polypeptide 
hormones is the plasma membrane of target cells. The short term 
responses elicited by these hormones are mediated by second messengers, 
involving the activation of protein kinases by cyclic nucleotides. 
However it is possible that some of the longer term responses might 
involve direct action of these hormones at the nuclear level, although 
current evidence (Houslay and Heyworth, 1983; Kono, 1983) argues 
against a direct nuclear role for insulin receptor. Nevertheless 
the possibility cannot be totally eliminated that the mitogenic effect 
of insulin is mediated by direct interaction with the target cell
nucleus.
Internalisation of at least a proportion of the hormone- 
bound plasma membrane receptors appears to be a property of most 
polypeptide hormone receptors (Catt et_al., 1980). This 
internalisation appears to be generally associated with degradation 
and resynthesis or recycling of the receptors.
Classically,steroid hormones are thought to operate via a 
receptor molecule which is contained within the target cell i.e. steroids 
must enter the target cell, but recently oestradiol receptors have 
been reported on the surface of endometrial cells and hepatocytes 
(Pietras and Szego, 1977, 1979, 1984; Szego, 1984). The remainder 
of this thesis will be confined to the molecular mechanisms of steroid 
hormone action.
1.2 Steroid Hormones
1.2.1 Classes of steroid hormones.
There are six classes of steroid hormones represented by 
oestrogens,progestins, androgens, glucocorticoids, mineralocorticoids 
and the recently included vitamin (cholecalciferol) metabolites 
(Wscksler and Norman, 1980; Pike, 1982).
The sex steroids (Oestrogens,Progestins and Androgens) 
act principally on the reproductive tissues. Reproduction,, however, 
involves a complex inter-relationship between different target organs 
and it seems surprising that such simple chemical compounds can 
produce such diverse effects on both metabolic and behavioural 
patterns.
1.2.2 Steroid structure.
Steroids are relatively small hydrophobic molecules derived
from cholesterol. The strong hydrophobic and therefore lipophilic 
nature of steroids is thought to assist in the diffusion of steroids 
across the cell membrane.
Cholesterol biosynthesis takes place mainly in the liver 
and the intestine. The endocrine glands can therefore use plasma
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cholesterol for synthesis of steroids, however the adrenal cortex, 
ovaries and other endocrine glands have the capacity to synthesise 
cholesterol from acetate. In the testis steroids are synthesised 
exclusively from acetate.
Figure 1 shows the various dehydrogenation reactions 
involved in the production of the final steroid structure. The 
steroid skeleton may be modified by various substitutions such as 
double bonds,hydroxyl or ketone groups, either alone or in 
combination. Biologically active steroids all possess an unsaturated 
A ring. Binding of the steroid to its specific receptor is determined 
by the spatial arrangement of the polar substituents. However, the 
nature of binding is largely non-pol ar due to the mainly non-polar 
structure of the steroid (Liao et al., 1973a). The structure and 
nomenclature of steroids is fully described by Gower (1979).
1.2.3 Oestrogens.
1.2.3.1 Synthesis.
Characteristically oestrogens have an A ring bearing a 
phenolic group in position 3 of the steroid nucleus (Fig.2). Steroidal 
oestrogens are 18 carbon atom compounds with substitutions at various 
positions in the ring structure. In premenopausal women the 
principal form is oestradiol-17/3 which is synthesised from cholesterol 
in the ovary by aromatisatlon, in the granulosa cells, of androgens 
produced by the theca cells-as a result of stimulation by 
gonadotrophins from the anterior pituitary. The ovaries of post­
menopausal women synthesise little oestrogen, the main source of 
oestrogen synthesis being the adrenal glands by the conversion of 
4-androstene-3, 17- dione to oestrone (England et al., 1974; Gower 
and Fotherby, 1975). A similar conversion takes place in the 
peripheral tissues (Siiteri, 1978).
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In males, oestradiol-17^ is synthesised in the Leydig cells 
of the testes and amounts to one fifth of that in non-pregnant 
females (Longcope et al., 1972).
Once released into the blood stream, the activity of 
oestrogen has to be regulated. Consequently,oestradiol is metabolised
to the less active oestrone with which it forms an equilibrium.
Oestrone can be further metabolised to oestriol. Other methods of 
inactivation include, hydroxylation and methylation at C-2, oxidation 
at C-6 and hydroxyl ation of C-ll. These conversions occur mainly in 
the liver, which is also responsible for the conjugation of oestrogens 
with glucuronic acid or sulphuric acid rendering the oestrogens more 
water soluble prior to excretion (see Figure 3).
1.2.3.2 Physiological action.
The principal actions of oestrogens include the following:
(1) The development of the female sex characteristics and 
reproductive organs at puberty such as uterus > vagina and mammary 
glands.
(2) Oaring the proliferative phase of the menstrual cycle, 
oestrogens promote growth and development of the uterine endometrium.
(3) During pregnancy, both the glycogen and actomyosin content
of the myometrium are increased by oestrogens which help in sensitising
the myometrium to the stimulatory actions of oxytocin, perhaps by
2+making available free Ca ions (Lee and Lay cock, 1978).
(4) The proliferation during pregnancy of the mammary duct in
preparation for lactation.
(5) In combination with progesterone, oestrogens are involved 
in the controlled development of the foetus.
(6) Oestrogens regulate the hypothalamus and the anterior 
pituitary glands through positive or negative feedback loops.
Oestrogens also regulate the activity of cortisol and thyroxine binding 
globulin by regulating their synthesis in the liver.
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Figure 2 - Structure of Oestrogens.
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(7) The characteristic deposition of fat observed in females and
calcification of epiphyseal cartilage.
(8 ) Some of the general metabolic effects of oestrogens include
mild retention of water and sodium, lowering the plasma cholesterol 
concentration, and the stimulation of cervical mucosa making the 
mucus thinner and more alkaline for the survival and capacitation of 
spermatozoa.
The elucidation of the mechanism by which the above mentioned 
processes are brought about was greatly assisted when it became 
possible to designate "oestrogen target tissues" as these which 
contained specific oestrogen receptors. It should be noted that not 
all the oestrogenic responses,for example water retention, are 
necessarily mediated by receptor-genome interaction (Tchernitchin, 1979).
1.2.4 Anatomy of the uterus.
The uterus can be functionally divided into two tissues, 
the myometrium and the endometrium. The endometrium is mainly composed 
of epithelial and stromal cells, while the myometrium comprises mostly 
of smooth muscle cells.
The endometrium is firmly attached to the myometrium and 
undergoes cyclic changes in response to ovarian secretory activity.
It is composed of two layers: the lamina basalis and the overlying
lamina functional is.
The glandular epithelium is a single layer of columnar 
cells, forming the lining to glandular structures. These glands 
grow rapidly in length during the normal oestrous cycle (see 
Section 1.2.5) and become distended with secretory material under 
the influence of progesterone (Dallenbach-Hellweg, 1981).
The epithelial cells lining the lumen of the uterus, 
resemble the glandular epithelium. They are very sensitive to
oestrogen stimulation and during the proliferative phase of the
ACETATE
/
CHOLESTEROL
/
PREGNENOLONE
/  \
PROGESTERONE 17a-HYDROXY PREGNENOLONE
ANDROSTENEDIONE
OESTRADIOL —  ^  OESTRONE
OESTRIOL
Figure 3 - Pathways Involved in Oestradiol and Oestrone Synthesis.
(Adapted from Lee and Laycock, 1978).
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oestrous cycle they divide in response to the increasing levels of 
circulating oestradiol.
The endometrial stroma consists of mesenchymal cells.
In the adult, under control of progesterone, endometrial stromal cells 
differentiate into two forms, endometrial granulocytes and predecidual 
cells. These are present in roughly equal proportions (Dallenbach- 
Hellweg, 1981).
A variety of other minor cell types are also occasionally 
found in the endometrium, such as lymphocytes, mast cells, plasma cells 
and eosinophils (Dallenbach-Hellweg, 1981). Increased infiltration of 
eosinophils in response to oestrogen stimulation has some important 
consequences (see Section 1.3.1).
The functionalis layer contains blood vessels which differ 
from vessels of other organs by their unique structure and sensitivity 
to hormones (Dallenbach-Hellweg, 1981). Particularly obvious are 
spiral arterioles which branch extensively. Blood capillaries, 
veins and lymphatic capillaries are all to be found in the endometrium.
It is thought that nerve fibres do not exist in the functionalis layer, 
but may occur in the lamina basalis (Dallenbach-Hellweg, 1981).
The myometrium is a massive coat of smooth muscle surrounding 
the endometrium and is contained within the outer sheath of the uterus 
(the perimetrium). The muscle fibres are separated by connective tissue. 
At least three layers of muscle may be distinguished, but are somewhat 
ill-defined owing to the presence of interconnecting bundles (Schoenberg, 
1977). Within the muscle is a rich network of arteries and veins 
supported by dense connective tissue. During pregnancy, under the 
influence of oestrogen, the myometrium increases greatly in size both by 
cell division and by cell growth (de Brux et al., 1981). At parturition 
(and occasionally at other times) strong contractions of the myometrium
are reinforced by the action of hormones (Sarosi et al., 1983).
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1.2.5 The Oestrous Cycle.
Female sex steroids can regulate their own synthesis via the 
hypo thalamic-pituitary axis (see Johnson and Everett, 1980). 
Consequently, the plasma levels of both oestrogen and progesterone 
change cyclically, giving rise to the oestrous or menstrual cycle 
In non-mated rats, the oestrous cycle is usually 4-5 days duration 
(Johnson and Everett, 1980), in humans the cycle lasts around 28 
days. The cycle coomences with a regenerative phase during which 
the denuded endometrium is re-epithelialised. In the following 
days the dominant feature is cell proliferation with development of 
all the individual structures, leading to an increase in thickness 
of the endometrium. This process is sustained under oestrogen 
stimulation until ovalation. The release of progesterone from the 
corpus luteum, which is formed after ovalation, promotes production 
of copious, thick, glycogen rich secretions by the ’endometrial1 
glands. During the first half of this phase major changes occur in 
the epithelium. Proliferation ceases and the cells engage in 
secretory activity. Spiral arteries and extracellular fibres reach 
their maximal development and predecidual cells and endometrial 
granulocytes appear. The secretory phase continues until progesterone 
levels decline. The decrease in progesterone levels, towards the 
"end" of the cycle, results in the sloughing off of the uterine 
endometrium, with subsequent bleeding in humans (menstruation), but 
not in rats, where reabsorption of the endometrium occurs.
1.2.6 Development of the Concept of Receptors and Target Tissues.
The physiological responses to oestrogens have been
recognised for several years and the biochemical mechanisms by which 
these responses are mediated and regulated are far from understood.
A major advance was made with the assumption that receptors 
were involved in the action of hormones (Hechter and Halkerston, 19 64).
- 12 -
It was assumed that the distribution of receptors determined tissue 
specificity and that the nature of the homrone receptor complex controlled 
the tissue response.
Shortly after an injection of tritium labelled oestradiol 
-17p, , the hormone could be detected in all rat tissues (Jensen and 
Jacobson, 1962) but only target tissues (uterus and vagina) retain and 
concentrate the hormone. It was also demonstrated that the oestradiol 
was retained in an unmetabolised form. Thus, it was proposed that target 
cells contain specific receptors which combine with oestrogen to form a 
complex. These studies were extended by Noteboom and Gorski (1965) 
who reported that the oestrogen receptor is stereo-specific and probably 
a protein. Toft et al. (1967) identified it by sucrose density gradient 
analysis in wholly in vitro experiments. This also confirmed the earlier 
results of Talwar et al. (1964) who had shown separation of a protein 
bound fraction from free tritiated oestradiol using sephadex chromatography. 
Steroid binding molecules have been shown to be heat labile and sensitive 
to proteolytic enzymes confirming their proteinaceous nature (Toft and 
Gorski, 1966).
As detailed investigations were undertaken, it was realised 
that the interaction of oestrogen with uterine cells is not a simple 
association effect. Using autoradiographic and ultracentrifugation 
techniques, radioactive hormone was found to be located in two separate 
regions (Toft and Gorski, 1966; Toft et al., 1967).' The data indicated 
that bound receptor was principally associated with the soluble and 
nuclear fractions. This led to the proposal of a two step model for 
the interaction of oestrogen with the uterus (Jensen et al., 1968;
Gorski et al., 1968). (See Section 1.4.3.7.1).
The general model for the mechanism of action of steroid 
hormones considers that, once inside the cell, the steroid complexes
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with a specific receptor protein. This complex then becomes 
activated and is able to interact with defined sites within the nucleus. 
Binding of receptor complexes at these defined sites leads to the 
specific changes in gene expression characteristic of the steroid in 
question.
Other target tissues identified through retention of labelled 
oestradiol-17/3 were the hypothalamus (Eisenfeld and Axelrod, 1966) 
and the mammary glands (Sander, 1968). Recently reports have been 
published which indicate that in addition to : the abundance of
oestrogen receptor in the target tissues, there are low concentrations 
of high affinity oestrogen receptor in what were previously considered 
non-target tissues. These include the liver (Aten et al., 1978), 
kidney (Li et al., 1974), adrenal glands (Muller and Wotley, 1978) and 
ovary (Richards et al., 1976). In the mammalian liver, for example, 
oestrogen enhances the production of plasma renin substrate, some blood 
clotting factors and some other serum proteins. In the ovary, 
oestrogen receptor may be involved in modulating binding of' follicle 
stimulating hormone and, therefore, corresponding follicular 
development (Gorski and Gannon, 1976).
1.3 Uterotrophic Responses
A single injection of oestradiol into an immature female rat 
stimulates a number of biochemical and metabolic events within the 
uterus. These events are classified into "early" or "late" 
uterotrophic responses (Clark and Peck, 1979).
1.3.1 "Early" Responses.
Early uterotrophic responses include a vast array of events 
which occur within the first 3-4 hr after oestrogen injection and 
they involve the generalised initiation of metabolic and biosynthetic 
mechanisms of the uterus. Examples of these responses include:- 
hyperemia, calcium influx, histamine release,eosinophil .'infiltration,
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increased RNA synthesis, increased uptake of RNA and protein precursors, 
and enhanced glucose oxidation. Some increased biosynthetic activities 
occur as part of the early responses to oestrogen and these are 
exemplified by rises in glucose-6-phosphate dehydrogenase and creatine 
kinase (induced protein) activities brought about by increased 
transcriptional activity induced by oestrogen (Kaye, 1983).
However, some of the early responses such as water inhibition, 
increase in vascular permeability and histamine release are not due to 
effects of oestrogen elicited through the oestrogen receptor system of 
uterine cells. These are thought to be caused by the effects of 
eosinophils which are attracted to the uterus by oestrogen. Eosinophils 
possess their own independent oestrogen receptor system (Tchernitchin, 
1979; Lee, 1982).
1.3.2 ' 'Late'' Responses.
Late uterotrophic responses are associated with cellular 
hypertrophy and hyperplasia of the uterus. These are considered to 
be true growth responses. They represent the culmination'of 
biosynthetic events, and are maximal 24-36 hrs after administration 
of oestrogen. At this time maximal rates of protein synthesis are 
observed, in addition both nucleic acid content and synthesis are 
elevated but the number of receptor/hormone complexes in the nucleus 
has declined to control levels. This suggests that the hormone has 
altered the uterine cells prior to 24 hrs. In fact, the receptor/ 
hormone complex must remain in the nucleus for 6-12 hr to elicit 
these late responses (Clark and Peck, 1976; 1979).
1.4 Mechanism of Steroid Action
1.4.1 Plasma Transport.
Hormones are released into the blood stream by the endocrine 
glands. The sex steroids are then transported in the blood stream
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by sex hormone binding globulin (SHBG), albumin and other plasma proteins 
(Clark and Peck, 1979). These transport proteins have several 
functions:-
(1) to protect the steroids from liver metabolism
(2 ) to overcome their insolubility and
(3) to provide a reservoir of available steroid.
The blood proteins bind steroid with varying affinities and 
the free hormone level determines the amount of steroid available to 
the tissue (Westphal, 1971; 1980).
1.4.2 Entry into cells.
Due to the lipophilic nature of steroid hormones it is 
.believed that their entry into cells is by passive diffusion (Rao, 1981) 
which explains the entry of steroid into target and non-target tissues 
(Jensen and Jacobson, 1962). However the facilitated transport 
mechanism proposed by Milgrom et al.(1973) cannot be ruled out.
Studies ofPietrasand Szego (1977) using affinity chromatography 
have shown the existence of oestrogen binding sites on the surface of 
endometrial and liver cells. Similar findings have been reported by 
others (O'Malley and Means, 1974; Wittliff, 1975). More recently 
Muller et al. (1979), Pietras and Szego (1979) and Szego (1984) have 
shown specific oestrogen binding sites associated with uterine plasma 
membranes, however the orientation of the membranes as assayed must 
be uncertain, and the enzyme digestion involved in the preparation 
of the cells could result in an abnormal distribution of receptors.
The binding sites could also represent steroid metabolising enzymes.
It would appear that the major difficulty in the interpretation 
of results on uptake is the failure to distinguish between binding of 
steroids to receptor and to other proteins.
1.4.3 Steroid Receptor Molecules.
Generally speaking receptor proteins should display high 
affinity saturable binding for a specific hormone or biological class 
of hormones. This specificity enables target cells to respond to a 
hormonal signal without interference from other signals.
Implicit in all studies of macromolecules that bind steroids 
is the assumption that the binding of hormone to putative receptors 
must precede or accompany tissue responses, and the extent of the 
response should relate to some function of receptor occupancy. The 
demonstration of receptor dependent hormonal responses is not often 
met, and is the most difficult to establish. Indeed the role of 
hormone receptors in oestrogen activity has been questioned (Meyers, 
1984).
1.4.3.1 The Oestrogen Receptor.
The oestrogen receptor was first characterised in the immature 
rat uterus by Toft and Gorski (1966) as a protein of molecular weight 
50,000. More recently the calf uterine oestrogen receptor has been 
purified to homogeneity using affinity chromatography (Sica and 
Bresciani, 1979) and shown to have a molecular weight of 70,000.
This compares with 76,200 for the rat uterine receptor (Jensen and 
De Sonibre, 1972) and 50,000 for the receptor from human breast tumour 
cells (Greene et al., 1980).
Recently Sakai and Gorski(1984a) reported a molecular weight 
of 65,000 for the immature rat uterine receptor and also that it is 
possible to reversibly denature the oestrogen receptor protein using 
2.3% SDS. The renatured receptor is similar to the native receptor 
in both affinity for oestradiol-17/3 and ability to bind DNA. The 
renaturation of cytosol and nuclear receptors to forms with properties 
indistinguishable from those of native receptor indicates that the
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protein is not proteolytically processed to a large extent after nuclear 
transformation as has been suggested previously (Puca et al., 1977).
Oestrogen receptor molecules correspond to the "classical" 
type I binding sites reported in both the cytosol and nuclei of target 
tissues and have a dissocation content of 10 for oestradiol in 
human tissue (McGuire and Julian, 1971). The molecules are responsible 
for the changes in transcriptional activity induced by oestrogen in 
target cells (Clark et al., 1978a). A secondary function of these 
molecules is to concentrate oestrogen within target cells (Clark and 
Peck, 1979; Leake, 1981).
Type II cytosolic binding sites have also been reported.
-9They have a lower affinity for oestrogens (Kd 3 x 10 M in humans) 
and have an ill-defined cellular function. They are not involved in 
the changes in transcription produced by oestrogens (Clark et al., 1978a; 
Eriksson et al., 1978). Type II binding sites seem to be a general 
phenomenon and have been found in many different tissues including rat 
uterus (Clark et al., 1978a) chick oviduct (Smith et al., 1979) and 
human breast tumour (Panko et al., 1981).
Type II nuclear binding sites have also been reported (Clark 
and Peck, 1979). The binding is steroid and tissue specific, though 
the affinity for oestrogen is lower than that observed for type I 
nuclear binding sites. Type II nuclear binding sites are in no way 
related to cytosolic type II sites, and the function of these nuclear 
type II sites is still unclear.
Similar type II binding sites have also been reported for 
glucocorticoids (Barlow et al., 1979).
Recently it has become apparent that the calf uterine oestrogen 
receptor is a phosphoprotein. The phosphorylation state of the 
receptor is regulated by a kinase/phosphatase system.
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Calmodulin has been shown to stimulate the phosphorylation 
of the protein (Auricchio et al., 1984; Migliaccio et al., 1984).
It has been reported that the phosphorylation state of the receptor 
regulates the binding of steroid,- steroid binding is greatly enhanced 
when the receptor isphosphorylated (Auricchio et al., 1981; Migliaccio 
and Auricchio, 1981; Migliaccio et al., 1982). The phosphorylated 
residue on the receptor has been shown to be a tyrosine moeity 
(Migliaccio et al., 1984).
Protein phosphorylation/dephosphorylation is a major regulatory 
process of cellular activity and several peptide hormone receptors 
e.g. insulin (Kasuga et al., 1982) and epidermal growth factor (Cohen 
et al., 1980) have also been reported to be phosphoproteins. These 
peptide receptor molecules are also substrates for tyrosine protein 
kinases, a relatively unusual class of kinase.
1.4.3.2 The Progesterone Receptor.
Several lines of evidence support the notion that the native 
structure of the progesterone receptor of chick oviduct is a dimer of 
two dissimilar subunits or higher aggregates thereof (Grody et al.,
1982). The 8S form of the receptor also contains proteins which do 
not bind progesterone (Gasc et al., 1984; Renoir et al., 1984). 
Transformation of this receptor by heat or salt causes a shift in 
sedimentation constant from 6-8S to 4S (Schrader et al., 1975;
Moudgilet_al., 1985). The 4S peak can then be shown using ion 
exchange chromatography to contain equimolar amounts of two dissimilar 
monomeric progesterone binding components. These proteins designated 
A and B possess kinetically identical hormone binding sites, but 
differ in their physical properties (Hansen et al., 1976). In addition 
the two proteins exhibit differential binding affinities for nuclear 
components: protein A binds with high affinity to DNA from a variety
of sources but not to chromatin, whereas B binds with high affinity to 
chromatin from target cells and only weakly to DNA (Vedeckis et al., 
1980). Proteins A and B have been purified to apparent homogeneity 
and found to have molecular weights of 79,000 (Coty et al., 1979) 
and 108,000 (Schrader et al., 1977) respectively. The A and B subunits 
share a common domain of approximately 60,000 daltons (Bimbaumer 
et al., 1983). A similar subunit composition has been proposed for 
the human progesterone receptor (Lessey et al., 1983).
The presence of a dimer containing dissimilar subunits has 
been questioned by studies of the rabbit progesterone receptor and its 
biosynthesis. The protein in non-fractionated uterine cytosol was 
separated using electrophoresis and then transferred to nitrocellulose. 
The nitrocellulose was then probed using monoclonal anti-receptor 
antibodies. This revealed a single 110,000 dal ton protein only when 
protease inhibitors were present during homogenisation. Smaller 
forms of the receptor (79,000 daltons) were present when these 
precautions were not observed (Loosfelt et al., 1984). The 
presence of a single subunit was further confirmed by translation of 
poly (A)+ RNA from rabbit uterus in a reticulocyte lysate. Using 
the monoclonal anti-receptor antibody only a single protein of 
molecular weight 110,000 could be observed. Similar results were 
obtained when the rabbit progesterone receptor was purified by affinity 
chromatography using the anti-receptor monoclonal antibody immobilised 
on a column (Logeat et al., 1985).
These findings realign the progesterone receptor with the 
other receptors (glucocorticoid, oestrogen and androgen) for which 
biochemical or genetic evidence is in favour of a single functional 
subunit.
Both the hen oviduct progesterone receptor subunits have 
been reported to be phosphoproteins (Ghosh-Dastidar et al., 1984).
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The subunits were phosphorylated on tyrosine residues in the presence 
of epidermal growth factor and the epidermal growth factor receptor.
Chick oviduct progesterone receptor has also been shown to be a phosphoprotein 
(Dougherty et al., 1982,1984).
1.4.3.3 The Glucocorticoid Receptor.
Following electrophoresis under denaturing conditions the 
receptor behaves as a single polypeptide chain of molecular weight
85,000-95,000 (Rousseau, 1984). Polyclonal (Carlstedt-Duke et al.,
1982) and monoclonal antibodies raised against the "non-transformed" 
or the "transformed" receptor have allowed one to delineate at least 
three distinct domains on the receptor molecule (Rousseau, 1984).
These domains are:- (1) the steroid binding domain, (2) the DNA binding 
domain and (3) the immunoreactive domain.
The steroid binding domain is responsible for steroid binding, 
little else is known about this domain. Inhibition of steroid 
binding by pyridoxal 5'-phosphate and 12 cyclohexanedione (Di Sorbo 
et al., 1980) may indicate that lysine and arginine residues are 
involved in steroid binding.
The DNA binding domain comprises a portion of the receptor 
that is distinct from but is about the same size as the steroid 
binding domain. Its affinity for DNA is greater than that of the 
holo-receptor (Di Sorbo et al., 1980).. The interaction of the receptor 
with DNA is understood in much greater detail (see Section 1.5.3).
The immunoreactive domain, which is roughly half the size of 
the holo-receptor, can be separated by proteolysis from the steroid 
and DNA binding domains. The latter domains are poorly immunogenic, 
probably because they are highly conserved. The immunoreactive 
domain is required for glucocorticoid activity and has therefore been 
called the specifier domain (Vedeckis, 1983).
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The receptor protein can be considered as the actual mediator 
of glucocorticoid action, while the hormone plays the role of an 
alios ter ic ligand which promotes the ’'transformation" of the receptor 
into its DNA binding conformation. Transformation is thought to 
involve the dissociation of the oligomeric receptor at a rate which 
is temperature-dependent, into monomers that are, by definition, 
endowed with DNA binding activity (Vedeckis, 1983). This is in 
contrast to the formation of the 5S form of the oestrogen receptor which 
is thought to arise through dimerisation of 4S monomers (Notides 
et al., 1981) (see Section 1.4.3.5). The transformation event,which 
was first described in cell free systems,has now been shown to occur in 
intact cells (Munck and Foley, 1980). One consequence of receptor 
transformation is exposure of positive changes on the surface of the 
molecule which thus binds to polyanions, including DNA itself.
The glucocorticoid receptor from rat liver cytosol has also 
been reported to be a phosphoprotein (Houslay and Pratt, 1983; Kurl 
and Jacob, 1984).
It has also been reported that the glucocorticoid receptor 
from rat liver cytosol displays protein kinase activity but no 
autophosphorylation of the glucocorticoid receptor was reported from 
these studies (Singh and Moudgil, 1984). Dephosphorylaticn of the 
receptor may be required for complete transformation to take place 
(Rousseau, 1984).
1.4.3.4 The Androgen Receptor.
The size of the activated androgen receptor depends on the 
tissue studied. Colvard and Wilson (1981) using Dunning prostate 
carcinoma found that an 8S receptor was generated from a 4.5S 
precursor, and have since claimed that the 8S receptor is composed 
of an activated 4.5S receptor and a non-steroid binding protein which
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renders the receptor incapable of binding nuclei (Colvard and Wilson,
1984). Using receptor from normal genital skin fibroblasts, Kovacs 
et al. (1983) showed that activation involved the conversion of a 
large complex (7S in human tissue) to a 3S molecule (in 0.3M KC1 
containing sucrose density gradients) which bound DNA.
Activation of the dihydrotestosterone receptor complex from 
rat prostate causes a decrease in the sedimentation rate from 3.8S to
3.05 (Liao, 1975). The 3S form of the receptor is believed to be the 
nuclear form which interacts with chromatin, inducing specific changes 
in gene transcription. Recently the androgen .receptor has been 
purified from steer seminal vesicles and shown to have a molecular 
weight of 60,000-70,000 (Chang et al., 1982). After purification 
the rat ventral prostate androgen receptor (Chang et al., 1983;
Goueli et al., 1984) was shown to have a molecular weight of
85,000-87,000. The differences reported here would be due to 
proteolysis of the receptor during preparation or may represent a 
true species difference.
Target tissues for androgens are unique in that they 
metabolise the naturally occurring androgen,testosterone to 5 ©c 
dihydrotestosterone which is the physiologically active form. The 
enzyme involved is 5ot reductase. No such activation of other 
steroid ligands is known to occur.
1.4.3.5 Activation of Steroid Hormone Receptors.
At present there is disagreement over the actual site of 
activation. The cytosol (Jensen and De Sombre, 1972; O’Malley 
and Means, 1974) has been proposed which agrees with the classical 
two step model of steroid hormone action (see Section 1.4.3.7.1).
More recently both the cytoplasm and nucleus (Linkie and Siiteri,
1978; Linkie, 1982) have been proposed, which is in agreement with
the equilibrium model of Martin and Sheridan (1982) (see Section 1.4.3.7.2).
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The nuclear model (see Section 1.4.3.7.3) suggests activation is a 
nuclear event although the recovery of oestrogen receptor in membrane 
fractions of cell homogenates (Szego, 1984) offers yet another possible 
site of activation to be considered.
All steroid receptors, including Vitamin (Brumbaugh and 
Hanssler, 1974) show a temperature dependent activation step which 
gives the receptor an increased affinity for nuclei, DNA, chromatin 
and other polyanions (Toft, 1972; Buller et al., 1975; Muller and 
Toft, 1978). Most investigators have found the change to be also 
dependent on changes in salt concentration or dilution. For some 
receptors e.g. the oestrogen receptor, activation is associated with 
major changes in molecular weight quaternary structure, sedimentation 
properties and other easily detectable physical parameters. This 
has become known as receptor transformation. Activation of oestrogen 
receptor also results in an increased affinity of interaction between 
the receptor and oestradiol.
Originally Williams and Gorski (1971) reported that activation 
was temperature sensitive. More recently Pavlick et al. (1979) and 
Traish et al. (1979) have reported activation at low temperature, 
although the rate of formation of active receptor remains temperature 
dependent.
The available or empty oestrogen receptor has been shown to 
sediment on a low ionic strength sucrose density gradient at around 
8S. However the in vivo significance of this 8S receptor form has 
been questioned recently (King, 1984) and it may represent an in vitro 
artefact. The 8S form of the receptor can be dissociated into 4S 
monomers by centrifugation in ionic strengths greater than 0.2M KC1 
(Korenman and Rao, 1968).
The process of activation of the oestrogen receptor from rat 
uterus was shown (Notides and Nielsen, 1974, 1975) to be accompanied 
by an increase in sedimentation constant (in 0.4M KC1) from 4S to 5S. 
The 4S to 5S conversion follows second order kinetics and the 5S 
complex is assumed to be a dimer of a modified form of the native 4S 
receptor (Little et al., 1975; Notides et al., 1975, 1981). A 
similar change in sedimentation constant has been shown to accompany 
activation in other species, although, for example in human breast 
tumour it can only be demonstrated under very exacting conditions 
(Hyder and Leake, 1982).
Arginyl residues are thought to play a role in oestrogen 
receptor activation and transformation.Muller et al. (1983\^ )propose 
that the nuclear binding site of the oestrogen receptor contains 
important arginyl residues and that the integrity of a distinct set 
of arginyl residues in the oestrogen binding domain is required for 
the heat induced formation and maintenance of the receptor state with 
slow oestradiol dissociation. Dimerisation of the receptor subunits 
does not involve arginyl residues. Sulphydral groups are also thought 
to play an important role in the binding of oestradiol (Jensen et al., 
1967; Muldoon, 1971).
In the case of the calf uterine oestrogen receptor (Muller 
et al., 1985) and the immature rat uterine receptor (Sakai and Gorski, 
1984) it has been reported that the heat induced acquisition of the 
high affinity state for oestradiol does not require 4S to 5S 
dimerisation. These findings suggest that the 4S monomers exist in 
equilibrium between low affinity and high affinity conformations. 
Oestradiol binding to the low affinity state causes conformational 
changes which result in stronger interactions between the steroid and 
the amino acid residues of the oestrogen binding domains, thus the
rate of oestradiol dissociation decreases. The formation of this
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4S state with higher affinity for oestradiol is independent from receptor 
dimerisation. Dimerisation of the high affinity receptor may shift the 
equilibrium to greatly favour the high affinity state.
These data may confirm earlier observations that oestrogen 
receptor activation is an independent process from transformation 
(Bailly et al., 1980; Gschwendt and Kittstein, 1980) and that 
activation precedes, and is not related to transformation (Muller 
et al., 1983).
The use of pyridoxal phosphate in the study of the 
dissociation of oestradiol from activated and activated/transformed 
oestrogen receptor has suggested that lysine residues in the oestrogen 
binding domain are important in oestradiol binding. Increased 
oestradiol dissociation from the receptor in the presence of pyridoxal 
phosphate is due to alteration of these lysine residues and not disruption 
of dimers into monomers (Traish et al., 1980; Muldoon et al., 1980;
Muller et al., 1985). The effects of pyridoxal phosphate on oestrogen 
receptor are reversible by the addition of agents that cause transschiffation 
(Muller et al~., 1980).
Apart from oestrogen, activation of other steroid hormone 
receptor complexes does not involve an increase in sedimentation 
constant. Indeed, activation of the dihydrotestosterone complex of 
rat prostate causes a decrease in sedimentation rate from 3.8S to
3.OS (Liao, 1975). Similar decreases have been reported for the 
progesterone receptor complexes of hamster (Chen and Levitt, 1979), 
guinea pig and rabbit uterus (Saffron et al., 1976). Progesterone- 
receptor complex of chick oviduct shows no change in sedimentation 
rate after activation (Buller et al., 1975), a situation which is 
usually reflected in studies of activation of the other steroid- 
receptor complexes. It is impossible to say that dimerisation does 
not occur for all complexes during activation. Such dimers could
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dissociate during the process of extraction and sedimentation.
Equally there is much evidence that specific proteases can be closely 
associated with receptor, even during extraction, and that these 
proteases can directly reverse polymerisation of receptor (Gregory 
and Notides, 1982).
1.4.3.6 Inhibition of Activation.
The involvement of a low molecular weight inhibitor of 
activation has been reported by several groups. Sato et al., (1978a,b, 
1979) have reported such an inhibitor for the oestrogen receptor in 
rat uterus and mouse Leydig cell tumours. Dialysis was found to 
increase the nuclear binding activity of oestrogen receptor. The rat 
liver glucocorticoid receptor complex has a similar inhibitor (Goidl et al., 
1977). Low molecular weight inhibitors do seem to be a common feature 
for steroid receptors (Bailly et al., 1977; Shyr and Liao, 1978;
Sato et al., 1979). Fishman (1981) has shown that electrolysis of rat 
uterus resulted in a marked increase in nuclear binding steroid 
receptor - a result attributed to removal of an inhibitor.
In contrast to low molecular weight inhibitors of activation, 
low molecular weight inhibitors of DNA or chromatin binding have also 
been reported (Cake et al., 1978).
Pyridoxal-5' -phosphate has been suggested as one such inhibitor 
(Nishigori and Toft, 1979; Muldoon and Cildowski, 1980). These 
factors seem to modulate the binding of activated receptor to chromatin 
and have been shown to be physiologically important (Disorbo et al., 1980). 
Recently pyridoxal 5'-phosphate has been shown to activate receptor but 
block subsequent DNA binding (Sekula et al., 1982). A class of 
macromolecular inhibitors may also regulate the binding of activated 
receptor to nuclei, DNA or chromatin (Milgrom and Atger, 1975; Lin and 
Webb, 1977; Atger and Milgrom, 1978).
Sodium molybdate has been found to inhibit the process of 
activation as measured by DNA binding in the case of the oestrogen
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receptor (Pettersson et al., 1982; Lukola and Punnonen, 1983;
Miller et al., 1983), progesterone receptor (Nishigori and Toft, 1980;
Weigel et al., 1981; Chang-Ren et al., 1983; Lukola and Punnonen,
1983; Moudgil et al., 1985). Androgen receptor (Tsai and Steinberger,
1982) and glucocorticoid receptor (Norris and Kohler, 1983; Sherman 
et al., 1983). The ability of molybdate to inhibit DNA binding is 
much less for the androgen receptor than that seen for oestrogen and 
progesterone receptor.
The mechanism by which molybdate inhibits the DNA binding 
ability of the oestrogen receptor has been the subject of great debate
(Grody et al., 1982; Gshwendt and Kittstein, 1983). Molybdate may
stabilise the 8S form of the receptor (Grody et al., 1980; Muller 
et al., 1982; Muller et al., 1983c0or it may inhibit the action of a 
phosphatase (Barnett et al♦, 1980; Leach et al., 1980; Nishigori and 
Toft, 1980; Ruh and Ruh, 1984) or RNase and protease (Chang and Lippman 
1981-82) whose activities are essential for DNA binding, or it may bind 
directly to the DNA binding site of the receptor (Lukola and Punnonen,
1983) or even stimulate a membrane bound guanylate cyclase (Fleming et al.,
1983). Although molybdate inhibits DNA binding by receptor from rat 
uteri it stimulates DNA binding by rabbit oestrogen receptor. When 
oestrogen receptors from different breast tumours were studied both types 
of response were observed though the majority of samples did show 
inhibition of DNA binding activity (Thomas et al., 1983). The
tissues which showed strong inhibition of DNA binding activity also 
contained a minor class of receptors which were still capable of being 
activated by heating in the presence of molybdate (Thomas et al., 1983).
In the case of the calf uterine oestrogen receptor two forms 
of the molybdate stabilised receptor can be resolved using ion-exchange 
chromatography (Ruh and Ruh, 1984). Evidence suggests that there is
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an equilibrium between the two forms of the molybdate stabilised 
receptor.
These findings, especially those of Thomas et al. (1983) 
leave the precise effects of molybdate on the activation of oestrogen 
receptor still unresolved.
Other less commonly used inhibitors of the activation process 
are discussed by Grody et al. (1982).
1.4.3.7 Models of Steroid Hormone Action.
1.4.3.7.1 The Classical Model.
The classical "two-step" model of steroid hormone action was
proposed simultaneously by Gorski and Jensen in 1968 (Gorski et al.,
1968; Jensen et al., 1968). It was formed largely from the
3
measurement of the distribution of specifically bound H-oestradiol 
in the nuclear and soluble fractions of homogenised tissues. The 
tissues of animals having low endogeneous oestrogen levels (i.e. 
ovariectomisedor immature animals) contained most of the available 
or empty receptor in the cytosol - the soluble portion of the cell 
homogenate remaining after high speed centrifugation. However after 
exposure to steroid in vivo, most of the hormone receptor complex 
could be recovered in the nuclear fraction, although 10-15% of total 
bound steroid always remained in the cytosol (Williams and Gorski,
1972). Very little unoccupied receptor was found in the nuclear 
fraction (Shyamala and Gorski, 1969).
Autoradiographic evidence was interpreted as supporting 
proposals that receptor with bound ligand was found in the nuclear 
fraction with available or empty receptor being found in the cytosol 
(Stumpf, 1968). Even in a cell free system, hormone receptor complexes 
acquire a high affinity for nuclei when incubated at 37°C but remain 
in the cytosol when incubated at 2°C (Jensen et al., 1968).
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The overall ideas of this model were that:- (1) after entry 
into the target cell, the steroid was complexed with an "extra-nuclear" 
receptor, (2) this receptor was then "activated" (see Section 1.4.3.5) 
after which it transferred the steroid to the nuclear compartment,so 
called translocation, (3) subsequent nuclear binding of the receptor 
complex resulted in altered gene transcription.
The formal proposals of this model were widely accepted.
1.4.3.7.2 The Equilibrium Model.
Implicit in the "two-step" model is that unoccupied receptor 
should not be found in the nucleus - receptor should only be retained 
in the nucleus after it has bound steroid and then become activated. 
Unoccupied nuclear receptors have been reported in human mammary 
tumours (Zava and McGuire, 1977; Panko and McLeod, 1978), normal 
and malignant human endometrium (Fleming and Gurpide, 1980; Levy 
et al. , 1980), hen liver (Mester and Banhen, 1972), rat hypothalmus 
(White and Lin, 1980) and the rat uterus (Thrower et al., 1981).
Sheridan et al. (1979) showed by using autoradiography, 
that even at 0°C, extensive nuclear localisation of specifically 
bound oestradiol occurred within 5 minutes. These data were in 
conflict with earlier work of Stumpf (1968) but were claimed to be more 
realistic due to the advance in methodology which had occurred in 
the intervening years CLe the thaw mount technique).
In another study (Martin and Sheridan, 1980), nuclei were 
prepared by an aqueous and a non-aqueous method. The aqueous method 
involved preparation of nuclei in normal Tris or phosphate buffers, 
both containing 10% glycerol and 0 .01% monothioglycerol, whereas the 
non-aqueous method involved preparation of nuclei in 100% glycerol.
When aqueous methods were used, the proportion of receptor recovered 
in the nuclear fraction depended on the volume of buffer used for
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homogenisation. However, when non-aqueous methods were used, the 
majority of the unoccupied receptor was recovered in the nuclear 
fraction.
The study was expanded to progesterone receptor in the rat 
uterus (Sheridan et al., 1981) and, by using the thaw mount auto­
radiography technique, they showed that localisation of steroid was 
nuclear. In complete contrast when the tissue was processed by 
standard aqueous techniques the receptor was recovered mainly in the 
cytosolic fraction.
As a result of these studies, Martin and Sheridan (1982) 
have proposed that, in the intact cell, unbound steroid receptors 
are in equilibrium, partitioned between the nucleus and the cytoplasm 
according to the free water content of each compartment.
The initial idea of such an equilibrium based on the free 
water content of each compartment was developed by Horwitz and Moore 
(1974) from studies on the movement of radioactively labelled inert 
macromolecules in the frog oocyte which revealed that macromolecules 
concentrated in the nucleus because it represented a "water rich" 
environment when compared to the cytoplasm. DNA polymerase has been 
shown to leak out of the nucleus as is proposed for steroid receptors 
when the water content of the cellular compartments is changed 
during homogenisation (Forster and Gumby, 1976).
Further support for nuclear origin of receptors came from 
Linkie and Siiteri (1978) studying the time course of oestrogen receptor 
activation in the immature rat uterus. They performed a careful 
analysis of the nuclear forms of the receptor over a 2 hour period 
after the first exposure to oestrogen. As expected of a mechanism in 
which 4S to 5S conversion is a pre-requisite of nuclear binding,
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the amount of 5S form recovered from the nuclear pellet increased from 
0-40 minutes - but they could also detect 4S receptor in their nuclear 
pellet at all the time points. This was not casual contamination since 
it was maintained at about 0.18 pmol/uterus throught the first 40 
minutes of the time course. At the same time the 5S:4S ratio rose 
from 0 to 6.41. This led the authors to suggest that the process of 
activation takes place in the nucleus and may require the presence 
of DNA as suggested by Yamamoto and Alberts (1972). Similar nuclear 
conversion of 4S to 5S oestrogen receptor has now been shown in other 
rat tissues and in other species (Linkie, 1982).
The concept that a specific high affinity cytoplasmic receptor 
as such, has little if any role to play in steroid hormone action, has 
gained popularity because of several experiments in addition to the 
above. Pietras and Szego (1979) showed that the use of hypotonic 
buffers for all cell homogenisation led to cytosol receptors but if 
0.25M sucrose was included in the buffers, the majority of unoccupied 
receptor was recovered in the particulate fraction. This suggests 
that in vivo receptor may be attached loosely or otherwise to membrane 
components of the cell.
1.4.3.7.3 The Nuclear Model.
The specific suggestion that unoccupied steroid hormone 
receptors may be associated permanently with nuclear structures came from 
studies on the structure and function of the nuclear matrix. Specific 
high affinity binding sites for oestrogens and androgens were detected 
in the nuclear matrix of rat uterus, chicken liver and rat prostate 
(Barrack et al., 1977; . Agutter and Birchall, 1979; Barrack 
and Coffey, 1980).
The nuclear matrix contains many DNA tight-binding proteins 
(Berezney and Coffey, 1977) and these proteins show a preference
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for single stranded DNA and AT-rich DNA (Comings and Wallack, 1978), 
properties which have been demonstrated for steroid receptors 
(Hughes et al., 1981; Payvar et al., 1981; Compton et al., 1983; 
Sluyser, 1983). Thus the nuclear matrix would provide an ideal 
binding site for steroid receptors and would assist in the interaction 
of filled, activated receptor with specific parts of the genome.
1.4.3.7.3.1 Studies using Monoclonal Antibodies.
Although polyclonal antibodies have been raised to various 
oestrogen binding protein preparations, specificity for a single 
oestrogen binding protein has been achieved in only a few cases 
(e.g. Raam et al., 1982). Given the impure nature of many receptor 
preparations, and the general ability of steroid binding receptor 
subunits to react non-specifically with a wide range of macromolecules 
(Clark and Peck, 1979) studies of specificity must be rigorously 
carried out.
The development of monoclonal antibodies to steroid receptors 
has given another tool with which to probe the intracellular 
distribution of receptor. King and Greene (1984) have recently 
developed five monoclonal antibodies each of which recognises a 
sequence on one or other part of the MCF-7 cell line oestrogen 
receptor. These antibodies have been used to localise oestrogen 
receptor by an indirect immunoperoxidase technique in frozen fixed 
sections of human breast tumour, human and rabbit uterus and in fixed 
MCF-7 cell cultures. In target cells not exposed to oestrogen, 
oestrogen receptor is localised predominantly in the nucleus.
Following short term treatment of animals or cells with physiological 
levels of oestradiol, little or no increase in nuclear staining occurs 
in either immature or ovariectomised rabbit uteri or MCF-7 cells 
indicating that empty oestrogen receptors are normally associated 
with the nucleus in the intact cell. The nuclear staining observed
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in each case fulfilled all the accepted criteria for specificity 
(Childs, 1983; 'Petrusz5 1983). Specific nuclear staining was 
either absent or limited to a very few cells in biochemically- 
determined, receptor poor breast tumours, and was completely absent in 
non-target tissues such as colon epithelium. The rabbits used in 
this study were immature and 70-95% of the empty receptors were 
recovered in the cytosol after cell fractionation, despite their 
apparent nuclear localisation in the intact cell suggesting that 
cytosolic receptor represents an artefact of tissue disruption.
This data suggests that,in the intact cell, empty receptor 
is loosely attached to some component of the nucleus and that after 
steroid binding and activation, it merely acquires a higher affinity 
for the chromatin/DNA.
Data indicating a similar situation exists for the 
progesterone receptor have been presented by Gasc et al. (1984); 
Renoir and Mester (1984) and Perrot-Applomet et al. (1985).
1.4.3.7.3.2 Enucleation of cultured cells.
Using very different techniques, Welshons et al. (1984) 
have produced data which points to the same conclusions reached by 
King and Greene (1984). Using cytochaiasin b induced enucleation of 
rat pituitary GH3 cells to obtain cy topi as t and nucleoplast fractions, 
they have shown minimal empty receptor within the cytoplast and 
quantitative recovery with the nucleoplast fraction. The total 
recovery of protein, DNA and oestrogen receptor was always close to 
100%, yet the receptor content of cytoplasts was only 5-10% of that 
in whole cells.
These results also strongly support the nuclear localisation 
of oestrogen in intact GH3 cells, but the generality of the findings 
from this cell line remains to be assessed in other systems using the 
same techniques.
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These studies and the studies using monoclonal antibodies 
suggest that cytosolic receptor and the translocation hypothesis are 
probably artefacts due to cell fractionation methodology.
1.4.3.7.4 Cooperativity of Oestrogen Binding.
There is evidence to show that the "experimentally" soluble 
oestrogen receptor shows cooperative binding of oestrogen but only 
when the receptor concentration is InM or greater (Notides et al.,
1981; Muller et al., 1984; Sakai and Gorski, 1984b). However when 
solubilised monomeric receptor (4S soluble in 0.4M KC1) is immobilised 
by binding to hydroxylapatite, subsequent oestrogen binding is not 
cooperative, regardless of the receptor concentration (Muller et al., 
1984; Sakai and Gorski, 1984b). Like the soluble receptor, 
the immobilised monomeric receptor can be activated as measured by 
the kinetics of oestrogen dissociation. Other receptor characteristics 
appeared unchanged indicating retention of function criteria.
In the intact target cell, the concentration of oestrogen 
receptor is estimated to be lOnM (Clark and Peck, 1979), which 
is 10 times the concentration necessary for solubilised monomeric 
receptor to show cooperativity. Similar to immobilised receptor, 
the binding of oestrogen, as well as the response to oestrogen in 
target cells or tissues is non-cooperative (Williams and Gorski, 1972; 
Katzenellenbogen and Gorski, 1975; Kassis et al., 1984). These 
observations, although indirect, are consistent with the hypothesis 
that unoccupied receptor in addition to the activated receptor may­
be immobilised in vivo by binding to some nuclear or membrane component 
(Gorski et al., 1984). However activated receptor clearly has a much 
greater affinity for nuclear material as indicated by the higher 
salt concentrations required to extract activated receptor from target 
cell nuclei.
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1.4.3.7.5 A New Model for Steroid Receptor Action.
The recent findings suggesting’that steroid receptors may be 
located in the nucleus require that the accepted model of steroid 
receptor action must be slightly modified.
gradient. It may be helped into the cell and/or stored in association 
with the type II soluble receptor sites - assuming that they are 
genuine soluble proteins. Free steroid then comes into contact 
with empty high affinity cellular receptor which is loosely attached 
to the nucleus. The binding of steroid causes activation which is 
manifest in acquisition of a high affinity for specific nucleotide 
sequences, located in or close to AT-rich sequences. The kinetics
iding of the activated receptor to specific sites in the chromatin
ill be aided by one or more non-histone chromosomal proteins.
1^4.3.8 Modulation of Oestrogen Receptor Levels.
The'oestrogenic response within target cells is dependent on 
a minimum level of oestrogen receptor. Oestrogen responsive cells 
in a castrate or immature rat maintain sufficient levels of receptor 
to enable responses to be elicited. The basal level of receptor is 
probably controlled by genetic mechanisms that are programmed for the 
constitutive synthesis of "soluble" oestrogen receptor (Clark and Peck, 
1979; Kassis and Gorski, 1983). However steroids can have a 
profound effect of oestrogen receptor levels, over and above the 
basal levels. It is possible that two genes coding for the oestrogen 
receptor exist, one of these is constitutively expressed, the other 
being sensitive to steroid hormones.
receptor levels has emerged from studies on the immature or castrate 
rat uterus. After injection of oestrogen there is a dose dependent 
depletion of "soluble" oestrogen receptors, with a concomitant
Steroid still diffuses into the cell down a concentration
A general picture of the modulation of cellular oestrogen
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increase in nuclear receptors. This is followed by a gradual rise in
unfilled "soluble" receptors (replenishment) which reach control
levels by 11-16 hr, and then continue to increase or overshoot control levels
(Clark and Peck, 1979). Receptor replenishment is necessary in
rendering a tissue responsive to subsequent oestrogen administration
and is therefore an important element in target organ function
(Kassis and Gorski, 1983).
Replenishment after a single injection of oestradiol-17 p 
is due to both recycling and resynthesis of receptor (Kassis and 
Gorski, 1983). However, replenishment of "soluble" unoccupied 
receptor lags behind nuclear receptor loss, and thus total receptor 
content is decreased 2-6 hr after oestradiol injection (Mester and 
BauLieu, 1975; Zava et al., 1976; Kassis and Gorski, 1981). This 
loss of receptor has been termed "processing" and, has been reported 
to occur both in vitro and in vivo. Processing refers to the loss 
of detectable binding of steroid and therefore may not be due to 
loss of receptor protein, but rather a change in binding properties 
of the receptor. Oestrogen receptor processing has been extensively 
studied in the MCF-7 breast cancer cell line in which processing 
appears to both correlate with, and be essential for induction of 
the progesterone receptor (Edwards et al., 1979; Kassis and Gorski,
1983).
In the rat uterus, oestrogen receptor processing also occurs, 
but many studies using short acting oestrogens such as oestradiol-16t?C 
have concluded that processing is not a prerequisite for some 
oestrogenic responses. Short acting oestrogens stimulate early 
oestrogenic responses (e.g. water inhibition, which is not a receptor 
mediated event and induced protein synthesis, which is a receptor 
mediated event) but not long.term responses (DNA synthesis) (Clark 
et al., 1977). These responses depend on recycling though it is
possible that "replenishment" of available receptor involves the 
production of functional receptor from a pool of inactive receptor 
precursors. These observations have led some authors to conclude 
that receptor processing in uterine cells need not be directly 
involved in the oestrogen response pathway but may have some 
alternative function (Kassis and Gorski, 1983).
Inhibitor studies suggest that progesterone may induce 
the synthesis of an oestrogen receptor regulatory factor which causes 
a rapid loss of occupied nuclear receptor (Evans and Leavitt, 1980; 
Evans et al., 1980). It has been suggested that this rapid loss of 
receptor may occur through a dephosphorylation-inactivaticn mechanism. 
Auricchio et al. (1981) have also suggested that the receptor is 
processed or inactivated by dephosphorylation in the nucleus, then 
reactivated by phosphorylation. Whether these in vitro activities 
are equivalent to processing and reversal of processing in the cell 
remains to be proven. These ideas suggest that receptor processing 
is due to inactivation rather than degradation. However, it has been 
reported Cidlowski and Muldoon (1976) that cycloheximide can block 
receptor replenishment, suggesting that protein synthesis may be 
required. It is possible however that it is the synthesis of a factor 
required to "activate" inactive receptor which is blocked. Data 
produced from such studies are difficult to interpret because of the 
highly toxic nature of the metabolic inhibitors used.
Anti-oestrogens cause prolonged retention of nuclear receptor 
and delay replenishment. It has been proposed that anti-oestrogens 
delay replenishment by interfering with recycling of the oestrogen 
receptor and Migliaccioand Auricchio (1981) have shown in their 
in vitro system that the anti-oestrogen/oestrogen receptor complexes 
are not inactivated.
These observations have led Kassis and Gorski (1983) to 
propose a model for receptor replenishment, which is based on the 
assumption that three forms of the oestrogen receptor exist. These 
are: -
(1) A form with high affinity for steroid, which is 
functionally activated by binding steroid.
(2) A form with low affinity for steroid which is 
functionally inactive.
(3) An "activated" form of the receptor which has a 
high affinity for steroid and an increased 
affinity for DNA, chromatin proteins, nuclei etc.
1.4.3.9 Hormonal Control of Oestrogen and Progesterone Receptor Levels.
Treatment of rat uterus with oestradiol results in the 
induction of oestrogen receptors. This is considered to be a marker 
of oestrogen action (Clark and Peck, 1979). Oestrogen also induces 
increased levels of "soluble" progesterone receptor in uterine cells 
(Clark and Peck, 1979). Increased cellular progesterone receptor 
levels confer increased sensitivity of target cells to progesterone 
(Clark and Peck, 1979). Furthermore, an established effect of 
progesterone is to decrease cellular levels of both oestrogen and 
progesterone receptors (Clark and Peck, 1979). Thus oestradiol and 
progesterone have antagonistic effects on the cellular levels of both 
their receptors. The modulation of progesterone receptor levels 
during the oestrous cycle is a major factor in the functional state 
of differentiation of uterine cells (Clark and Peck, 1979). Induction 
of progesterone receptor represents one of the few specific markers of 
oestrogen action, which can be used to distinguish oestrogen 
stimulation from the effects of other hormones.
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1.4.3.10 Anti-Oestrogens.
Anti-oestrogens are typically non-steroidal compounds which 
prevent oestrogens from expressing their full effects on oestrogen 
target tissues. As such they antagonise a variety of oestrogen 
dependent processes, including uterine growth and growth of oestrogen 
dependent mammary tumours (Katzenellenbogen et al., 1979). Examples 
of these compounds are Nafoxidine and Tamoxifen. In vivo tamoxifen 
is metabolised to the more active derivative 4-hydroxytamoxifen, 
which is thought to be the physiologically active form though several 
other metabolites are under investigation.
The properties of anti-oestrogens show a wide species 
variation. In the rat uterus these compounds are partial oestrogen 
agonists - partial antagonists. The uterus is a complex organ 
containing several groups of functionally different'cells, and these 
different cell populations show different responses to anti-oestrogens 
(Clark et al., 1978b; Jordan and Dix, 1979; Dix and Jordan, 1980; 
Martin, 1981). Most studies in the rat indicate that whilst anti- 
oestrogens can increase the overall DNA content of the uterus, the 
luminal epithelial’cells undergo prolonged hypertrophy but not 
hyperplasia. The situation in the oestrogen withdrawn chick oviduct 
appears to be less complex with anti-oestrogens demonstrating only 
.oestrogen antagonism (Sutherland, 1981; Mester et al., 1981). In 
the mouse, tamoxifen is fully oestrogenic (Lee, 1974).
1.4.3.10.1 Mechanism of Action of Anti-Oestrogens.
Conceivably the antagonistic action of an anti-oestrogen 
could take place at any of the stages of oestrogen interaction with 
the receptor mechanisms of target cells or at hypothetical control 
points post receptor action.
Much of the evidence available suggests that anti-oestrogens 
act at three main points:- (1) they compete for available receptor;
(2) they appear to alter the association of the receptor ligand 
complex and the nuclear binding sites; and (3) they interfere with the 
regeneration of "soluble" receptor.
Generally speaking anti-oestrogens have a lower affinity for the 
oestrogen receptor than oestradiol but, the active metabolite- 4- 
hydroxytamoxifen has an affinity for the receptor which is comparable 
to that of oestradiol (Borgna and Rochefort, 1981; Fabian et al., 1981).
Studies on the binding of anti-oestrogens/oestrogens to the 
oestrogen receptor have shown that anti-oestrogens bind directly to the 
"soluble" receptor with the binding of oestrogen and anti-oestrogen 
being mutally competitive, indicating that the agonist and antagonist 
bind to the same site or closely interacting sites. The rates of 
association of agonists and antagonists are similar while the rates of 
dissociation may be slower e.g. 4-hydroxytamoxifenjor faster e.g. 
tamoxifen than oestradiol, leading to dissociation constants for the 
oestrogen receptor which are greater or less than that for oestradiol 
(Capony and Rochefort, 1978; Katzene1lenbogen et al., 1978; Borgna 
and Rochefort, 1980; Mester et al., 1981). It appears likely that 
there are few differences between oestrogens and anti-oestrogens 
in their kinetic interaction with soluble oestrogen receptor. However 
differences in the physicochemical characteristics of the molybdate 
stabilised oestrogen receptor when bound by oestrogen and anti-oestrogen 
have been reported (Ruh et al., 1983; Keene et al., 1984).
Previously two forms of the molybdate stabilised calf uterine oestrogen 
receptor had been reported which could be separated by DEAE-sephadex 
chromatography. When the molybdate stabilised oestrogen receptor
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was labelled with the high affinity anti-oestrogen H1285, only one of 
these forms was present. This suggests the initial interaction of 
anti-oestrogen with the molybdate stabilised receptor may be different 
from that of oestradiol.
Several recent studies indicate tht the high affinity 
anti-oestrogenic ligands 4-hydroxytamoxifen and Cl 628M can activate 
the oestrogen receptor as assessed by standard criteria (Katzenellenbogen 
et al., 1981; Mester et al., 1981; Rochefort and Borgna, 1981).
However there is lack of agreement on the affect of "heat activation" 
on the dissociation kinetics of anti-oestrogen/oestrogen receptor 
complexes. Rochefort and Borgna (1981) found that activation by 
heating decreased the dissociation rate for oestradiol but not that 
of 4-hydroxytamoxifen, whilst Katzenellenbogen et al. (1981) found 
that similar activation produced a decreased rate of dissociation 
for both oestradiol and Cl 628M under similar conditions. This could 
of course be a difference in the behaviour of the two anti-oestrogens.
After injection of anti-oestrogen into immature rat, the 
anti-oestrogen/oestrogen receptor complex is retained in the nucleus 
for a much longer period of time than oestradiol/oestrogen receptor 
complex. This prolonged retention results in reduced replenishment 
of "soluble" receptors hence the "soluble" receptor levels are 
depleted for a longer period of time (Rochefort and Capony, 1972;
Clark et al., 1973; Katzenellenbogen et al., 1979). During this period 
of depleted "soluble" receptor, the uterus is incapable of responding 
to oestradiol, as monitored by synthesis of the oestrogen induced 
protein or by uterine weight gain (Katzenellenbogen and Ferguson,
1975). Such data led Clark et al. (1974) to postulate that oestrogen 
antagonism was primarily due to inhibition of "soluble" receptor 
replenishment. However depletion of "soluble" receptor levels and
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apparent lack of replenishment are not confined to antagonists, but can 
be induced by high doses of synthetic oestrogens that give full 
uterotrophic responses (Katzenellenbogen et al., 1977; Jordan et al., 
1978). This and subsequent work by Clark et al. (1978b)make it seem 
likely that receptor replenishment is impaired in anti-oestrogen 
treated rats and chicks, probably as a result of the inability of the 
nuclear anti-oestrogen receptor complex to fully stimulate synthesis 
of new oestrogen receptor.
Differences in the binding of anti-oestrogen and oestrogen 
receptor complexes to chromatin have been reported. Baudendistal 
and Ruh (1976) showed that anti-oestrogen receptor complexes were 
completely extractable with 0.3M KC1 or 50mM spermine, whereas 
oestradiol receptor complexes demonstrate a salt resistant form. 
Differential extraction of oestradiol and anti-oestrogen receptor 
complexes was also reported using actinomycin D or ethidium bromide.
The salt resistant receptor complex was assumed to be bound at a 
limited number of "acceptor" sites, binding at which was a requisite 
for true uterine growth (Clark and Peck, 1976). Anti-oestrogens 
were considered not to induce this type of binding, this did not give 
true uterine growth. However, the cis isomer of clomiphene which 
is capable of eliciting a full uterotrophic response (Jordan et al.,
1981) is unable to form salt resistant nuclear receptor sites 
(Ruh and Baudendistal, 1977) shedding doubt on the significance of 
salt resistant sites in mediating oestrogen action.
The binding of ^H-oestradiol and ^H-H1285 (a high affinity 
anti-oestrogen) receptor complexes to rabbit uterine chromatin has 
been studied by Singh et al. (1984). They report enhanced binding 
of "oestrogen" receptor complexes to chromatin binding sites exposed 
by various guanidine hydrochloride concentrations. The binding of
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"anti-oestrogen" receptor complexes to these sites was markedly decreased 
as was the affinity of the interaction. Thus the differences in the 
physiological and physiochemical properties of oestrogens and anti- 
oestrogens may be related to their differential interaction with uterine 
chromatin subfractions.
In more sophisticated studies on the nature of nuclear 
receptor chromatin interactions in hen oviduct nuclei, Massol et al.
(1978) were able to identify a specific 13-14S peak of oestradiol binding 
following moderate digestion of nuclei with micrococcal nuclease.
This specific binding peak was absent in oestrogen withdrawn immature 
chick oviducts and could not be induced with tamoxifen, either alone or 
in combination with oestradiol (Lebeau et al., 1981), despite the fact 
that tamoxifen and oestradiol when administered at appropriate doses 
can induce similar levels of nuclear oestrogen receptor in the chick 
oviduct (Sutherland et al., 1977). These data have been confirmed 
using 4-hydroxytamoxifen and they provide strong evidence that in the chick 
oviduct, where these compounds are pure antagonists, the oestrogen receptor 
complex and the anti-oestrogen receptor complex do not bind to the same 
nuclear acceptor sites. At concentrations above lpM, 
tamoxifen has been shown to be cytotoxic for both oestrogen receptor 
positive and negative mammary carcinoma cell lines, i.e. at these high 
concentrations tamoxifen's cytotoxic effects occur via receptor and 
non-receptor mediated events (Taylor et al ., 1984).
Specific anti-oestrogen binding sites have been reported in 
all. tissues of the rat (Sudo et al., 1983). These sites are not 
competable by oestrogens and the binding of anti-oestrogens is of high 
affinity (dissociation constant l-3nM). Oestrogenic stimulation of 
the specific anti-oestrogen binding sites in rat uterus and liver has 
been reported by Winneker and Clark (1983). Specific anti-oestrogen
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binding sites have also been reported in the human breast cancer MCF-7 
cell line cytosol (Faye et al., 1983). In the case of the specific 
anti-oestrogen binding sites present in all rat tissues, Sudo et al.
(1983) postulated that because of their wide distribution they may 
represent binding sites for other natural ligands which bear a structural 
resemblance to anti-oestrogenic molecules. Subsequently Brandes et al. 
(1985) have shown that the anti-oestrogen binding sites present on rat liver 
microsomes may be a histamine like receptor which mediates cell growth. 
Histamine formation has been implicated in certain types of rapid 
tissue growth (Szego, 1965).
1.5 Receptor Chromatin Interaction
1.5.1 Nuclear Binding.
Many oestrogen receptor mediated responses are known to 
involve changes in the expression of specific genes.(Gorski and Gannon,
1976).
Generally speaking nuclear binding can be divided into two 
types. Extraction of nuclei with 0.3M-0.4M KC1 does not remove all 
of the nuclear bound oestrogen (Puca and Bresciani, 1969; Mester and 
Baulieu, 1975; Clark and Peck, 1979). Love et al. (1983) have shown 
that in human endometrium, only 40% of the nuclear receptor can be 
released in this way, thus nuclear binding can be divided into a form 
which is salt extractable and a form which is resistant to extraction 
with salt. This would suggest that some oestrogen receptor complexes 
are bound more tightly than others. Clark and Peck (1976) have also 
shown that only a limited number of nuclear binding sites (1000-3000 per 
cell) are involved in the production of maximal uterine growth. These 
sites are retained for longer than 4-6 hr in the nucleus and are equal 
in number to the sites resistant to salt extraction. They propose 
that these are the true acceptor sites for oestrogen receptor complex.
Characteristics expected of an acceptor site are:- (1) high affinity 
binding; (2) a limited number of binding sites must exist; (3) steroid 
specificity.
The major stumbling block to universal acceptance of the 
acceptor site model is the disagreement between authors regarding the 
binding of receptor complexes to purified nuclei or chromatin. Many 
authors have shown that nuclear binding of steroid receptor complexes 
is a saturable phenomenon (Allerga et al., 1971; Fang and Liao, 1971; 
Mainwaring and Peterken, 1971; Higgens et al., 1973; Buller et al.,
1975) whereas others claim that limited numbers of specific nuclear sites 
do not exist (Chamness et al., 1973, 1976; Andre and Rochefort, 1975), 
although Yamamoto and Alberts (1974, 1975) have suggested that specific 
binding sites could be masked by the very large amount of low affinity 
binding which occurs to DNA. However despite the problem with in vitro 
binding systems, it is possible to show that a limited number of 
nuclear binding sites must be involved in the events leading to maximal 
uterine growth in the rat, and to suggest that these nuclear sites may 
represent nuclear acceptor sites (Clark et al., 1978c).
Recently good evidence has been presented to show that, under 
defined conditions, saturable binding of steroid receptor complex to 
target cell nuclei can be demonstrated and that unsaturable binding is 
mainly a result of the use of poor methodology in the binding assay 
(Spelsberg et al., 1976a: Kon and Spelsberg, 1982). The inclusion of 
a salt concentration which is almost physiological in these binding 
assays is necessary to facilitate the study of tissue specific saturable 
binding.
Such saturation analyses can be used to calculate the total 
number of specific binding sites per nucleus that are available to steroid 
receptor complex. The number of binding sites present are much higher
than is consistent with the activation of a small number of genes
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(Clark and Peck, 1979; Leake, 1981). Kon et al. (1980) estimated 
2,500 sites/cell for the hen oviduct. Mulvihill and Palmiter (1977) 
estimated 10,000 sites/cell for the chick oviduct and Anderson et al.
(1975) 6,000 sites/cell for the rat uterus.
Analysis of the saturable binding of progesterone receptor 
complexes to oviduct nuclei led Spelsberg (1976) to conclude that there 
were, in fact, several classes of nuclear "acceptor" sites with differing 
affinities for the hormone receptor complex. The highest affinity class 
(approx. 100 sites/cell) were fully saturated before any physiological 
changes were observed. The Kd for these was 10 and they would be fully 
saturated at physiological plasma steroid concentrations. The next two 
classes, in terms of binding affinities, constitute 900 and 4,000 sites/cell 
for oestrogen receptor and 1,000 and 10,000 sites/cell for progesterone 
receptor (Thrall et al., 1978). When these two classes of "acceptor" are 
filled maximum physiological responses ensue. These calculations involve 
the critical assumption that only one hormone receptor complex is bound 
to one "acceptor" site at any one instant. In fact the total number of 
acceptor sites which must be filled in order to get full physiological 
response to oestrogen-receptor complex has been calculated as only 
1,000-2,000 sites/cell (Clark and Peck, 1979).
In the light of the finding of these multiple classes of 
nuclear binding sites it is not surprising that "acceptor" activity has 
been reported in more than one chromatin protein fraction (Spelsberg,
1982; Spelsberg et al., 1983).
1.5.1.1 The role of Nuclear Components in Nuclear Binding.
Over the years each component of the nucleus has been 
proposed as the specific nuclear acceptor site, principally because it 
has been isolated in association with steroid receptor complex.
The nuclear components proposed have included:- 
ribonucleoproteins (Liao et al., 1973b; Liang and Liao, 1974), the
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nuclear envelope (Jackson and Chalkley, 1974; Smith and Van Holt, 1981), 
the nuclear matrix (Barrack and Coffey, 1980, 1982; Barrack, 1983;
Colvard and Wilson, 1984), histone proteins (King and Gordon, 1967), 
non-histone chromatin proteins (King and Gordon, 1972; Puca et al., 1974, 
1975; Mainwaring et al., 1976; Thrall et al., 1978; Ruh et al., 1981; 
Ruh and Spelsberg, 1983; Spelsberg et al., 1984) and DNA (Higgins et al., 
1973; Yamamoto and Alberts, 1974, 1975; Payvar et al., 1981, 1983).
It is, however, the DNA of the activated genes and the possible 
role of chromatin proteins that has attracted most attention and the 
evidence for their involvement will be considered in turn.
1.5.2 General Nuclear Control.
A large proportion of the DNA of an organism is beyond doubt 
potentially transcribable, yet it has been recognised for many years that 
all cells and organisms exercise strict control over which genes are 
expressed and at which time. The phenomenon of cell differentiation 
results in a specialised cell expressing only a very small subset of 
the tens of thousands of genes at its disposal. The mechanisms which 
allow the cell to select which genes to express, and when, are of 
fundamental importance in molecular biology.
1.5.2.1 Role of Nucleotide Sequences.
In prokaryotes, transcription is controlled by regions of 
DNA on the upstream, or 5’ side of structural genes. These regulatory 
or promoter regions are composed of a set of DNA sequence elements whose 
function, in most cases, has been clearly demonstrated. As a logical 
extension of this knowledge, the attempt to identify transcriptional 
control elements in eukaryotes has also been focussed with considerable 
success on the DNA sequences upstream of structural genes. The upstream 
control elements of eukaryotic genes are classified into three types
based on their function, their sequence characteristics and their 
position relative to the start of transcription (Chambon et al., 1984).
(See Figure 4).
One type termed a TATA box element, is involved in fixing 
the start site of transcription to a point 30bp downstream from its own 
position. A second type, the upstream element, is a broad class of 
sequences at a variable distance from the transcription start site 
that seem to be important in determining the level of transcription.
These elements have previously been referred to as G-C rich elements. 
Finally enhancer elements which were first reported in mammalian viruses, 
seem to be able to stimulate gene transcription from considerable 
distances and have been postulated to be tissue specific modulators 
of transcription for some mammalian genes (Picard and Schaffner, 1984; 
Walker et al., 1984).
The role of the TATA box is reasonably clear but the occurrence 
of the other two types of sequences is of great interest.
Examples of such sequences are short stretches of DNA amidst 
the 5' hyper sens it ive sites of the genes for the heat shock proteins 
of molecular weight 83,000 and 70,000 in Drosophila, which are found 
to be resistant to exonuclease digestion. The resistant regions cover 
both the TATA box sequence and an upstream control element. These DNA 
sequences are considered to represent binding sites for regulatory 
proteins involved in the activation of the adjacent gene (Pelham, 1982; 
Parker and Topol, 1984; Wu, 1984; Bienz, 1985). The pattern of 
resistance to nuclease digestion before and after induction of gene 
expression suggests that the heat shock genes are activated by the 
sequential binding of at least two non-histone proteins. Binding 
of one in the TATA box region may establish the transcriptional potential 
of heat shock genes, with the potential being realised during heat
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shock activation by the additional binding of a second protein. The 
fact that a second binding site is only found in active genes, argues 
that the second protein is a positive activator of transcription. 
Purification of this second protein is currently being attempted (Wu, 1985). 
Binding of these protein factors is envisaged to create deoxyribonuclease I 
(DNase I) hypersensitive sites which are thought to be characteristic 
of genes available for transcription. Binding of steroid receptors to 
DNA sequences is discussed more fully in Section 1.5.3.
Further examples of such upstream sequences are those present 
in the 5' flanking sequence of a human gene for metallothionein (Karin 
et al., 1984). Deletion experiments have defined two stretches of 
DNA lying close to the promoter of the gene, which separately mediate 
the induction of the gene by heavy metals, particularly cadmium and by 
glucocorticoids. The element responsible for induction by cadmium is 
duplicated, yet a single copy is fully functional. The element 
responsible for induction by glucocorticoids is coincident with the 
DNA-binding site for the glucocorticoid hormone receptor. Both of these 
elements can activate heterologous promoters located at least 600bp 
away suggesting they operate as "enhancer like" elements. Further 
evidence that upstream binding sites for steroid hormone receptors 
activating enhancer sequences is presented in Section 1.5.3.
There is now growing evidence that control elements that are 
downstream i.e. within the coding region, of a structural gene are also 
important in regulating the expression of some genes. Such an element 
has been reported in the adult p -globin gene (Charney et al., 1984;
Wright et al., 1984), this gene also has a full complement of 
functionally important upstream control elements. Further examples 
include the Xenopus 5S ribosomal RNA gene (Schlissel and Brown, 1984) 
and some mouse immunoglobulin genes (Picard and Schaffner, 1984).
Especially relevant to steroid hormone action is the report by Moore et al. 
(1985), that the first intron of the human growth hormone gene contains 
a binding site for the glucocorticoid receptor. This binding was 
selectively inhibited by methylation of two short, symmetrically arranged 
clusters of guanine residues within the binding site.
1.5.2.2 DNA Base Methylation.
A feature of eukaryotic DNA which has long held attractions 
as a possible signal for the control of gene expression is the variable 
extent to which its bases, in particular cytosine, are methylated. Two 
to seven percent of cytosines in mammalian DNA occur as 5-methyl cytosine, 
and 90% of these occur as the dinucleotide CpG. The extent to which a 
gene is methylated can be partially determined by digestion with paired 
isoschizomeric restriction endonucleases which recognise the same 
nucleotide sequence but are differently affected by its methylation.
Using this approach, it has been shown that glob in genes are 
undermethylated in tissues expressing them (Waalwijk and Flavell, 1978; 
McGhee and Ginder, 1979; Shen and Mariatis, 1980; Van der Ploeg and 
Flavell, 1980). This negative correlation between gene expression and 
under -methylation is also seen in the case of the chicken egg white 
protein genes (Mandel and Chambon, 1979) the mouse immunoglobulin genes 
(Rogers and Wall, 1981) the mouse oC-fetoprotein genes (Andrews et al.,
1982) and the human growth hormone gene (Hjelle et al., 1982). Stumpf 
et al. (1983) have shown that the 31 end of ovalbumin gene has a region 
greatly enriched in methylation and that this region is specifically 
undermethylated in the oviduct where the gene is expressed. Thus it 
appears that site specific undermethyl at ion is associated with gene 
expression, but this is not the only factor involved as a gene can be 
undermethylated and not expressed, as is the case with the Morris 
Hepatoma o<2u-globin gene (Nakhasi et al., 1982). This is confirmed
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by Wilks et al. (1982) who have shown that oestrogen causes the specific 
undermethylation of a sequence near the 51 end of the chicken vitellogenin 
gene. However it does this in two target tissues of the hormone, the 
liver where the gene is expressed and in the oviduct where it is not.
It also appears that the demethylation event occurs subsequent to the 
onset of transcription, so it seems that it is a consequence rather than 
a cause of transcriptional activity. In contrast this demethylation 
event does not occur in the oestrogen inducible vitellogenin genes in 
Xenopus, which are expressed when fully methylated (Gerber-Huber et al.,
1983). As a result the role of methylation in oestrogen induced,and 
indeed gene expression in general is still unresolved. One possible 
answer is that not all the methyl groups are involved in gene expression. 
Perhaps the loss of a single methyl group is sufficient to "switch on"
a gene. Such a loss would be difficult to detect.
1.5.2.3 Chromatin Conformation and the Availability of G;enes for
Transcription.
The best evidence that the conformation, packaging or composition 
of chromatin exerts an influence on gene transcription comes from the 
studies using DNase I and micrococcal endonuclease. Genes available 
for transcription are preferentially digested by these enzymes and by 
implication are part of a chromatin arrangement more available to enzyme 
interaction. Thus an increase in the DNase I sensitivity of the four 
Xenopus vitellogenin genes can be demonstrated in oestrogen treated
liver cells. No such increase occurs in non-target tissues (Gerber- 
Huber et al., 1981). Similar changes have been reported for the chicken 
vitellogenin genes (Dimitriadis and Tata, 1982; Williams and Tata, 1983). 
The egg white protein genes of the chick oviduct after exposure to 
oestrogen show a similar increase (Garel and Axel, 1977; Lawson et al., 
1980; Fritton et al., 1983). These changes do not occur in non-target
"  5 3  ■
tissues. The ovalbumin gene is coordinately expressed with two 
pseudogenes X and Y and the three are linked in a 100Kb domain of DNA,
The whole of this domain is preferentially sensitive to DNase I (Lawson 
et al., 1982), with a sharp change in sensitivity at either end.
Repetitive DNA elements of the CR1 family are located in opposite 
orientations at or very near the transition points and Stumpf et al.
(1983), have suggested that repetitive regions may play a role in defining 
the ends of DNase I sensitive regions.
As with methylation, the increase in the DNase I sensitivity 
of active genes is related to their availability for transcription and 
does not necessarily imply that they are being transcribed.
In addition to the general DNase I sensitivity of transcribable 
genes, there are often narrow regions of 50-400bp which are especially 
sensitive to digestion. These so called hypersensitive sites are often 
located at the 5' end of genes and their occurrence may be related to the 
level of gene transcription (Fritton et al., 1983).
The features of the chromatin of active genes which make them 
more DNase sensitive are not known in detail but are dependent on the 
specific occurrence in their constituent nucleosomes of two of the high 
mobility group (HMG) non-histone proteins, HMG14 and HMG17 (Weisbrod and 
Weintraub, 1981). Differential DNase sensitivity is lost when non-histone 
proteins are removed but is restored by the addition/of HMG14 and HMG17 
(Weisbrod and Weintraub, 1979). Other proteins which have been 
associated with active chromatin include ubiquitin-conjugated histone 
H2A (Levinger and Varshavsky, 1982) and acetylated histones (Nelson et al., 
1980). Nucleosomes which are deficient in histones H2A and H2B have 
been shown to be heavily enriched in active genes and also able to 
selectively bind RNA polymerase II (Baer and Rhodes, 1983). Numerous 
reports have shown that oestrogen action is accompanied by qualitative
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and quantitative changes in chromatin proteins (Teng and Hamilton,
1969; Barker, 1971; Cohen and Hamilton, 1975), ^ including HMG protein 
accumulation (Teng and Teng, 1981) and very rapid hormone induced changes 
in histone acetylation (Pasqualini et_al., 1983). The role that these 
and other chromatin components might play in oestrogen control of gene 
expression is unclear.
1.5.3 Binding to DNA.
As a result of early investigations, it has been reported that 
a variety of steroid receptor complexes bind to DNA (Baxter et al., 1972; 
King and Gordon, 1972; Musliner and Chader, 1972; Spelsberg et_al.,
1971, 1976; Toft, 1972; Yamamoto and Alberts, 1974, 1975; Rousseau 
et al., 1975; Simons et al., 1976; Bugany and Beato, 1977; Thanki 
et al., 1978; Kallos and Hollander, 1978). There have been reports of 
specific interaction in terms of preference of steroid receptors for 
substituted over unsubstituted DNA (Andre et al., 1976; Kallos and 
Hollander, 1978), for eukaryote over prokaryote DNA (Clemens and 
Kleinsmith, 1972) and finally for native DNA over RNA (Toft, 1972,
Yamamoto and Alberts, 1974). However this binding is of relatively 
low affinity (Buller and O'Malley, 1976) and shows no species specificity 
although there is preferential binding to AT-rich DNA (Kallos and Hollander, 
1978; Kallos et al., 1978). Although these studies may explain in part 
the large number of apparent nuclear binding sites, they do nothing to 
reveal how, in some target tissues, the hormone-receptor complex is 
capable of selectively activating a small number of specific genes. 
Nevertheless, the interaction with DNA would appear to be important.
Thus in the human breast cancer cell line MFC-7, in which oestrogens 
induce the synthesis of a glycoprotein, the incorporation of 
bromodeoxyuridine into DNA, inhibits the induction. Since the synthesis 
of other proteins is unaffected, it seems likely that the inhibition 
is due to interference with chromatin recognition sites, rather than with
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RNA transcription (Garcia et al., 1981).
The first good evidence that steroid receptor complexes might 
specifically associate with the genes that they activate comes from studies 
on the insect hormone ecdysterone. Both Gronemeyer and Pongs (1980) 
and Dworniczak (1983) used photoactivation to cross-link the hormone to 
the giant polytene chromosomes of Drosophila salivary glands. This allowed 
the bound complexes to withstand the preparation of chromosome squashes.
They then used immunof 1 uorescent labelling to show that the hormone was 
specifically localised at chromosome puffs which were known to correspond 
to ecdysterone induced genes. Further work by Schallman and Pongs (1982) 
showed that by crosslinking covalently bound ecdysterone to its receptor 
protein that both the hormone and receptor protein were bound to the 
activated genes.
These studies with ecdysterone have not identified whether the 
hormone receptor binding site is on the DNA or some other component of the 
polytene chromosome. They do indicate however, that at least in this 
system, there are highly specific binding sites. It is tempting to 
speculate that, in addition to a general relatively low affinity for all 
DNA, steroid hormone receptor complexes might possess a high affinity for 
specific nucleotide sequences associated with the genes they activate.
In recent years the isolation of hormone responsive genes, together with 
the increased availability of purified receptor proteins and monoclonal 
antibodies to receptor protein, has allowed a search for such binding 
sites. The following approaches have been used:-
1. DNA Binding Studies - The affinity of a DNA fragment
for the hormone-receptor complex has been monitored by its ability to 
displace the complex from DNA-cellulose (Mullvihill et al., 1982), by 
the ability of a receptor to retain a DNA fragment on a nitrocellulose 
filter (Hughes et al., 1981) and by the ability of the receptor complex
to protect a region of the gene from nuclease digestion' (Scheidereit
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et al., 1983).
2. Gene Transfer Experiments - The relevance of specific 
nucleotide sequences to hormonal control of gene expression has 
been tested by introducing the gene into cells which contain 
functional receptor for the hormone concerned but do not normally 
express the gene (Buetti, 1981; Kurtz, 1981). In this way it 
has been shown that sequences 5' to a number of genes could be 
associated with the control of their expression. Furthermore, 
these sequences have subsequently been fused to genes not normally 
influenced by hormones, with the result that the gene becomes 
responsive (Chandler et al., 1983; Hynes et al., 1983). Fragmentation 
and selective mutation of the active sequences can be employed to 
define more precisely the nucleotides involved.
3. Search for consensus sequences - Sequences derived by 
the approaches in.(1) and (2) can be searched for in similar 
locations in other genes activated by the same hormone. This may 
lead to the identification of a consensus sequences for the binding
of that hormone-receptor complex (Mulvihill et al., 1982; Scheidereit 
et al., 1983).
Unfortunately the use of the above systems to analyse the 
binding of oestrogen-receptor complexes to the genes they activate has 
lagged behind that of other hormones. The greatest progress has been 
made with genes which are responsive to glucocorticoids and/or 
progesterone.
Some of the most striking advances have been made with 
the mouse mammary tumour virus (MMTV), a retrovirus which causes mammary 
carcinoma in mice and which will also replicate in rodent cells in tissue 
culture. Glucocorticoids dramatically enhance the rate of virus 
replication, and the tissue culture system serves as an excellent model
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for the study of steroid hormone action.
Several groups have demonstrated that rat liver glucocorticoid 
receptor binds specifically to at least five widely separated regions 
on pure pro-viral DNA (Payvar et al., 1982, 1983; Gustafsson et al.,
1984). One of these specific binding domains, which itself contains at 
least two distinct receptor binding sites, resides within a fragment of 
viral DNA that maps -110 to -449bp upstream of the initiation site for MMTV 
RNA trasncription. Four other binding domains lie downstream of the 
promoter and within the MMTV primary transcription unit. Chimaeric 
genes containing restriction fragments from these binding domains fused 
to various marker genes have been used to identify regions associated 
with the response to the hormone. Recently Hynes et al. (1983) have 
shown that the enhanced expression by glucocorticoids was associated 
with that portion lying 0 to -202bp upstream of the transcription 
initiation site. Furthermore Scheidereit et al. (1983) have shown 
using monoclonal antibodies,that partially purified receptor selectively 
protects two areas within the sequence from digestion by deoxyribonuclease 
I. These areas are -72 to -124 and -163 to -192bp upstream of the 
initiation site. They share some sequence homology, both with each other, 
and with the 5' flanking sequences of other glucocorticoid-regulated 
genes, but a clear consensus sequence does not emerge from this study. 
Recently Cato et al. (1984) have shown that a region 2.6Kb upstream of 
the rabbit uteroglobin gene recognises the glucocorticoid receptor.
The region contains three binding sites, and all three show homology 
with the glucocorticoid receptor binding sites reported for other genes. 
These elements may be responsible for the glucocorticoid regulation of 
uteroglobin gene expression by acting over a relatively long stretch of 
nucleotide sequence.
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The binding of progesterone receptor complexes to the fowl egg 
• white protein genes has also been extensively studied. As with the 
binding of glucocorticoids to MMTV DNA, there appear to be multiple 
progesterone binding sites (Mulvlhill et al., 1982; Compton et al.,
1983, 1984). Mulvihill et al. (1982) identified a binding site located 
250-300bp upstream of the initiation site of the ovalbumin gene. This 
region showed considerable sequence homology with the 5' flanking regions 
of genes for the other egg white proteins conalbumin and ovomucoid as 
well as with two ovalbumin pseudogenes. By comparing these homologies 
they proposed a 19bp progesterone binding consensus sequence.
Compton et al. (1984), have demonstrated preferential binding of the 
progesterone receptor complex to a region 150 to 190bp upstream of the 
ovalbumin gene. Dean et al. (1983) have also shown that a segment of 
DNA containing this sequence (95 to 222bp upstream of the ovalbumin gene) when 
fused to a marker gene and used in gene transfer experiments, caused 
the marker gene to become progesterone responsive.
Renkowitz et al. (1984) have shown that deletion of sequences 
from the chicken lysozyme promoter renders the gene insensitive to both 
glucocorticoids and progesterone. They were able to detect a strong 
glucocorticoid receptor complex binding site between -74 and -39bp 
upstream of the promoter and a weaker binding site between -208 and 
-161bp upstream of the gene. Subsequent work by von der Ahe et al.
(1985) has shown that deletion of 44bp from the chicken lysozyme 
promoter (-208 to -164 upstream of the initiation site) results in 
co-ordinate loss of both glucocorticoid and progesterone dependent gene 
expression. Finally, by studying the promoter regions of both the 
chicken lysozyme and MMTV genes,they showed that purified glucocorticoid 
receptor from rat liver and progesterone receptor from rabbit uterus 
yield similar or overlapping exonuclease III foot-prints, implying that
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at least sane of the binding sites for these two steroid receptor complexes 
may be the same.
Similar studies involving oestrogen receptor complexes have 
recently shown that both a DNA sequence upstream of the chicken vitellogenin 
II gene (Jost et al., 1984) and a region at least 1Kb upstream from the 
rat prolactin gene (Maurer, 1985) selectively bind oestradiol receptor 
complex.
In summary, from these studies it seems that the signal for 
the binding of a hormone receptor complex to the gene it activates may be 
encoded in the DNA, however the sequence homology so far detected between 
different binding sites is not good and more may be involved than the 
base sequence. In the well characterised systems studied to date, there 
appears to be multiple binding sites which can be either upstream of^  and 
within the gene. There is some evidence that the binding sites may 
function in a manner analogous to viral enhancers of transcription.
Enhancers can act over several kilobases regardless of their orientation. 
Hynes et al. (1983) have shown that the MMTV glucocorticoid responsive 
region can function 500bp from the viral promoter and Chandler et al.
(1983) have shown that it will work in both orientations. Further 
support for this idea comes from Wilks et al. (1982), who show that 
oestrogen receptor complexes bind to a region of the chicken vitellogenin 
II gene which contains the oestrogen-dependent methylation site and 
contains a binding site that shows considerable homology with an enhancer 
of the virus SV-40 (Jost et al., 1984).
However the affinity of the hormone receptor complexes for 
the specific DNA sequences isolated so far is only 10-40 times greater 
than that for a heterologous DNA such as total calf thymus DNA. This 
seems inadequate to provide a mechanism for the specific activation of
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a small number of genes and is certainly too little to allow rapid 
attraction of incoming steroid receptor complexes. This implies that 
some other recognition signal must be involved. It is very likely 
that DNA is an essential component of a three dimensional acceptor site 
but it does not offer the exclusive determinant of steroid receptor complex 
binding. Previous work has shown that treatment of nuclei with DNase 
causes release of bound receptor (King and Gordon, 1972) implying that 
DNA is involved in the binding. However it has also been shown that 
proteases can destroy binding activity (Puca et al., 1974), which implies 
that nuclear proteins also have a role to play in the binding of steroid 
receptor complexes.
1.5.4 The Role of Chromatin Proteins.
Chromosomal proteins are likely to be involved in the 
availability of a gene to hormone activation. In any differentiated 
tissue there are genes that are permanently "switched off", genes that 
are always available for transcription and genes that can be activated.
The chromosomal proteins are assumed to be strongly involved in this 
process and in the case of hormone activated genes, may well be associated 
with the differential effects of the hormone on different target tissues.
It also seems likely that chromosomal proteins may be involved directly 
in the nuclear binding process.
1.5.4.1 Non Histone Chromatin Proteins.
By convention non-histone chromatin proteins are considered 
to be acidic in nature, but work has been published which reports binding 
activity to be present in both basic non-histone chromatin proteins 
(Puca et al., 1974, 1975; Mainwaring , et al., 1976) and acidic non-histone 
chromatin proteins (e.g.Spelsberg, 1982; Spelsberg et al., 1983).
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1.5.4.1.1 Acidic Proteins.
To date the best characterised system is the interaction of 
progesterone receptor complexes with the avian oviduct (Spelsberg, 1982; 
Spelsberg et al., 1983). The "acceptor" function is tightly bound to 
DNA and can be destroyed by proteases (Spelsberg et al., 1984). The 
protein fraction is confined to chromatin and is more active in target 
tissues than non-target tissues (O’Malley et al., 1972; Chytil, 1975; 
Pikler et al., 1976; Spelsberg and Toft, 1976). Deproteinisation of 
chromatin to remove histones and some non-histone proteins reveals that 
the "acceptor" activity is present in all hen tissues but is masked in 
non-target tissues, primarily by non-histone proteins. Indeed, even 
in target tissue chromatin approximately 70% of the high affinity 
"acceptor" sites are also masked (Spelsberg, 1982; Spelsberg et al.,
1983). Using chromatin dissociation and reconstitution techniques it 
has been possible to transfer "acceptor" activity from target to non­
target tissues (Spelsberg et al., 1971, 1972). Recently Spelsberg 
et al. (1984) have performed reconstitution studies and presented data 
to support the involvement of specific chromatin proteins in "acceptor" 
site function. Furthermore they show that the "acceptor" protein 
fraction will only interact with a limited number of specific DNA 
sequences in the avian genome. This is supported by the observation 
that it is not possible to reconstitute native like acceptor activity 
if the oviduct "acceptor" protein fraction is re-annealed to bacterial 
DNA. The transfer of "acceptor" activity from target to non-target 
tissue has also been reported by Klyzsejko-Stefanowicz et al. (1976) 
when studying the interaction of androgen receptor with various male rat 
tissues including prostate. More recently Ross and Ruh (1984) report 
the reconstitution of native like acceptor ac tivity when studying the 
interaction of oestradiol-receptor complexes with calf uterine chromatin.
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However the techniques of chromatin fractionation and reconstitution 
have been heavily criticised by a number of groups (Zasloff and Felsenfeld, 
1976; Fuhner and Fasman, 1979; Stein, 1979).
Characterisation of the protein fraction responsible for 
"acceptor” activity in the avian oviduct has revealed that the bulk of 
"acceptor" activity falls into a molecular weight range of 14,000-18,000. 
Using isoelectric focussing two primary peaks of activity could be 
resolved,one which focussed at a pH range of 5.0-5.5 and the other over 
a broader pH range of 6.0-7.0 (Spelsberg, 1982; Spelsberg et al., 1983).
Ruh et al. (1981) have shown that oestradiol-receptor complexes 
binding to calf uterine chromatin can be resolved into three components 
by selective deproteinisation of the chromatin using guanidine hydro­
chloride. Using different techniques, similar results have been reported 
for progesterone receptor complexes binding to chick oviduct chromatin 
(Thrall et al., 1978). The majority of the receptor complex binding in 
both cases was resistant to 0.4M KC1 extraction and this is in agreement
with a similar report by Perry and Lopez (1978) regarding the binding of
oestrogen-receptor complex to sheep hypothalamic chromatin. These findings 
that acidic proteins„seem to constitute a necessary component of "acceptor" 
activity is consistent with the findings of Spelsberg et al. (1975, 1976b, 
1979) in the chick oviduct system, Klyzsejko-Stefanowicz et al. (1976) 
in the rat prostate and Tsai et al. (1980) in rat sertoli cells.
Using similar extraction procedures to Ruh et al. (1981),
Ruh and Spelsberg (1983) studied the binding of oestradiol-receptor
complexes to hen oviduct chromatin. The peak of acceptor activity was 
uncovered by 5M guanidine hydrochloride. This was similar to the 
concentration required to uncover "acceptor" activity for progesterone 
receptor complex binding and this led to the conclusion that the "acceptor"
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protein fractions for each receptor complex may have similar properties. 
Earlier work (Kon and Spelsberg, 1982) had shown that oestrogen-receptor 
complexes and progesterone-receptor complexes did not compete for the 
same nuclear binding sites. In this study oestrogen-receptor complex 
binding to purified hen oviduct nuclei was assessed. A single class of 
binding site was detected (Kd = 1.8 x 10 ^M, with 3000-5000 binding 
sites/nucleus). This Kd value compares well with the value of
1.5 x 10 "^ M, which was the value measured by Ruh and Spelsberg (1983) 
when studying the binding of oestrogen-receptor complexes to guanidine 
hydrochloride extracted hen oviduct chromatin. This study also indicated 
that a large percentage of the "acceptor" sites for oestrogen-receptor 
complexes were masked in the nuclei of the avian oviduct as had been shown 
previously for the progesterone receptor (Spelsberg, 1982; Spelsberg et al., 
1983).
1.5.4.1.2 Basic Proteins.
Reports in the literature have been far less extensive
concerning the role of basic non-histone chromatin proteins in acceptor
activity. Puca et al. (1974, 1975) have reported a tightly bound
chromatin protein fraction which is extractable in 2M NaCl from calf uterine
nuclei which exhibits "acceptor" activity for the oestrogen receptor
complex. The binding activity is destroyed by proteases confirming its
protein nature. The basic nature of the protein was established using
hydroxylapatite chromatography. The assay of binding activity was carried
out by immobilising the various fractions obtained after exposing the
3
calf uterine nuclei to 2M NaCl on sepharose 4B and eluting H-E2 labelled
oestrogen receptor complex through the nuclear extract sepharose resins.
-9Receptor complex binding was saturable and displayed a Kd of 3 x 10 M. 
Formation of receptor comp lex/acceptor protein complexes in solution, 
followed by sephadex G-100 chromatoraphy allowed a molecular weight of
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85,000 to be estimated for the acceptor protein at neutral pH and almost 
physiological ionic strength. DNA immobilised o.n polymers could 
efficiently bind the acceptor proteins, which in turn could then specifically 
bind the receptor complex. This is not unexpected as the proteins were 
presumably bound to DNA in the nucleus before disruption of the chromatin.
The advantages of forming an insoluble matrix suitable for 
affinity chromatography as has been done by Puca et al. (1974) are threefold:-
(1) Bulk preparation of stable acceptor matrix, (2) Extreme analytical 
precision, (3) Experimental flexibility.
Mainwaring et al. (1976) have reported two distinct sets of bind­
ing sites, for androgen receptor complexes present in the 2M NaCl extract of 
rat prostate nuclei. Prior to analysis, the nuclear extracts were 
immobilised on sepharose 2B essentially as outlined by Puca et al. (1974). 
These binding sites comprised:- (1) a small number of specific high affinity 
sites, (2) a large number of low affinity non-specific sites. The high 
affinity sites were shown to be a fraction of the basic but non-histone 
proteins using both Bio-Rex-70 ion exchange chromatography and isoelectric 
focussing. The acceptor protein was estimated to have a molecular weight 
of 70,000 as shown by gel exclusion chromatography. The apparent Kd for 
the interaction of the high affinity sites with androgen receptor complex was
2.5 x 10 ^M. The low affinity, non-specific sites were recovered with 
the acidic non-histone proteins.
As in the case of the work of Puca et al. (1974, 1975) the 
interaction between receptor complex and acceptor site were studied under 
conditions far removed from their authentic environment in the intact cell, 
especially in respect of the complete absence of DNA.
Care must be exercised in the classification of these acceptor 
proteins. The classification appears to be clearly that they are either
basic or acidic in charge. This nomenclature refers to the proteins after 
they have been removed from the chromatin, and thus may not be a realistic 
picture of their overall charge when they are associated with chromatin.
Thus proteins which carry an overall acidic or basic charge after extraction 
may not carry this charge in vivo. How much the charge on the protein 
changes after extraction will be governed by the nature of its attachment 
to chromatin in vivo i.e. ionic or hydrophobic,although the former is the 
most likely. Changes in the overall charge of a protein may also be 
introduced by any conformational changes which occur during its extraction.
1.5.4.1.3 Histone Proteins.
Several reports have appeared in the literature which suggest 
the interaction between steroid hormone receptor complexes and histones 
is completely non-specific (King et al., 1969; Steggles and King, 1970;
Puca et al., 1974, 1975).
In contrast, Kallos et al. (1981) report that oestrogen receptor 
complexes from rabbit uterus can interact selectively with purified histones 
with the strongest binding being to histones H2A and H2B with histone HI 
only displaying weak binding activity.
It is difficult to rule out a modulating role for histones in 
regulating steroid hormone mediated gene expression in view of the data 
of Kallos et al. (1981) and that of Ruh et al . (1981) who showed that a major 
fraction of acceptor activity was found in only partially dehistonised 
calf uterine chromatin but it is probable that histones are involved in 
general control mechanisms, with more selective and specific controls 
involving non-histone proteins.
1.5.4.2 The Nuclear Matrix.
The nuclear matrix is the structure which remains after nuclei 
have been sequentially extracted with high salt buffers and detergent and 
then digested with DNase and RNase. It represents 2% of the total nuclear
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phospholipid and RNA, 0.1% of the total nuclear DNA and 10% of the total 
nuclear protein (Barrack and Coffey, 1982). It consists of a net-work 
of thin proteinaceous fibres together with structural elements of the 
pore complexes, lamina, the internal net-work and nucleolus. The matrix 
has been shown to have a key role in DNA replication (Bucholtz, 1981;
Hunt and Vogelstein, 1981) and in hriRNA production and processing 
(Jackson et al., 1981). DNA is arranged in supercoiled loops anchored 
to the matrix, and studies have shown that genes are randomly arranged 
within these loops. Indeed it has been shown that transcriptionally 
active genes are closely associated with the matrix. Thus, Robinson 
et al. (1982; 1983) have shown that ovalbumin and conalbumin genes are 
preferentially associated with the nuclear matrix in oviduct cells. 
Furthermore ovalbumin genes selectively dissociate from the oviduct nuclear 
matrix during oestrogen withdrawal and reassociate with it after re­
stimulation (Robinson et al., 1983).
The concept that steroid hormone activated genes are attached 
to the nuclear matrix forces a re-assessment of the reports that steroid- 
receptor complexes bind to the matrix. Many groups have reported that a 
substantial component of nuclear hormone-receptor complexes cannot be 
extracted with 0.3 - 0.6M KC1, and some have presented data that these 
residual complexes are bound to the nuclear matrix (Barrack et al. , 1977; 
Barrack and Coffey, 1980; Barrack and Coffey, 1982; Barrack, 1983). 
Androgen receptor has also been reported associated with the nuclear 
matrix of normal and hyperplastic human prostate (Donnelly et al., 1984).
It would seem a possibility worthy of further investigation that the 
steroid, its receptor protein, the gene to be activated and the nuclear 
matrix are all part of a complex in which the gene takes up a new 
conformation with increased accessibility for transcription.
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1.6 The Distribution of Receptor Acceptor Complexes within
Chromatin.
At present little is known about the intranuclear interactions 
in which steroid receptors are involved and even less is known about the 
intranuclear location of these interactions. Attempts to answer these 
questions have utilised chromatin fractionation techniques which 
separate transcriptionally active and inactive regions using either 
mechanical (Levy and Baxter, 1976; de Boer et al., 1978; Franeschi and 
Kim, 1979) or enzymatic (Hemminiki, 1977; Senior and Frankel, 1978;
Rennie, 1979; Scott and Frankel, 1980; Thomas and Bell, 1983; . Pratt 
et al., 1984) disruption of chromatin. However the results have not been
unambiguous. Oestrogen receptors from chick-oviduct (Franeschi and 
Kim, 1979) and rat uterus (de Boer et al., 1978) have been reported to 
associated predominantly with fast sedimenting chromatin which is 
considered to be inactive. Similar observations have been reported for 
androgen receptors in prostate chromatin (Rennie, 1979) and glucocorticoid 
receptors in putuitary chromatin (Levy and Baxter, 1976). Conversely other 
investigators have reported that transcriptionally active regions of 
chromatin are enriched in oestrogen receptors (Hemminiki, 1977;
Hemminiki and Vaukhonen, 1977; Scott and Frankel, 1980). Pratt et al. . 
(1984) have also shown that oestrogen receptor complexes bind to calf 
uterine chromatin at pre-existing nuclease hyper sensitive sites which are 
known to occur in regulatory regions (often at the 5' end of actively 
transcribed genes). Bruchovsky et al. (1981) have reported that 95% of 
nuclear androgen receptors are associated with linker DNA.
In the case of rat prostate chromatin, Davies and Thomas 
(1984) show that, after controlled digestion of prostate nuclei by 
micrococcal nuclease, the majority of androgen receptor complexes could 
be recovered in an oligonucleosome fraction which was transcriptionally 
active and only represented 10% of the genome. A similar report that
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glucocorticoid receptors are preferentially associated with a fraction of 
rat thymocyte chromatin which is transcriptionaly active, has been made 
by Thomas and Bell (1983).
Having studied the intra-nuclear distribution of rat uterine 
oestrogen-receptor complexes Pavlick and Katzenellenbogen (1982) propose 
a model where the majority of receptors are located in a fraction of 
chromatin which is transcriptionally inactive,with only a small minority 
of receptors being associated with transcriptionally active chromatin.
Data presented by de Boer et al. (1984) studying oestrogen receptor 
binding to chicken target cell nuclei support the above model.
Since a close correlation exists between the concentration 
of nuclear bound oestrogen receptor complex and synthesis of oestrogen 
induced protein in the rat uterus (Katzenellenbogen and Gorski, 1971,
1975) and the number of RNA initiation sites in the chick oviduct 
(Kalimi et al., 1976), it would seen reasonable that the bulk of oestrogen 
receptor complexes in the nucleus have a productive role in the mechanism 
of steroid action. Conversely it has been suggested that only a small 
number of oestrogen-receptor complexes productively bind to high affinity 
sites on the genome, while the remainder bind to lower affinity non­
productive sites (Yamamoto and Alberts, 1975). Those binding to 
productive sites could possibly be those associated with active chromatin 
or the 10-20% which are released from chromatin more easily than DNA is 
liberated. Schoenberg and Clark (1981) report such a fraction of 
receptor complexes, which are released in this way and presumed to be 
associated with active chromatin. The remainder of receptor complexes 
are associated with sites in the nucleus which are not nuclease sensitive.
1.7 Relevant Techniques
1.7.1 Affinity Chromatography.
Classical procedures of protein separation and purification
are generally based on the relatively small differences in the physico-
chemical properties of proteins in the mixture. They are hence 
unselective, tedious and of poor resolution.
Affinity chromatography occupies a unique place in separation 
technology since it is the only technique which enables purification of 
almost any biomolecule on the basis of its biological function or individual 
chemical structure.
Affinity chromatography is a type of adsorption chromatography 
in which the molecule to be purified is specifically and reversibly 
adsorbed by a complementary binding substance (ligand) immobilised on an 
insoluble support (matrix). For example, specific adsorbants can be 
used to purify enzymes, antibodies, nucleic acids and cofactors, vitamins, 
repressors, transport, drug or hormone binding receptor proteins. 
Purification is often of the order of several thousand-fold and recoveries 
of the active material are generally very high. Many spectacular 
separations have been achieved in a single step allowing immense time- 
saving over less selective multi-stage procedures. Affinity chromatography 
has a concentrating effect which enables large volumes to be conveniently 
processed. The high selectivities of the separations derive from the
natural specificities of the interacting molecules. For this reason 
affinity chromatography can be used for:-
(1) purifying substances from complex biological mixtures,
(2) separating native from denatured forms of the same substance,
(3) removing small amounts of biological material from large
amounts of contaminating substances.
The first application of affinity chromatography was the 
selective adsorption of amylase onto insoluble starch in 1910. The complex 
organic chemistry required to synthesise a reliable matrix and to attach 
ligands covalently, prevented the technique from becoming generally 
established in biological laboratories. However Axen et al. (1967)
reported that molecules containing primary amino groups could be coupled
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to polysaccharide matrices activated by cyanogen bromide. This 
represented the beginning of affinity chromatography as a routine 
separation technique.
Examples of purifications achieved using affinity 
chromatography have included, avidin from crude egg white (Cuatrecassas 
and Wilchek, 1968), neuramidase from Vibrio cholerae (Cuatrecassas and 
Illiano, 1971), Staphylococcal nuclease (Cuatrecassas et al., 1968), 
vertebrate collagenases (Bauer et al., 1971). Especially relevant to 
the actions of oestrogens has been the purification of the receptor for 
oestradiol-17^ from calf uterus by Sica and Bresciani (1979).
A slightly different use of affinity chromatography has been 
made by Puca et al. (1974, 1975) and Mainwaring et al. (1976). The 
object of these studies was not to purify a specific molecule but to 
demonstrate the existence of specific nuclear binding sites for both 
oestrogen and androgen receptor complexes. By coupling crude extracts 
of target cell nuclei to sepharose,they were able to probe these affinity 
resins with labelled steroid hormone receptor complex and establish the 
existence of specific binding sites (see Section 1.5.4.1.2).
1.7.2 Protein Blotting.
Over the years sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) has become one of the most extensively used 
methods in the many facets of molecular biology. The visual evaluation 
of the composition of a protein sample is quite often the final step, 
the ultimate assay in a particular experiment. Protein blotting is an 
extension to SDS-PAGE and is rapidly becoming widely accepted as the 
optimal means of identifying and characterising proteins in complex mixtures.
In principle, a protein mixture is separated into its 
constituents using a gel system of choice, most commonly SDS-PAGE (Laemmli, 
1970); however, non-denaturing gels, urea containing gels, acrylamide
or agarose gels as well as isoelectric focussing and two-dimensional gels
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have all been used successfully (Gershoni and Palade, 1983), After 
electrophoresis, the separated proteins are eluted from the gel and 
adsorbed onto an immobilising matrix, under conditions that maintain the 
electrophoretic pattern. Elution can be accomplished electrophoretically 
or by diffusion or convection. Elution is most efficiently performed 
electrophoretically. The main problem encountered during this phase of 
blotting is that high molecular weight proteins migrate out. of the gel more slow 
than do low molecular weight proteins, thus creating a biased plot. This 
problem can be overcome in several ways including altering the buffer 
composition (Gershoni and Palade, 1982; Nielsen et al., 1982), using 
reversibly crosslinked gels (Renart et al., 1979) or composite agarose/ 
acrylamide gels (Elkon et al., 1984) or using an apparatus that generates 
a gradient in the electric field (Gershoni et al., in press).
A variety of immobilising matrices exist, such as 
nitrocellulose, membrane filters, nylon based membranes and diazotised 
papers; all have advantages and disadvantages, the ultimate blotting 
matrix has yet to be developed. The protein should be adsorbed to the 
immobilising matrix strongly enough to allow the blot to be thoroughly 
washed so that any non-specifically bound probe can be removed. The 
problem of non-specific background is common to all the procedures 
published so far. The background can be minimised by quenching i.e. 
blocking all the unoccupied potential binding sites of the blot. This 
is usually achieved by preincubating the blot in a solution containing 
an "inert" protein such as bovine serum albumin (BSA) (Towbin et al.,
1979). Another approach has been to decrease the stickiness of the 
probe by including non-ionic detergents in the various solutions,
Tween 20 is particularly good for this (Batteiger et al., 1982).
The blot i.e. immobilising matrix containing the transferred 
proteins, is then reacted with an appropriate probe or probes usually with 
continual rocking or shaking. Non-specifically bound probe is then
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removed by exhaustive washing of the blot. The most popular probes used 
are either radioactively labelled,or conjugated to enzyme systems to 
enable their detection.
The most common application of protein blotting,"immiino- 
overlays" has been developed for the detection of an antigen with a specific 
antibody. This process is straightforward and well established.
However, blots can be used in the analysis of glycoproteins and various 
receptors, as well as studies of protein-ligand association.
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Aims
To obtain a reasonably pure preparation of myometrial nuclei. 
Fractionate the nuclei, immobilise the fractions on sepharose 
4B and probe the various nuclear fractions for the ability to 
specifically interact with activated, labelled oestrogen 
receptor from various sources.
Characterise the binding activity of the appropriate nuclear 
fractions with respect to affinity, saturability and 
specificity of binding by the steroid receptor complex.
The chemical nature of any high affinity binding fractions 
was also to be investigated.
2.1 Materials
2.1.1 Fine Chemicals.
Fine chemicals were obtained as follows
Bovine Serum Albumin (BSA) - Sigma, London
(Fraction V)
Charcoal (Norit A - activated) - 
(untreated powder)
Coomassie Brilliant Blue R-250 - 
Deoxyribonucleic Acid (DNA) - 
(Calf Thymus type V - sodium salt, 
highly polymerised)
Dextran T-70 - Pharmacia, Sweden
Di-isopropyl Fluorophosphate (DFP) Sigma, London
Sigma, London
Sigma, London 
Sigma, London
Dithiothreitol (DTD -
Methanol, ethanol, acetone, 
isopropanol - 
p -mercaptoethanol -
Potassium chloride -
Ribonucleic acid (RNA) - 
(Yeast)
Sepharose 4B (CN-Br activated) - 
Sucrose -
Triton X-100 (purified) -
Koch Light Laboratories, 
Colnbrook, England
Fisons, England 
Reidel - De Haen AG, 
Seelze - Hannover 
Koch Light Laboratories, 
Colnbrook, England 
and BDH AnalaR Grade 
Sigma, London
Sigma, London 
Koch Light Laboratories, 
Colnbrook, England 
Koch Light Laboratories, 
Colnbrook, England
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Tween-20 - Aldrich Chemical Co.,
Gillingham, Dorset 
All other chemicals used were, whenever possible,
AnalaR grade reagents.
2.1.2 Buffers.
N-2-hydroxypiperazine-N'-2-ethane sulphonic acid (HEPES) 
was obtained from BDH Chemicals Ltd., Poole, Dorset.
IRIS (hydroxymethyl) aminoethane was obtained from Sigma, 
London and the Boehringer Corporation (London) Ltd..
2.1.3 Radiochemical s.
The following radiolabelled compounds were obtained from
Amersham International, Amersham, Bucks.
[1,2,6,7-^H]corticosterone (80-105Ci/mmol)
3
[1,2,4,5,7- H] dexamethasone (78Ci/mmol)
3
5c<-dihydro [1,2,4,5,-6,7- H] testosterone (5<*-DHT)
(104Ci/mmol)
3
[17oC-methyl- H] mibolerone (7,17 -dimethyl-19-nor-
testosteroneX 76Ci/mmol) 
,4,6,7-^ H] oestradiol ^ X  101-104Ci/mol)[2
ORG-2058 (16 <*-ethy1-21-hydroxy-19-nor t6,7-^ H]
Pregn-4-ene-3,20-DioneX45Ci/mmol)
3
[N-methyl- H] tamoxifen (Trans l-(p-js dimethyl- 
aminoethyloxyphenyl)-1,2-diphenyl (but-1-ene) (89Ci/mmol) 
[1,2,6,7-^ H] testosterone(80-103Ci/mmol)
123 12516oC- I iodooestradiol (approx. 2000Ci/mmol)and KCarrier free
Unlabelled dexamethasone, 5&C-DHT, and E2 and were obtained
from Sigma, London.
Unlabelled ORG 2058 and mibolerone were obtained from
Amersham International, Amersham, Bucks.
Unlabelled tamoxifen was obtained from I.C.I. Pharmaceuticals
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Macclesfield, Cheshire.
2.1.4 Scintillation Materials.
The following materials were obtained from Koch Light 
Laboratories, Colnbrook, England.
Toluene (AnalaR Grade)
2,5, diphenoxazole (PPO) 
l,4-di(2-(5,phenyloxazolyl)) benzene (POPOP)
Triton X-100 (Scintillation grade) was obtained from 
Rohm and Haas, Croydon, England.
2.1.5 Autoradiography Materials.
The following materials were obtained from Kodak.
Kodak LX-24 X-ray developer 
Kodak FX-40 X-ray liquid fixer 
Kodak X-OMAT AR film
2.1.6 Enzymes.
Deoxyribonuclease I from Bovine Pancreas (1400-1800 
units/mg)
Ribonuclease type A from Bovine Pancreas (3000-4000 
units/mg)
Trypsin - TPCK from Bovine Pancreas (180-220 units/mg) 
were all obtained from Worthington, U.S.A.
Papain type III from Papaya Latex (16-40 units /mg) was 
obtained from Sigma, London.
Pronase (Streptomyces griseus) (approx. 6 units/mg) was 
obtained from Boehringer Mannheim, West Germany.
Protease S.aureus (Staphyloccus aureus V8)(570 units/mg) 
was obtained from Miles Scientific, U.S.A.
2.1.7 Livestock.
Rats were all Albino Wistar (Glasgow University Colony), 
Immature females were (16-23 days old) and mature were
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more than 60 days old. Prostatic tissue was obtained from adult 
males weighing approximately 250g.
Liver tissue for the glucocorticoid work was obtained from 
females weighing approximately 150g.
2.1.8 Human Tissue.
Human breast tissue was kindly supplied by surgical staff 
at various hospitals in the West of Scotland.
Samples of human myometrium and endometrium were obtained 
from several gynaecologists working in the:- 
Victoria Infirmary, Glasgow 
Western Infirmary, Glasgow 
Royal Infirmary, Glasgow 
Southern General Hospital, Glasgow 
David Elder Infirmary, Glasgow.
2.1.9 Miscellaneous.
Plastic disposable mini columns were obtained from the 
Amicon Corporation, Massachusetts, U.S.A.
Glass/glass tissue grinders were obtained from 
Kontes, U.S.A. or Cowie Scientific, Middlesborough, England.
Teflon/Glass homogenisers were obtained from Jencons 
(Scientific) Ltd., Leighton Buzzard, Beds.
Nitrocellulose was obtained from Schleicher and Schull, 
West Germany.
Protein A from Staphyloccus aureus was obtained from 
Sigma, London.
Before use^all glassware was washed and rinsed in glass 
distilled water.
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2.2 Methods
2.2.1 Human Tissue Handling.
2.2.1.1 Tissue Collection.
Tissue was collected fresh from the operating theatre.
In the case of breast tissue, collection was into an empty sterile 
container which was then transported to the laboratory on ice. In 
the case of myometrium, the tissue was obtained at hysterectomy.
The uterus was collected from the operating theatre and transported 
to the hospital Pathology Department on ice. Sections of 
myometrium were then cut by a pathologist. These sections were 
then transported to the laboratory on ice for analysis. Endometrial 
tissue was obtained at dilation and curretage, transferred to an 
empty sterile container, then transported to the laboratory on ice 
for analysis.
2.2.1.2 Tissue Storage,
Whenever possible, tissue was used fresh, but when this was 
not possible the tissue was stored at -20°Cin a medium of 50% (v:v) 
glycerol, 0.25M sucrose, 1.5mM MgC^, lOmM HEPES (N-2-hydroxyl- 
piperazine-N'-2-ethane sulphonic acid) pH7.4. Before use, the 
tissue was rehydrated in 0.25M sucrose, 1.5mM MgC^s lOmM HEPES 
pH7.4 for 20-30 minutes at 0-4°C. The properties of this storage 
medium have been described elsewhere (Crawford et al., 1984).
2.2.2 Purification of Human Myometrial Nuclei.
Myometrial tissue was dissected free of connective and other 
non muscle tissue before nuclear purification was commenced. The 
basic procedure was a modified version of that described by Widnell 
and Tata (1964).
Myometrial tissue was minced into very small pieces using 
both scissors and scalpel. These small pieces were then 
homogenised in 3-4 volumes of 0.32M sucrose/1.5mM MgCl2/0.2%
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Triton X-100 using 3 x 20 second bursts of an Ultra turrax homogeniser 
(Model TP 18/2). ' The homogenate was cooled on ice between each burst. 
The homogenate was then passed through 4 layers of cheese-cloth, and 
the clear filtrate rehomogenised using a teflon/glass homogeniser 
(2-3 strokes). The volume of this clear homogenate was then doubled 
using 0.32M sucrose/1.5mM MgC^ and the sucrose concentration reduced 
to 0.25M using distilled water. The homogenate was then layered over 
10ml of 0.32M sucrose/1.5mM MgC^ in 4-6 batches and centrifuged at
700g for 10 minutes using a JS 13 rotor in a Beckman J2-21 centrifuge
at 4°C. The crude nuclear pellet obtained was resuspended in 25ml of 
2.4M sucrose/1.5mM MgC^ using a teflon/glass homogeniser (1-2 strokes) 
and then centrifuged at 50,000g for 60 minutes using a JA 20.1 rotor 
in a Beckman J2-21 centrifuge at 4°C. The final nuclear pellet was 
taken up in 1.0ml of 0.32M sucrose/1.5mM MgC^ and washed once using 
this medium before final resuspension in 1.0ml of the same medium.
2.2.2.1 Assessment of the Purity of the Nuclear Preparation.
The purity of the nuclear preparation was assessed in two
ways. The first involved the use of phase contrast microscopy and 
the second by calculating the DNA: Protein ratio of the final nuclear
pellet (see Sections 2.9 and 2.10).
2.2.2.2 Fractionation of Human Myometrial Nuclei using 2M NaCl.
After purification the nuclei were "pelleted" by
centrifugation at 2000g and resuspended in 10-15 volumes of 50niM 
sodium phosphate buffer pH7.1/2M NaCl/1OmM di-isopropyl fluorophosphate 
(DFP). DFP was included to prevent degradation of protein by serine 
proteases. The nuclei were incubated for 2 hours at 4°C under 
these conditions, with occasional mixing. The extract was then 
centrifuged at 48,000g for 30 minutes at 4°C. The precipitate 
(Fraction A) was "resuspended" in 25mM sodium phosphate buffer pH7.1.
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The supernatant was dialysed overnight against 5-10 volumes of 25mM 
sodium phosphate buffer pH7.1 at 4°C with several changes of buffer. 
The contents of the dialysis bag were then centrifuged at 46,000g 
for 30 minutes at 4°C. The pellet (Fraction C) was taken up in 
25mM sodium phosphate buffer pH7.1/2M NaCl. Centrifugation was 
carried out using a Beckman J2-21 centrifuge.
The above procedure separates nuclear material on the basis 
of solubility in, or resistance to 2M NaCl. Fraction A represents 
the material insoluble in 2M NaCl. The supernatant from this step 
represents the nuclear material solubilised by 2M NaCl. Dialysis 
separates this material into Fraction B, the material which remains 
in solution at low ionic strength and Fraction C, the material soluble 
in 2M NaCl.
The three nuclear fractions were then assayed for protein 
DNA and RNA content (see Sections 2.9, 2.10 and 2.11).
2.2.2.3 Extraction of Myometrial Nuclei with 0.1M H^SO^.
The purified nuclei were "pelleted" as described in Section 
2.2.2.2. They were then resuspended in 10-15 volumes of 0.1M l^SO^/ 
5niM dithiothreitol (DTT)/10nM DFP at 4°C for 20 minutes. The extract 
was then centrifuged at 40,000g for 30 minutes at 4°C. The 
supernatant was removed at the extracted proteins precipitated at 
-20°C with 4 volumes of ethanol for 50 minutes. The precipitated 
protein was collected by centrifugation at 40,000g for 30 minutes at 
4°C. The pellet of precipitated protein was taken up in 25mM sodium 
phosphate buffer pH7.1/l.QM KC1.
The protein, DNA and RNA content of the final pellet was . 
then assayed (see Sections 2.9, 2.10 and 2.11).
Centrifugation was carried out using a Beckman J2-21 
centrifuge.
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2.2.2.4 Electrophoretic Analysis of the Nuclear Fractions.
2.2.2.4.1 Nuclear Fractions B and C.
These nuclear fractions were subjected to sodium dodecyl 
sulphate (SDS) polyacrylamide gel electrophoresis (P.A.G.E.) as described 
by Laemmli (1970). Analysis was carried out using slab polyacrylamide 
gels of 12.57o and 157o. In all cases a stacking gel of 5.37o was used. 
Slab gels were run at 50-60mA in an apparatus which incorporated a 
cooling system.
Gels were stained with Coomassie Blue (0.047, Brilliant Blue 
R 250/257, isopropanol/I07 acetic acid) overnight and destained with 
107, acetic acid/107, methanol in distilled water.
The protein present in nuclear Fraction B was precipitated 
by 4 volumes of acetone at -20°C for 1 hour. The protein was then 
collected by centrifugation and taken up in sample buffer.
Nuclear Fraction C was taken up in sample buffer. A small 
volume was then acetone precipitated to enable a protein determination 
to be carried out.
2.2.2.4.2 0.1M I^SO^ Nuclear Extract.
This was carried out essentially as described by Panyim and 
Chalkley (1969).
Electrophoresis was carried out on 1570 polyacrylamide gels 
in the presence of 6M urea. Pre-electrophoresis was carried out for 
approximately 11 hours. The nuclear extract was taken up in 0.9M 
acetic acid/157, sucrose. The tank buffer used was 0.9M acetic acid. 
Electrophoresis was carried out at 1.5mA/gel for approximately 
2\ hours.
Staining and destaining was carried out essentially as 
described in Section 2.2.2.4.1 with destaining being achieved using 
107, acetic acid.
- 82 -
2.2.2.5 Immobilisation of Nuclear Fractions on CN-Br activated
Sepharose 4B.
Nuclear fractions were prepared as described previously 
(see Sections 2.2.2.2 and 2.2.2.3). Prior to coupling, CN -Br 
activated Sepharose 4B was allowed to swell in lniM HC1 for 2Q-30 
minutes. Typically 500mg of Sepharose was used for each column. 
After swelling the Sepharose was collected on a sintered glass filter 
and washed with a further 40ml of ImM HC1. This was followed by 
washing with 5-10ml of 25niM sodium phosphate buffer pH7.1/0.1M KC1. 
The Sepharose was then immediately transferred to the appropriate 
nuclear fraction. The nuclear extract was then incubated with the 
Sepharose overnight at 4°C with continuous end-over-end mixing. The 
remaining unreacted groups on the Sepharose were then blocked by 
incubating the Sepharose resin with 0.2M glycine pH9.4 at room 
temperature for 2 hours. Again end-over-end mixing was employed 
throughout.
The Sepharose resin was then washed to remove any proteins 
which were not covalently bound. This was achieved using high and 
low pH washes in the presence of 0.5M NaCl. Initially the resin was 
washed with 20ml of 25ihM sodium phosphate buffer pH7.1/0.5M NaCl, 
this was followed by 20ml of 0.1M sodium acetate buffer pH4.0/0.5M 
NaCl, then finally by 20ml of 25mM sodium phosphate buffer pH7.1/
0.5M NaCl. To remove the NaCl the Sepharose resin was washed with 
100ml of 20mM HEPES pH7.4/1.5mM EDTA (HE buffer). The Sepharose was 
then stored in 20mM HEPES pH7.4/1.5mM EDTA/0.12M KC1 (HE/0.12M KC1). 
Control columns were prepared by coupling glycine to the Sepharose 
alone.
To check on the efficiency of protein coupling to the 
CN-Br activated Sepharose 4B, the supernatant from the initial
coupling incubation and subsequent washes were assayed for protein
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content (see Section 2.9). Usually 70-807o of protein present in 
solution initially was coupled to the Sepharose.
2.2.2.6 Pouring of Sepharose Resins in to Columns.
Plastic disposable mini-columns were used throughout. The 
columns were poured under gravity at 4°C using HE/0.12M KC1 as buffer..
Before use, each column was washed exhaustively with at least lOOmls 
of HE/0.12M KC1.
2.2.2.7 Buffers used in Binding Assays.
The running buffer used in all cases was HE/0.12M KC1. To
elute labelled receptor complex bound to the columns the buffer was changed' to
HE/2M KC1. The columns were then thoroughly washed with HE/0.12M KC1.
3
2.2.3 Labelling of Various Tissue Cytosols with H-oestradiol-17
3
2.2.3.1 Preparation of H-oestradiol and other Radioactive Steroid
Solutions.
3
Stock H-labelled oestradiol-17/3 was prepared at a 
concentration of 5 x 10 in absolute alcohol and stored at -20°C.
3
The other H-labelled steroids were prepared at the same concentration
in absolute alcohol, and stored at -20°C.
Solutions of non-radioactive steroids vere also prepared in
-4absolute alcohol usually at a concentration of 5 x 10 M and stored 
at -20°C.
2.2.3.2 Immature Rat Uterine Cytosol..
Immature female rats (16-23 days) were anaesthetised using 
chloroform and killed by cervical dislocation. The uteri were removed, 
dissected free from any adhering fat and mesentery and placed in 20mM 
HEPES pH7.4/1.5M EDTA/0.25nM DTI (HED buffer) at 4°C. The uteri were 
then homogenised (1.5 uteri/ml) in HED buffer using a glass/glass tissue 
grinder. The homogenate was then made 10nM with respect to di-isopropyl 
fluorophosphate (DEP) (using a stock solution of 1M in isopropyl alcohol) 
and centrifuged at 2000g in a Beckman J2-21 centrifuge at 4°C. The
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resultant supernatant ("cytosol”) was retained in this crude form for the 
labelling of receptor.. The cytosol was then labelled overnight at 4°C 
with 5 x 10 ^H-oestradiol 17-J3 (H). A 200 fold excess of diethyl- 
stilboestrol (DES) was included in a separate incubation to determine 
non-specific binding - (H+C). The final alcohol concentration in the H 
was 0.01% and in the H+C 0.02%.
Following this overnight incubation the cytosol was incubated 
at 37°C for 20 minutes to ensure activation of the receptor had taken 
place (Notides et al., 1981).
2.2.3.3 Removal of Unbound Steroid from the Cytosol.
This was achieved using 0.25% Dextran Coated Charcoal 
solution (0.25% w/v Nor it A Charcoal, 0.0025% w/v dextran T70 in 0.25M 
sucrose 1.5nM EDTA, lOmM HEPES pH7.4).
The same volume of DCC solution as cytosol to be "stripped" 
was centrifuged at lOOOg for 5 minutes to give a charcoal pellet. The 
supernatant was poured off and the cytosol added to the charcoal pellet. 
After resuspension, stripping was continued for 15 minutes at 0°C with 
periodic mixing of the tubes. At the end of this time, the charcoal 
was pelleted by centrifugation at lOOOg for 5 minutes. The "stripped" 
cytosol was then transferred to a clean tube.
lOpl aliquots of the H and H+C were then placed in plastic 
scintillation vials, 10ml of Triton toluene scintillant (1400ml toluene/ 
PPO (2,5-diphenyloxazole), (5g/1)POPOP (1,4-di-(2-(5-phenyloxazole))- 
benzene), (0.24g/l): 600ml Triton X-100: 200ml absolute alcohol) was
added to each vial and the vials counted in a Searle MKII Liquid 
Scintillation Analyser. The counting efficiency was calculated to be 
approximately 30%. The concentration of receptor in the cytosol could 
thus be calculated, and the appropriate volume (calculated as number of 
specific cpm) to be applied to the Sepharose column could be determined.
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2.2.3.4 Human Myometrial Cytosol.
Myometrial tissue was minced very finely using both scissors 
and scalpels. The tissue was then homogenised in HED/0.12M KC1 at 
a concentration of lOQmg/ml. Homogenisation was carried out using 
an Ultra-Turrax homogeniser (model TP 18/2). The homogenate was then 
passed through 4 layers of cheese-cloth, and the "filtrate" further 
homogenised using a glass/glass tissue grinder. This final 
homogenate was then made lOniM with respect to DFP. The remaining 
procedures were as described in Sections 2.2.3.2 and 2.2.3.3.
2.2.3.5 Human Breast Tumour Cytosol.
Tissue from tumours, previously shown to be oestrogen 
receptor positive, was homogenised in HED/0.12M KC1 at a 
concentration of 50mg/ml. Homogenisation was carried out using an 
Ultra-Turrax homogeniser (model TP 18/2), followed by the use of a 
glass/glass tissue grinder. The homogenate was then made lOniM with 
respect to DFP. The remaining procedures were as described in 
Sections 2.2.3.2 and 2.2.3.3.
2.2.3.6 Preparation of H-Oestradiol 17-p labelled Oestrogen 
Receptor in an Unactivated Form.
Immature rat uterine cytosol was prepared as described in 
Section 2.2.3.2 except for the inclusion of 20mM sodium molybdate 
which has been shown to inhibit the process of activation (Muller 
et al., 1983oJ),
2.2.4 Assay of the Various Nuclear Extract/Sepharose Columns
3
for the Ability to Bind Activated H-Oestradiol 17-p 
labelled Oestrogen Receptor.
Binding assays were carried out at 4°c using the buffers 
described in Section 2.2.2.7.
The volume of cytosol to be applied to the column (whether
H or H+C) was calculated as described in Section 2.2.3.3. About
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10,000 cpm were normally applied to each column. Before applying 
the sample,the flow rate of the column was recorded. After the 
sample had been applied,10 fractions each approximately 1ml in 
volume were collected in plastic scintillation vials. The eluting 
buffer was then changed from HE/0.12M KC1 to HE/2M KC1 and 6 fractions, 
each approximately 1ml in volume, were collected in plastic 
scintillation vials. The columns were then washed with approximately 
10ml of HE/0.12M KC1 before further use. 10ml of Triton toluene 
scintillant was added to each vial and the vials counted in a Searle 
MKII Liquid Scintillation Analyser at about 30% efficiency.
2.2.4.1 Calculation of Results.
Specifically bound cpm were calculated as the difference
between the cpm eluted with HE/2M KC1 after cytosol labelled in the 
3
presence of H E2 alone (H) was eluted through the columns and the
3
cpm eluted with HE/2M KC1 after cytosol labelled with H E2 plus a 
200 fold excess of DES (H+C) had been eluted through the column.
Binding was expressed as f mol bound/mg of protein immobilised on 
the column.
2.3 The Effect of Enzymic Digestion of Binding Activity
2.3.1 Preparation of Nuclear Extract/Sepharose Resins.
Both the 2M NaCl soluble nuclear material (Fraction C)/
Sepharose resin and the 0.1M nuclear extract/Sepharose resin
were prepared as described in Sections 2.2.2.2 and 2.2.2.3 
respectively.
2.3.2 Preparation of Enzyme Solutions.
Solutions of enzyme (lmg/ml) were made fresh before use,
Papain was supplied already in solution. DNase and RNase were dissolved 
in 20rriM HEPES pH7.4 supplemented-with ImM MgC^.
Trypsin was dissolved in HE buffer and in 20mM HEPES pH8.0. 
Protease S.aureus was dissolved in 50mM Tris/HCl pH7.8.
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Papain was activated at room temperature for 30 minutes in 
20mM HEPES pH6.4/55rriM cysteine-HCl/llmM EDTA/66pM mercaptoethanol 
before use.
Pronase was dissolved in HE buffer.
2.3.3 Digestion of the nuclear extract/Sepharose resins 
with various enzymes.
lOOmg of the appropriate nuclear extract/Sepharose resin was 
placed in a total volume of 1.0ml of each of the above enzyme solutions 
(lmg enzyme/ml), in a siliconised Eppendorf tube. The digestion reaction 
was carried out at 37°C for 2 hours with continuous end-over-end mixing. 
Following this incubation serine protease were inhibited by adding 
di-isopropyl fluorophosphate to a final concentration of lOmM.
2.3.3.1 Washing of the nuclear extract/Sepharose resins after 
digestion.
After digestion, the nuclear extract/Sepharose resins were 
collected on a sintered glass filter and washed with at least 100ml 
of HE buffer to remove the digestive enzymes.
2.3.3.2 Storage of the digested nuclear extract/Sepharose resins.
After washing, lOmg amounts of the digested nuclear extract/
Sepharose resins were placed in siliconised Eppendorf rubes and 0.2ml 
of HE/0.12M KC1 added. The Eppendorf tubes were then stored at 4°C 
until binding assays were carried out.
2.3.4 Assay of the ability of digested nuclear extract/Sepharose 
resin to bind labelled activated oestrogen receptor.
Immature rat uterine cytosol was labelled and "stripped" as
described in Sections 2.2.3.2 and 2.2.3.3.
A volume of cytosol corresponding to 10,000 cpm was placed 
in each Eppendorf tube and the total volume made up to 1.0ml using 
HE/0.12M KC1. The tubes were then incubated at 4°C for 60 minutes 
with continuous end-over-end mixing. At the end of this period the
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nuclear extract/Sepharose resin was pelleted by centrifugation.
0 .8ml of the supernatant was then placed in a plastic scintillation 
vial, 10ml of Triton toluene scintillant added and the vials counted 
in a Searle MKII Liquid Scintillation Analyser at about 30% 
efficiency. Each binding assay was carried out in triplicate.
2.3.4.1 Expression of results.
Controls were performed by using nuclear extract/Sepharose 
resin which had not been digested in any way. Binding activities 
measured after digestion of the nuclear extract Sepharose resin are 
expressed as a percentage of this control.
2.4 Saturation analysis of the binding activity
2.4.1 Preparation of nuclear extract/Sepharose resins.
Both the 2M NaCl soluble nuclear material (Fraction C)/ 
Sepharose resin and the 0.1M f^SO^ nuclear extract/Sepharose resin 
were prepared as described in Sections 2.2.2.2 and 2.2.2.3 respectively.
2.4.2 Methodology of the saturation binding assay.
After preparation the nuclear extract/Sepharose resin520mg
amounts were weighed into siliconised Eppendorf tubes and 0.2ml of
HE/0.12M KC1 added. The tubes were then stored at 4°C until a
binding assay was performed.
Immature rat uterine cytosol was "labelled" and "stripped"
as described in Sections 2.2.3.2 and 2.2.3.3.
An increasing range of cpm (corresponding to an increasing
amount of labelled activated oestrogen receptor) was added to each
set of assay tubes. The range of cpm added was usually 1,000 cpm-
30,000 cpm. This gives a range of 1.5 x 10 ^ M  to 4.5 x 10 ^ M  
3
H E2 (receptor bound). The total volume in each assay tube was 
then made up to 1.0ml using HE/0.12M KC1. The tubes were then
incubated at 4°C for 60 minutes with continuous end-over-end mixing.
After this incubation the nuclear extract/Sepharose resin was
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"pelleted" by centrifugation. 0 .8ml of the supernatant was placed 
in a plastic scintillation vial, 10ml of Triton toluene scintillant 
added, and the vials counted in a Searle MKII Liquid Scintillation 
Analyser at about 307o efficiency.
2.4.3 Expression of results.
The results were analysed using the method of Scatchard
(1949).
2.5 Labelling of immature rat uterine cytosol with various
3 -9H-compounds at a concentration of 5 x 10 M
2.5.1 ORG 2058.
Labelling was carried out essentially as described in 
Section 2.2.3.2 except for the inclusion of 10% glycerol in the 
homogenisation buffer. This has been shown to enhance the stability 
of the progesterone receptor. ORG 2058 was used as the ligand to 
probe for progesterone receptor as it does not cross react with the 
glucocorticoid receptor. Stripping of the cytosol was carried out 
as described in Section 2.2.3.3. A 200 fold excess of non 
radioactive ORG 2058 was used instead of DES. Stock solutions of 
the ligands were prepared as described for oestradiol-17p  in 
Section 2.2.3.1.
2.5.2 Tamoxifen.
3
Cytosol was "labelled" and "stripped" with H-tamoxifen 
(+ a 200 fold excess of unlabelled tamoxifen) as described in Sections
2 .2 .3.2 and 2 .2 .3.3 using "hot" and "cold" tamoxifen solutions prepared 
exactly as described for oestradiol-17 3^ in Section 2.2.3.1.
2.5.3 5 oi-dihydrotestosterone, mibolerone.
"Labelling" and "stripping" were carried out essentially 
as described in Sections 2.2.3.2 and 2.2.3.3 with a 200 fold excess
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of the appropriate non-radioactive ligand being used instead of DES. Stock 
solutions were prepared as described for oestradiol-17 ^  in Section 
2.2.3.1. Where appropriate, see text, glycerol (10%) and molybdate 
(20mM) were included in the homogenisation buffer.
2.5.4 Dexamethasone.
"Labelling” and "stripping" was carried out essentialy as 
described in Sections 2.2.3.2 and 2.2.3.3 with a 200 fold excess of 
the appropriate ligand being used instead of DES. Stock solutions 
were prepared as described for oestradiol-17/3 in Section 2.2.3.1.
2.5.5 With various ligands in the presence of DES.
The cytosol was labelled with the following ligands both 
alone and in the presence of a 200 fold excess of cold DES overnight at
4°C:-
Corticosterone, mibolerone, testosterone and 
5o< DHT.
• Stripping was carried out as described in Section 2.2.3.3.
2.5.6. Application of the cytosols prepared in Sections 2.5.1-2.5.5
to the nuclear extract/Sepharose resin columns.
Application was essentially as described in Section-2.2.4 but 
the specific activity of each radioactive ligand was taken into account 
when the volume of cytosol to be applied was being calculated. This 
was to ensure that the amount of protein-bound ligand applied was
3
comparable to that applied when H E2 labelled oestrogen receptor was 
applied to the column.
Binding to the nuclear extract/Sepharose resins was expressed 
as f mol bound/mg of protein bound to the column.
2.5.7 Labelling of female rat liver cytosol with ^H-Dexamethasone.
A female rat (approximately 150g) was anaesthetised using 
chloroform and killed by cervical dislocation. The liver was 
removed and washed on ice with HE/0.12M KC1, then minced using scissors.
Homogenisation was then carried out in approximately 10ml of 
HED/0.12M KC1 using a teflon/glass homogeniser. The homogenate was then 
made lOmM with respect to DFP. The homogenate was then centrifuged at
4°C at 50,000g for 15 minutes. The fat layer was then carefully removed
and the resultant cytosol was then labelled overnight at 4°C with either
-9 3 -9 35 x 10 M H-dexamethasone alone (H) or 5 x 10 M H-dexamethasone plus a
200 fold excess of non-radioactive dexamethasone (H+C).
After incubation, stripping of the cytosol was carried out
as described in Section 2.2.3.3. The stripped cytosol was then applied
to the nuclear extract/Sepharose column as described in Section 2.5.5.
3
2.5.8 Labelling of rat prostatic cytosol with H mibolerone
or 5o(dihydrotestosterone.
Ventral prostates were removed from male rats (approximately 
250g) which had been anaesthetised using chloroform and killed by 
cervical dislocation. After washing on ice using HE/0.12M KC1, 
homogenisation was carried out in HED/0.12M KCl/lOT, (v/v) glycerol 
using a glass/glass tissue grinder at 75mg prostate/ml. The homogenate 
was then made lOmM with respect to DFP. The homogenate was then spun 
at 46,000g at 4°C for 15 minutes.
The fat layer was then carefully removed and the resultant
o —9 3cytosol was then labelled overnight at 4 C with either (5x10 M) H-5oCdihydro-
3
testosterone or H-mibolerone. In each case a 200 fold excess of the 
appropriate non-radioactive ligand was included in the H+C incubation.
"Stripping" of the cytosol was carried out as described 
in Section 2.2.3.3. The stripped cytosol was then applied to the 
nuclear extract/Sepharose resin as described in Section 2.5.5. In some 
cases 20mM molybdate was included in the homogenising buffer.
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2.6 Measurement of possible competition between progesterone
receptors and oestrogen receptors for nuclear binding sites.
Parallel columns of nuclear extract/Sepharose resin were set 
3
up. Binding of activated H oestradiol—17 (3 labelled oestrogen 
receptor was then measured either alone or in the presence of 
cold ORG 2058 labelled progesterone receptor. The difference in bound 
label was assumed to represent the level of competition.
The reciprocal experiment was performed by measuring the
3
binding of H-ORG 2058 labelled progesterone receptor either alone 
or in the presence of excess cold DES labelled oestrogen receptor.
Again the difference in bound label was assumed to represent the level 
of competition.
Immature rat uterus was used as a source of receptor.
Binding to the nuclear extract/Sepharose columns in all 
cases was expressed as f mol bound/mg of protein immobilised on the 
column.
2.7 Protein Blotting Experiments
2.7.1 Fractionation of Human Myometrial Nuclei using 2M NaCl.
This was carried out essentially as described in 
Section 2.2.2.2. After nuclear Fractions B and C had been obtained 
they were treated as follows
An aliquot of nuclear Fraction B was retained for protein
assay and the remainder was precipitated using 4 volumes of acetone at
-20°C for approximately 1 hour. The precipitate was collected by 
centrifugation and boiled for 5 minutes in Laemmli sample buffer 
(62.5niM Tris HC1 pH6.8/2% SDS/57o 2-mercaptoethanol/10% sucrose).
Nuclear Fraction C was taken up in Laemmli sample buffer 
by boiling for 5 minutes. A small aliquot was removed and the 
protein precipitated using 4 volumes of acetone at -20°C for 
approximately 1 hour. The precipitate was collected by centrifugation
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and taken up in 25niM sodium phosphate buffer pH7.1/2M NaCl. A 
protein assay was then carried out.
2.7.2 SDS polyacrylamide gel electrophoresis of Nuclear 
Fractions B and C.
This was carried out essentially as described by Laemmli 
(1970). The main separating gel contained 12.570 acrylamide and the 
stacking gel contained 5.3% acrylamide. The gels run were of the 
slab type. Electrophoresis was carried out at a constant current of 
50-60mA using electrophoresis apparatus which incorporated a cooling 
system.
Gels were stained overnight in 0.047o Coomassie Blue (0.047o 
Brilliant Blue R-250/25% isopropanol/10% acetic acid) and destained 
using 10% acetic acid/15% isopropanol/75% distilled water.
2.7.3 Transfer of Electrophoretically separated Proteins 
onto Nitrocellulose.
The transfer of proteins to nitrocellulose was achieved 
electrophoretically at a constant current of 40mA overnight at room 
temperature using a Bio Rad Laboratories Trans blot TM cell and 
using 25mM Tris pH8.3/0.192M glycine/20% (v/v) methanol/2% SDS 
as electrode buffer.
After transfer the remaining unreacted groups on the 
nitrocellulose were blocked by incubating the nitrocellulose for 
2 hours at room temperature in 20mM HEPES pH7.4/0.12M KCl/0.5%
Tween-20 with constant shaking. Finally the nitrocellulose was 
washed for approximately 10 minutes in HE/0.12M KC1.
1252.7.4 Labelling of Immature Rat Uterine Cytosol with I- 
iodo oestradiol.
This was carried out as described in Section 2.2.3.2 with
-9 3 -9 1255 x 10 M H-oestradiol being replaced with 5 x 10 M I-oestradiol-
17 Q . The H+C incubation was omitted.
Stripping was carried out as described in Section 2.2.3.3. 
To determine how many cpm were being applied to the 
nitrocellulosej lOpl of the cytosol were counted using an LKB WALLAC 
1275 min-gamma counter.
2.7.5 Incubation of Cytosol with the Nitrocellulose.
The nitrocellulose was placed in a tailor-made polythene
125bag, double sealed on 3 sides. The I-E2 label led cytosol was 
then added to the bag and the fourth side of the bag sealed. The 
cytosol was then smoothed over the whole of the nitrocellulose before 
incubation at 37°C for 40 minutes with constant gentle shaking.
At the end of this incubation, the nitrocellulose was 
removed from the bag and washed at room temperature with 50ml of 2QmM 
HEPES pH7.4/0.12M KCl/0.5%, Tween-20 for 20 minutes with continuous 
shaking. This buffer was replaced with 30ml of HE/0.12M KC1 and 
the above washing repeated. This buffer was subsequently changed 
a further 3 times.
The nitrocellulose was then air dried and subjected to 
autoradiography at -70°C against an intensifying screen to enhance 
the sensitivity of the procedure.
2.7.6 Protein Blot using Rabbit Antiserum raised against 
Oestrogen Receptor.
2.7.6.1 Nuclear Fractions B and C.
Fractionation of human myometrial nuclei with 2M NaCl was 
carried out as described in Section 2.2.2.2.
Electrophoresis and transfer of the protein onto 
nitrocellulose were carried out as described in Sections 2.7.2 and
2.7.3 respectively. After transfer the remaining active groups 
were blocked using 20rhM HEPES pH7.4/0.12M KCl/37o BSA/0.17o azide 
(blotting buffer) for 2 hours at room temperature, with continuous 
shaking. The nitrocellulose was then washed with HE/0.12M KC1 at
- 95 -
room temperature for 10 minutes.
-9Immature rat uterine cytosol was "labelled" with 5 x 10 M
cold E2 essentially as described in Section 2.2.3.2 and "stripped"
before use as described in Section 2.2.3.3.
The cytosol was then incubated with the nitrocellulose
essentially as described in Section 2.7.5 with the incubation being
at 37°C for 60 minutes.
At the end of this incubation the nitrocellulose was
washed with 6 changes of 20mM HEPES pH7.4/0.12M KC1 (washing buffer)
over a period of 60 minutes at room temperature.
After this washing, blotting buffer containing rabbit
antiserum raised against oestrogen receptor was added to the
nitrocellulose, and the incubation continued at room temperature for
60 minutes with continuous shaking. The antiserum was preblocked
in blotting buffer overnight at 4°C before use, as it had been shown
previously to cross-react with serum albumin.
The nitrocellulose was then washed with 6 changes of
washing buffer over a 60 minute period at room temperature.
125I-labelled protein A (approximately 80,000 cpm) was
then added in blotting buffer to the nitrocellulose and the incubation
continued for 60 minutes at room temperature.
125I-labelled protein A was prepared by dissolving lmg in 
lml of 20mM Tris/HCl buffer pH7.2 containing 150niM NaCl and labelling
continued for 15 minutes at room temperature with Iodogen (lmg) and
175 175
300-500pCi of Na I (Salacinski et al., 1981). I-Iodide was
removed by gel filtration on Sephadex G-25. Fractions containing
the labelled protein A were pooled, divided into small samples,and
keptat -20°C until use.
Finally the nitrocellulose was washed with 6 changes of
washing buffer over a 60 minute period at room temperature.
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The nitrocellulose was then air dried and subjected to autoradiography 
at-7.0°C against an intensifying screen to enhance the sensitivity of 
the procedure.
Two types of control experiment were performed. The 
first omitted the addition of immature rat uterine cytosol i.e. 
activated occupied oestrogen receptor, the rest of the procedures 
were as above. In the second control experiment antiserum was 
replaced by normal rabbit serum, again the rest of the procedures 
were as above.
2.7.6 .2 0.1M HoS0, Nuclear Extract.2 4
Fractionation of human myometrial nuclei was carried out 
using 0.1M H^SO^ as described in Section 2.2.2.3. The precipitated 
protein was then taken up in Laemmli sample buffer.
Electrophoresis and transfer of the proteins onto 
nitrocellulose were carried out as described in Sections 2.7.2 and 
2.7.3.
The remaining procedures were carried out as described in 
Section 2.7.6.1.
2.8 Assay of Binding activity present in various Immature
Female Rat Tissues
Nuclei were purified from kidney, liver, spleen and uterus 
essentially as described in Section 2.2.2. The fractions of nuclear 
proteins were then prepared on the basis of initial solubility in 
or resistance to 2M NaCl as described in Section 2.2.2.2. In each 
case the appropriate Fraction C was then coupled to CN-Br activated 
Sepharose 4B as described in Section 2.2.2.5. The nuclear extract/ 
Sepharose resin complexes were then poured into columns as described 
in Section 2.2.2.6 .
2.8.1 Assay of binding Activity .
Immature rat uterus was used as the source of oestrogen 
receptor as described in Section 2.2.3.2 and Section 2.2.3.3.
Binding was expressed as f mol bound/mg of protein 
immobilised on the column.
2.9 Protein Determination
This was carried out using both the micro and standard 
Bradford assays (Bio Rad Laboratories Ltd., West Germany).
2.10 DNA Determination
DNA was determined by the modification by Katzenellenbogen 
and Leake (1974) of the method of Burton (1956).
2.11 RNA Determination
RNA was determined by the Orcinol reaction as described 
by Plummer (1978).
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3. Results
3.1 Assessment of Nuclear Purity and Composition of Nuclear
Fractions
3.1.1 Phase Contrast Microscopy.
An example of a final nuclear pellet under the phase contrast 
microscope is shown in Figure 5 . Many of the nuclei are long and thin, 
reflecting the fact they have come from the long thin muscle cells of the 
myometrium. The nuclei are in the main intact but look slightly damaged. 
The techniques required to disrupt muscle tissue are fairly harsh.
Nuclear preprations which contained mainly ruptured nuclei i.e. masses 
of chromatin could be seen under the microscope; were not used for subsequent 
protein extraction. The yield of pure nuclei varied from preparation to 
preparation but was usually between 30 and 35% as assessed by recovery of 
DNA from the initial homogenate. This relatively low and variable recovery 
was probably due to the fibrous nature of myometrial tissue which also 
varied from sample to sample.
3.1.2 DNA:Protein Ratio.
The protein and DNA content of the final nuclear pellet was 
determined as described in Sections 2.9 and 2.10 respectively. The values 
were then expressed as a ratio. The ratio of DNA:Protein was found to 
be in the range of 0.5-0.6 .
The non-histone protein content of metabolically active nuclei 
is much higher than the non-histone protein content of less active nuclei 
(Allfrey, 1971). Myometrial cells are fairly inactive, except during 
pregnancy and as such will have a lower non-histone protein content.
The DNA:Protein ratio of the purified nuclei reflects the lower level of 
non-histone protein found in these nuclei.
A DNA: Protein ratio within this range and the appearance of the 
nuclei under the phase contrast microscope were considered adequate for 
the nuclei to be used for subsequent protein extraction. The integrity
Figure 5 - Phase contrast photograph of human myometrial nuclei purified 
as described in Section 2.2.2.
(Magnification x 400).
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of each nuclear preparation to be used for protein extraction was assessed 
using the phase contrast microscope. Nuclear preparations containing 
large numbers of ruptured nuclei were discarded.
3.1.3 Composition of the Nuclear Fractions A, B and C.
The typical composition of the nuclear fractions after the 
human myometrial nuclei had been exposed to 2M NaCl as described in 
Section 2.2.2.2 is shown in Table 1. Protein, DNA and RNA determinations 
were carried out as described in Sections 2.9, 2.10 and 2.11 respectively. 
NaCl Extract
The majority (range 0.6mg-1.0mg) of protein was recovered in 
nuclear Fraction C (2M NaCl soluble material), with approximately equal 
amounts of protein being recovered in the other two fractions. However, 
the insoluble material remaining after the nuclei had been exposed to 
2M NaCl (Fraction A), was very sticky and impossible to redissolve. 
Subsequent analysis by the Lowry method (Lowry et al., 1951) of this 
’’particulate" fraction revealed significant amounts of protein remaining 
in this fraction (up to 400pg). The Bradford protein assay proved 
unreliable for particulate proteins and the conditions required to 
solubilise these proteins e.g. alkali or detergents subsequently 
interfered with the assay.
From the initial experiments (using the Bradford assay the 
recovery of protein seemed on the low side when compared to the recovery 
of DNA (see Table 1). On the basis of the protein and DNA content of 
pure nuclei, - it would be expected that the amount of protein recovered 
should be greater than the amount of DNA recovered. The same situation was 
still observed following assay of Fraction A by the Lowry method, suggesting 
that further protein may still be trapped and unassayable in Fraction A.
The bulk of DNA was recovered in nuclear Fraction A, with 
lesser amounts in nuclear Fractions C and B respectively.
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TABLE 1
Nuclear Fraction/ 
Constituent
0.1M HpSO/
Nuclear
Extract
A B C
Protein
(mg) 1.3 + 0.5 0.26 + 0.14 0.30 + 0.13 0.8 + 0.2
DNA
(mg) 0 1.5 +0.3 0.05 + 0.01 0.4 +0.05
RNA
(mg) 0.085 + 0.02 2.0 + 0.2 1.5 +0.2 0.23 + 0.03
Means of 4 Exps. + SD
Table 1 - The constituents of the various human myometrial nuclear fractions. 
Protein,DNA and RNA were determined as described in Sections 2.9, 2.10 and 2.11 
respectively. In each case the starting material was 12.5g of human 
myometrium.
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The bulk of RNA was recovered between nuclear Fractions A and 
B, with a much lesser amount being recovered in Fraction C.
0.1M HpSO/^  Nuclear Extract
The typical composition of the extract after human myometrial 
nuclei had been exposed to 0.1M as described in Section 2.2.2.3
is shown in Table 1 . The extract contains no DNA and only low levels of 
RNA.
3.1.4 Electrophoretic Analysis.
Fractions A, B and C.
Due to the "sticky” nature of Fraction A, this nuclear fraction 
was not subjected to electrophoretic analysis. Further, the high DNA 
content of this fraction would have interfered with the proper running 
of an electrophoretic gel.
Figure 6 shows nuclear Fractions B and C subjected to 
electrophoresis as described by Laemmli (1970) on al2.5% acrylamide gel.
The predominant features of Fraction C are the bands corresponding 
to the core histone proteins. These bands are absent in Fraction B.
Fraction C also contains numerous other higher molecular weight bands.
Fraction B contains many bands, the majority of which 
correspond to molecular weights greater than those of the core histone 
proteins.
Figure 7 shows the 0. 1M nuclear extract electrophoresed
as described by Panyim and Chalkley (1969). As with Fraction C, this 
nuclear fraction contains the core histone proteins and numerous other 
higher molecular weight proteins.
Figure 8 shows the 0.1M nuclear extract electrophoresed
as described by Laemmli (1970) on a 12.5% acrylamide gel. The major
bands correspond to the core histone proteins, with a cluster of bands 
present at a molecular weight of approximately 28,000 - 32,000.
m
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Figure 6 - SDS polyacrylamide gel electrophoresis of nuclear Fraction B 
(20pg, track 2) and nuclear Fraction C (20pg, track 3) on a 
12.5?0 acrylamide gel as described by Laemmli (1970).
After electrophoresis the gel was processed as described in 
Section 2.2.2.4.1. Track 1 standard molecular weight proteins. 
Phosphorylase b (94,000), bovine serum albumin (67,000), 
ovalbumin (43,000), carbonic anhydrase (30,000), soyabean 
trypsin inhibitor (20,100) and oC-lactalbumin (14,400).
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Figure 7 - 0.1M H^SO^ nuclear extract (15yg) electrophoresed as described 
by Panyim and Chalkley (1969) (See Section 2.2.2.4.2).
After electrophoresis the gel was processed as described in 
Section 2.2.2.4.2.
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Figure 8 - SDS polyacrylamide gel electrophoresis of the 0.1M H SO^ nuclear 
extract (20pg) (track 2) on a 12.570 acrylamide gel as described 
by Laemmli (1970) After electrophoresis the gel was processed 
as described in Section 2.2.2.4.1.
Track 1 standard molecular weight proteins as described in 
Figure 6.
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Figure 9 - SDS polyacrylamide gel electrophoresis of nuclear Fraction C 
(20pg)(track 2) and the 0.1M nuclear extract (20pg)
(track 3) on a 15% acrylamide gel as described by Laemmli 
(1970). After electrophoresis the gel was processed as 
described in Section 2.2.2.4.1.
Tracks 1 and 4 standard molecular weight proteins as 
described in Figure 6.
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Figure 9 shows the 0. 1M F^SO^ nuclear extract and nuclear 
Fraction C electrophoresed as described by Laemmli (1970) on a 15% 
acrylamide gel. As can be seen,both fractions contain the same pattern 
of core histone bands. Both fractions also contain a common band at a 
molecular weight of approximately 28,000 with numerous other high 
molecular weight bands being present.
3.1.5 Discussion.
Many published methods for the purification of mammalian 
nuclei work well with certain types of tissue but not with others. The 
chief difficulty in purifying nuclei lies in the initial disruption of the 
tissue,and the conditions under which it is carried out. A balance must 
be achieved between disrupting sufficient tissue to release the maximum 
number of nuclei possible without further damaging the already released 
nuclei any more than is necessary. In this study initial homogenisation 
was achieved using a fairly rough technique (Ultra Turrax homogeniser).
The remaining fibrous debris was then separated from the "homogenate" 
using cheesecloth and the resultant solution rehomogenised using a 
teflon/glass homogeniser to disrupt any remaining intact cells. The 
inclusion of 0.2% triton X-100 in the homogenisation medium proved 
successful in eliminating problems caused by erythrocyte contamination.
The use of these two methods of homogenisation minimised the damage caused 
to the released nuclei. However, as already mentioned in Section 3.1.1, 
the yield of nuclei was never very high. One problem often observed in 
the purification of nuclei is that of clumping, but the inclusion of 1.5mM 
MgCl2 in the homogenising medium seems to minimise this problem as well 
as helping to preserve the integrity of the nuclei.
The inclusion of triton X-100 in the homogenisation medium will 
destroy cell membranes and also strip off the outer nuclear membranes. The 
use of such detergents will also disrupt intracellular membranes releasing
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the enzyme components of the lysosomes, hence some damage to nuclear 
components must be anticipated under these circumstances (Hyodo and 
Ono, 1970).
No perfect method is available for the isolation of nuclei and, 
as such, each method available must be considered something of a compromise. 
The suitability of some methods to certain tissues must also be borne 
in mind as must the initial reason for isolating the nuclei. If metabolic 
studies are to be performed, the nuclei must be isolated in such a way 
that metabolic activity is preserved i.e. use of isotonic, sucrose 
containing media. However, if metabolic activity is not under 
investigation but purity and ease of preparation are important, procedures 
such as that of Higashi et al. (1966) which involve the use of citric acid 
may still be relevant. Dense sucrose methods have been used to isolate 
nuclei for metabolic studies, but they are perhaps best suited to the 
study of nucleic acids or other chemical constituents of the nucleus.
Assessing the purity of a nuclear purification is fraught 
with difficulty. Several tests of composition, and determination of 
enzymic activity, have been used as means of assessing the purity of 
nuclear components. All systems have built within them the hazards 
inherent in cell fractionation and differential centrifugation. Enzyme 
relocation, activation or destruction may modify the results obtained. 
Ascertaining yields on the basis of nuclear DNA has the problem of 
heterogeneity of the cell population in the original material as well as 
potential losses of DNA through lysis or experimental manipulation.
Use of enzymic assays particularly those designated to detect components of 
the endoplasmic reticulum must take into consideration the outer nuclear 
envelope as a component of the endoplasmic reticulum. Probably the most 
successful means of assessing the relative purity of a nuclear preparation 
with respect to cytoplasmic constituent contaminants, is electron
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microscopy. However using this technique alone is not enough, and the 
best idea of purity and integrity is achieved through the use of 
microscopic techniques in conjunction with some biochemical parameter.
The composition of the various nuclear fractions after the nuclei 
had been exposed to 2M NaCl indicates that under the conditions of 
extraction not all of the protein is dissociated from chromatin (see 
Table 1). A substantial amount remains associated with the material 
which is not solubilised under these conditions. This is not surprising 
as more severe extraction conditions have been reported to be required for 
complete dissociation of proteins from chromatin (e.g. Levy et al., 1972;
Van den Broek, 1973). Under these conditions 90-95% of the proteins 
present in chromatin was released. It has also been reported that 2M 
NaCl in conjunction with 5M urea fully dissociates histone protein but 
only 15% of the non-histone protein from rat liver chromatin (Wilhelm 
et al., 1972). Similar treatment of chromatin from rat livers bearing 
chemically induced tumours with 2.5M NaCl in conjunction with 5M urea releases 
only 20% of the non-histone proteins as well as the histone protein fraction 
(Chiu et al., 1975). The use of 0.1M was more efficient in releasing
proteins from chromatin, as suggested by the consistently higher protein 
content of the 0.1M nuclear extract when compared to nuclear
Fractions B and C.
Electrophoretic analysis of both nuclear Fraction C and the 
0.1M nuclear extract (see Figure 9) shows that their major
constituents are the histone proteins,with numerous minor bands 
corresponding to non-histone proteins. This is what would have been 
expected from previous studies(e.g. Levy et al., 1972). The loading of 
samples onto gels presented problems since the nuclear histone proteins 
represent nearly 60%, of total chromosomal proteins (Peterson and McConkey, 
1976). Hence the majority of any sample loaded for electrophoresis
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corresponds to histone protein, with the remainder of the sample 
corresponding to many non-histone proteins which are only present in 
small amounts. The use of 2-dimensional gel electrophoresis as described 
by O'Farrell (1977) would have given better resolution of the components 
of these nuclear extracts but for the purposes of the present work 
analysis using SDS PAGE was considered sufficient.
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3.2 Assay of the Various Nuclear Fractions Abilities to
3
Bind Activated H-E^ labelled Oestrogen Receptor.
3.2.1 Labelling of various cytosols.
Various tissues were used as a source of oestrogen receptor
for these studies.
Human Breast Tumour (oestrogen receptor positive), Human 
myometrial and immature rat uterine cytosols were prepared as described 
in Sections 2.2.3.5, 2.2.3.4 and 2.2.3.2 respectively. Labelling and 
DCC "stripping" were carried out as described in Sections 2.2.3.2 and
2 .2 .3.3 respectively.
The labelling pattern obtained with these different cytosols 
is presented in Table 2.
In these labelling experiments, the cytosol which shows the 
greatest difference in CPM between the "H" and "H+C" incubations i.e. 
competition,was considered to contain the largest number of specific 
binding sites i.e. oestrogen receptor molecules. All cytosols were of 
similar protein content. As can be seen in Table 2 the best source of 
oestrogen receptor is immature rat uterus.
This may reflect the fact that this tissue is probably the 
easiest to prepare a "cytosol" from, the other two being rather fibrous. 
Consequently the techniques required to disrupt them are more severe and 
probably result in damage to the native receptor.
3
3.2.2 The elution of H-E2 labelled immature rat uterine cytosol
through the various nuclear extract sepharose derivatives « 
Immature rat uterine cytosol (l-2mg protein/ml) was prepared,
labelled and DCC stripped as described in Sections 2.2.3.2 and 2.2.3.3 
respectively. It was then eluted through the various nuclear extract/ 
sepharose columns as described in Section 2.2.4. The composition of 
each affinity resin is indicated in Table 3 .
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TABLE 2
Source of Cytosol lOpl "H" lOpl "H+C"
Immature Rat Uterus 1600 + 200 150 + 50
l-2mg/ml
Human Breast Tumour 550 + 50 100 + 30
l-3mg/ml
Human Myometrium 300 + 50 120 + 40
1.8 - 2.4mg/ml
Means of 3 Exps. + SD
Table 2 - The labelling pattern obtained when different tissue cytosols
-9 3were labelled with 5x10 M H-E2 both alone and in the presence of a 
200 fold excess of cold DES. Labelling and stripping were carried out 
as described in Section 2.2.3.2 and 2.2.3.3.
The cytosols were prepared as described in Sections 2.2.3.2,
2 .2 .3.4 and 2 .2 .3.5.
Values quoted are cpm. Breast tumour samples were pre-selected 
as those being oestrogen receptor positive. Aliquots of cytosol were 
counted as described in Section 2.2.3.3.
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The elution profiles obtained from this experiment are 
presented in Figure 10.
As can be seen from Figure 10, in all cases a peak of 
radioactivity passes through the column and is not retained. However when 
HE/2M KC1 is applied to the columns differences emerge. The largest peak 
of radioactivity (labelled oestrogen receptor) is released from either 
the 2M NaCl soluble nuclear material (nuclear Fraction C) or the 
0.1M nuclear extract columns. Lesser amounts of radioactivity
(labelled oestrogen receptor) are released from the other nuclear fraction 
columns (Fraction A and B). A smaller peak of radioactivity is released 
from the control column which only has the o<-amino acid glycine coupled 
to the sepharose.
These results suggest that nuclear Fraction C and the 0.1M 
nuclear extracts possess an increased ability to bind activated
3
H-E2 labelled oestrogen receptor.
A more .important observation however, is that when an equivalent 
3amount of free H-E2 in HED buffer is eluted through the various nuclear
extract/sepharose columns, no large peak of radioactivity was released
on the application of 2M KC1. This observation answers several questions.
3
The first of these is that in order to observe binding of H-E2 to the
nuclear extract sepharose columns, the ligand must be bound by the
oestrogen receptor molecule. This was further confirmed by labelling
-9oestrogen receptor negative human breast tumour cytosols with 5 xlO 
3
H-E2 and eluting them through the various nuclear extracts. When 
2M KC1 was applied, no large peak of radioactivity was released. This 
suggests the presence of the oestrogen receptor is necessary to observe 
high levels of binding and also indicates that the binding cannot be 
induced by other cellular proteins which bind H-E2 . The second question 
this observation answers is that the binding is not due to either the
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binding of free ligand in the cytosol applied to the column or binding
of ligand which has become dissociated from receptor during equilibration
of cytosol with the column. Further, free ligand is not being retained
through binding to oestrogen receptor spuriously incorporated into the
protein initially immobilised onto the sepharose 4B resin. An observation
which also supports these ideas is that eluting cold DES in.HED buffer
through the columns prior to the application of labelled cytosol did not
3
reduce the observed binding of H-E2 labelled activated oestrogen receptor 
to any extent.
From this experiment is appears that the bulk of oestrogen
receptor binding activity is extracted into both the 2M NaCl soluble nuclear
material (Fraction C) and the 0.1M nuclear extract. Consequently
the majority of experiments concentrated on these two nuclear fractions.
The next question to be answered concerns the specificity of
the binding activity which is being observed, i.e. how much of the binding
activity is due to oestrogen binding proteins which are, nevertheless,
different from normal receptor —  defined in terms of affinity and binding
capacity. To answer this question immature rat uterine cytosol labelled 
3
with H-E2 either alone or in the presence of a 200 fold excess of cold 
DES was applied to the nuclear extract/sepharose columns.
The elution profile obtained when the above cytosols were 
applied to a nuclear Fraction C/sepharose column is presented in Figure 11.
As can be seen the majority of binding observed in the presence
3 3of H-E2 alone is due to the binding of activated H-E2 labelled oestrogen
receptor. In the presence of excess cold DES occupied oestrogen receptor,
3
the levels of H-E2 binding to the column are much lower. This level of 
competition strongly suggests that the binding activity observed is specific 
and represents the binding of activated H-E2 labelled oestrogen receptor 
to defined sites present on the nuclear Fraction C/sepharose column.
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TABLE 3
Nuclear Fraction Coupled to 
Sepharose 4B
3
f mol ( H-E2 labelled receptor) 
specifically bound/mg of 
immobilised protein
Fraction A (2M NaCl insoluble material) 
(500pg protein coupled) 15 + 1.5 (3)
Fraction B (material soluble at 
low Ionic strength)
(600pg protein coupled) 24 + 4.0 (3)
Fraction C (2M NaCl soluble material) 
(lOOOpg protein coupled) 40 + 2.5 (3)
0.1M I^SO^ extract 
(900pg protein coupled)
43+1.5 (3)
Control Column 
(Glycine coupled) 4 + ! (3)
Mean + SD No-Expts.
Table 3 - The abilities of the various nuclear fraction/sepharose resins
3
to specifically bind activated H-E2 labelled receptor complexes.
Specific binding was assessed as described in Section 2.2.4.1. 7,000 cpm
of both the H and H+C cytosols were applied in each case.
Immature rat uterine cytosol (l-2mg protein/ml) was used as a 
source of oestrogen receptor. Columns were run as described in Section 
2.2.4.
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The same experiment was repeated with the other nuclear 
extract/sepharose resins and the results are presented in Table 3.
The results in Table 3 confirm earlier observations that 
nuclear Fraction C and the 0.1M extract possess the greatest ability
o
to specifically bind activated H-E2 labelled oestrogen receptor.
3.2.2.1 Elution of various oestrogen receptor containing tissue
cytosols through a nuclear Fraction C sepharose column.
Cytosols were prepared as described in Section 3.2.1. These 
were eluted through a nuclear extract Fraction C/sepharose column as 
described in Section 2.2.4. The results from these experiments are 
presented in Table 4.
As can be seen there is variation in the amount (units) of
activated labelled oestrogen receptor from these different sources
bound to the nuclear Fraction C/sepharose resin. The concentration of
specific receptor applied to the column from each source does not reflect
the amount retained by the column. The binding induced by activated 
3
H-E2 labelled human myome trial oestrogen receptor is much lower than the 
receptor from human breast tumour cytosol and immature rat uterine cytosol, 
which can induce similar levels of specific binding to the nuclear 
Fraction C/sepharose resin. Again, this may be a reflection on the 
homogenisation techniques which are required to disrupt the myome trial 
tissue, possibly causing some damage to the acceptor binding domain of 
the receptor.
The levels of binding which are induced by oestrogen receptor 
from immature rat uterus and oestrogen receptor positive human breast 
tumour are comparable. However since not all breast tumour cytosols 
were capable of inducing specific binding, and immature rat uterus 
represents a more "convenient" source of oestrogen receptor it was used 
for all subsequent studies.
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TABLE 4
Source of Oestrogen Receptor
3
f mol Specifically bound ( H-E2 
labelled oestrogen receptor)/mg 
immobilised protein
Human breast tumour cytosol
(l-3mg/ml) 36+3.0
Human myome trial cytosol
(1.8-2.4mg/ml) 15+1.5
Immature rat uterine cytosol
(l-2mg/ml) 40 + 2.5
Means of 3 exps. + SD
Table 4 - The ability of activated oestrogen receptor from various sources 
to induce binding to the nuclear Fraction C/sepharose resin. The cytosols 
were prepared as described in Sections 2.2.3.2, 2.2.3.4, 2.2.3.5 and 
eluted through the column as described in Section 2.2.4. Specific 
binding of labelled oestrogen receptor complex was calculated as described 
in Section 2.2.4.1.The nuclear extract sepharose column contained 
lOOOpg of immobilised protein.
7,000 cpm of both the H and H+C cytosols were applied in
each case.
3.2.2.2 Effect of assay conditions on binding activity.
The results from these studies are presented in Tables 5 and
6 .
From these tables the binding activity appears to be reasonably
stable at a salt concentration between 0.12M and 0.15M KC1 but increasing
the KC1 concentration to 0.2M results in a sharp drop of 50-60% in the
observed binding activity. This drop is slightly more pronounced with
the 0.1M nuclear extract/sepharose resin. Increasing the KC1
concentration further to 0.5M, results in a loss of approximately 90%
of observed binding activity with both the nuclear Fraction C and 0.1M
I^SO^ nuclear extract/sepharose resins. Consequently all future binding
assays were carried out in the KC1 range of 0.12M - 0.15M, usually at a
KC1 concentration of 0.12M, which is approaching physiological ionic
strength in vivo.
Figure 12 shows the effect of the KC1 concentration on the
3
bound/free (B/F) values for the observed interaction of H-E2 labelled 
activated oestrogen receptor with the nuclear extract sepharose resins.
As can be seen, the B/F values are very sensitive to the KC1 concentration
in the range of 0.12M - 0.2M, a finding suggested by the data in Tables
5 and 6 . These data suggest that the interaction of the oestrogen 
receptor complex with the nuclear extract/sepharose resin is very- 
sensitive to the KC1 concentration within this range.
As shown in Tables 5 and 6 , the presence or absence of either
EDTA or DTT in the binding assay buffer had no effect on the observed
binding activity hence the buffer of choice for future binding assays was 
HE/0.12M KC1.
3.2.2.3 The effect of sodium molybdate on the observed binding activity 
Immature rat uterine cytosol was prepared and labelled + 20mM
sodium molybdate as described in Sections 2.2.3.2 and 2.2.3.6 . "Stripping1 
was carried out as described in Section 2.2.3.3. The cytosols were then
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TABLE 5
Eluting Buffers Used to run Column
f^ mol Specifically bound 
( H-E2 labelled oestrogen receptor)/ 
mg immobilised protein
HE/0.12M KC1 210 + 10
HED/0.12M KC1 200 + 10
HE/0.15M KC1 200 + 7
HE/0.2M KC1 107 + 6
HE/0.5M KC1 1 2 + 4
20mM HEPES pH7.4/0.12M KC1 195 + 6
HE/0.12M KC1 210 + 10
Means of 3 Exps. + SD
Table 5 - The influence of assay conditions on the levels of specific 
binding of activated oestrogen receptor to nuclear Fraction C/sepharose 
resin. Experiments were carried out using columns containing 500mg 
of sepharose resin with 500pg of immobilised protein. Immature rat 
uterine cytosol (l-2mg protein/ml) was used as a source of oestrogen 
receptor. 10,000 cpm of both the H and H+C cytosols were applied in 
each case. Specific binding was calculated as described in Section 
2 .2 .4.1.
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TABLE 6
Eluting Buffer used to run Column
f^ mol Specifically bound 
( H-E2 labelled oestrogen receptor) 
mg immobilised protein
HE/0.12M KC1 6 5 + 6
HED/0.12M KC1 6 4 + 5
HE/0.15M KC1 70 + 5
HE/0.2M KC1 25 + 1.5
HE/0.5M KC1 5 + 1.5
20mM HEPES pH7.4 0.12M KC1 61 + 3
HE/0.12M KC1 64+1.5
Means of 3 Exps. + SD
Table 6 - The influence of assay conditions on the levels of specific
binding of activated oestrogen receptor to the 0.1M H^SO^ nuclear
extract/sepharose resin. Experiments were carried out using columns
containing 500mg of sepharose resin with 900pg of immobilised protein.
Immature rat uterine cytosol (l-2mg protein/ml) was used as a source of
oestrogen receptor. 10,000 cpm of both the H and H+C cytosols were 
applied in each case specific binding was calculated as described in
Section 2.2.4.1.
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Figure 12 - The effect of KC1 concentration on the B/F ratio measured
3
from the specific binding of H-E2 labelled activated, 
oestrogen receptor to the nuclear Fraction C/sepharose 
resin. Immature rat uterine cytosol (l-2mg protein/ml) 
was used as a source of oestrogen receptor. 10,000 cpm 
of cytosol (H and H+C) were used for each point.
Columns of nuclear Fraction C/sepharose resin (300ug 
immobilised protein/500mg resin) were used.
eluted through parallel nuclear extract/sepharose resin columns as 
described in Section 2.2.4. •
The results from these studies are presented in Table 7.
As can be seen, the inclusion of 20mM sodium molybdate in
the homogenisation buffer has no effect on the subsequent binding of 
3
H-E2 labelled oestrogen receptor to both nuclear Fraction C and the 
0.1M l^SO^ nuclear extract sepharose resins made from human myometrium.
Previous reports have shown that molybdate inhibits the activation 
of oestrogen receptor (e.g. Muller et al., 1983a),as assessed by its ability 
to bind to DNA or nuclei. As such the data in Table 7 is somewhat difficult 
to reconcile.
However, earlier experiments studying the binding of immature 
rat uterine oestrogen receptor, prepared in the presence of 20mM sodium 
molybdate, to the 0.1M nuclear extract/sepharose resin prepared from
immature rat uterine nuclei showed that, in this case, the presence of 20niM 
sodium molybdate in the homogenisation buffer resulted in a decrease of 
approximately 50% in the observed binding activity. However, possible 
species differences after exposure of oestrogen receptor to molybdate 
seem unlikely.
3.2.2.4 Further studies of the binding of receptor to nuclear
Fractions B and C.
3
The initial studies on the binding of activated H-E2 labelled 
oestrogen receptor were carried out by coupling the entire nuclear fraction 
to sepharose, with the result that the various nuclear extract resins 
did not have equal amounts of protein immobilised on them.
For these studies, the separation of nuclear Fractions B and 
C was carried out as carefully as possible during the preparation.
Finally equal amounts of both fractions (0.3mg) were coupled to sepharose 
4B and multiple parallel affinity columns were set up and run as described
in Section 2.2.4.
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TABLE 7
Buffer used for Receptor Preparation
3
f mol Specifically bound ( H-E2 
labelled oestrogen receptor)/mg 
immobilised protein
Nuclear Fraction C
HED/0.12M KC1 212 + 9
HED/0.12M KCl/20mM
Sodium molybdate 232 + 8
0.1M HoSO^ Nuclear Extract
HED/0.12M KC1 63 + 6
HED/0.12M KCl/20mM
sodium molybdate 66 + 4
Means of 3 exps. +_ SD
Table 7 - The effect of preparing oestrogen receptor in the presence of 
20niM Na MoO^ on the specific binding to both the 0.1M H^SO^ nuclear
extract and nuclear Fraction C/sepharose columns. Immature rat uterine
cytosol (l-2mg protein/ml) was prepared as described in Section 2.2.3.6.
10,000 cpm of both the H and H+C cytosols were applied in each case.
500mg columns of sepharose resin were used containing 300pg immobilised
protein (Fraction C) and llOOpg immobilised protein (0.1M i^SO^ nuclear
extract). Specific binding was calculated as described in Section
2 .2 .4.1.
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The results from these studies are presented in Table 8 .
From these results it can be seen that nuclear Fraction C is
greatly enriched in binding activity compared to Fraction B. The more 
similar levels of binding observed in the two nuclear fractions previously 
may have been caused by contamination of nuclear Fraction B by small 
amounts of Fraction C.
3.2.2.5 Storage of the resins.
When stored in HE buffer containing 0.2% (w/v) NaN^ at 4°C, 
both nuclear Fraction C and the 0.1M nuclear extract/sepharose
resins lost less than 10% of their binding activity over an 8-10 week 
period. Nuclear extract/sepharose resins were not normally stored for 
longer periods of time than this.
3.2.3 Discussion.
The results presented in this section are in broad agreement 
with those of Mainwaring et al. (1976) and Puca et al.(1974) who report 
a binding activity for androgen and oestrogen receptor complexes 
respectively which can be extracted from target cell nuclei using buffers 
containing 2M NaCl. Subsequently Puca et al. (1975) have reported that 
the binding activity can also be extracted from target cell nuclei using 
^SO^. The data presented regarding the 0.1M extract of human
myometrial nuclei are in agreement with this.
One possible criticism of this work is the conditions 
which are required to solubilise the binding activity from target cell 
nuclei. Hie integrity of the structure of proteins, in particular, 
after they have been exposed to 2M NaCl or 0.1M must be uncertain.
Similar criticisms have been expressed of work carried out by Spelsberg, 
where high concentrations of denaturing agents such as guanidine 
hydrochloride have been used to either uncover or extract nuclear binding 
sites which can bind the progesterone receptor complex from chick
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TABLE 8
Nuclear
Fraction
cgm Specifically Bound 
( H-E2 labelled oestrogen 
Receptor
f mol. Bound/mg 
Protein Immobilised
B 375 + 120 18.5 + 6
C 4800 + 400 238 + 20
Means of 5 Exps. + SD
Table 8 - The data obtained when 500mg columns of sepharose resin 
containing 300pg of immobilised protein (both nuclear Fractions B and C) 
were assayed for the ability to specifically bind activated labelled 
oestrogen receptor. Immature rat uterine cytosol (l-2mgprotein/ml) was used 
as a source of oestrogen receptor. 10,000 cpm of both H and H+C cytosols 
were applied in each case. Specific binding was calculated as 
described in Section 2.2.4.1.
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oviduct. However, the best criterion by which to judge the integrity 
or nativeness of a biological structure is to assess whether or not the 
extracted biological molecule can still perform its intended in vivo 
function in vitro. In the case of the above studies by Puca et al.
(1974, 1975), and Mainwaring et al. (1976) this is clearly demonstrated 
by the specific high affinity saturable binding of steroid receptor 
complexes to nuclear proteins which have been immobilised on sepharose 
in vitro. The same can also be said for the two nuclear fractions (i.e. 
nuclear Fraction C and the 0.1M nuclear extract) isolated from
purified human myometrial nuclei with enhanced ability to specifically 
bind activated oestrogen receptor.
From this set of experiments it can be seen that all three 
nuclear fractions i.e. A, B and C, are able to bind activated labelled 
oestrogen receptor (see Table 3). The greatest binding activity was 
found in nuclear Fraction C. Subsequent experiments revealed that 
nuclear Fraction B possessed a much lower binding activity than nuclear 
Fraction C than appeared initially (see Table 8 ). The nature of the 
nuclear material remaining after 2M NaCl extraction made it impossible 
from these studies to be certain that the total binding activity of that 
fraction was being detected i.e. the bulk of Fraction A will not be 
coupled to the sepharose resin because of its insoluble nature. This 
was a limitation of the assay techniques used. The residual protein 
content of Fraction A (see Section 3.1.3) suggests more binding sites 
than those detected may be present in this fraction.
These results are in conflict with those of Ota et al. (1984), 
who report that the majority of binding sites for androgen receptor/ 
testosterone complexes reside in the material remaining after rat liver 
chromatin had been extracted with 2M NaCl which is equivalent to Fraction 
A. They also report binding sites for the androgen receptor complex in
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the material solubilised from chromatin with 0.35M NaCl and 2M NaCl. The 
detection of binding sites associated with the nuclear material insoluble 
in 2M NaCl lends support to the involvement of the nuclear matrix in the 
binding of steroid receptor complexes as has been previously suggested 
(e.g. Barrack and Coffey, 1982).
Varying the conditions under which the binding activity was 
assayed revealed that the optimum KC1 concentration for the interaction of 
labelledjactivated oestrogen receptor with both the nuclear Fraction C and 
0.1M H2SO^ nuclear extract/sepharose resins is in the range of 0.12 - 0.15M. 
Above this KC1 concentration the observed binding activity decreases 
sharply (see Figure 12 and Tables 5 and 6). It is appropriate that 
maximal binding activity can be observed at an ionic strength which is 
approaching the physiological value. At high ionic strength (0.5M KC1) 
only low levels of binding activity could be observed and are assumed to 
represent non-specific background binding. It seems unlikely that specific 
interaction between steroid receptor proteins and nuclear components could 
take place under such conditions. 0.5M KC1 also corresponds to a salt 
concentration which dissociates a large proportion of bound oestrogen 
receptor'from intact nuclei (Clark and Peck, 1979).
However it would appear that the optimum ionic strength for 
the interaction of steroid receptor complexes with nuclear components in 
vitro is not constant and varies depending on the system which is being 
studied. Mainwaring et al. (1976) omit KC1 from their assay buffers but 
show that the inclusion of 0.5M KC1 enables the specific high affinity, 
low capacity sites to be distinguished from non-specific, unsaturable 
binding. Puca et al. (1974, 1975) include KC1 in their assay buffers 
to a final concentration of approximately 0.1M and as reported by 
Mainwaring et al. (1976) use 0.4M KC1 to distinguish between specific 
high affinity binding and non-specific background binding. Kon and
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Spelsberg (1982) report that the optimum specific binding of the progesterone 
receptor to hen oviduct nuclei is observed if 0.18M KC1 is included in the 
binding assay buffer. Ruh and Spelsberg (1983) report that maximal 
binding of hen oviduct oestrogen receptor to purified hen oviduct chromatin 
occurs in buffers containing 0.1M KC1. When studying the binding of calf 
uterine oestrogen receptor to various target cell nuclei de Boer et al. 
(1984) include 0.15M KC1 in the assay buffers. From these studies it 
can be seen that no set of standard, defined assay conditions are available 
to study the binding of steroid receptor complexes to nuclear components 
in vitro. It is, however, important that the assay conditions in vitro 
should at least resemble the conditions in which the interactions occur 
in vivo.
Puca et al. (1975) report an optimal DTT concentration of 
l-2mM for the interaction of partially purified 4.5S oestrogen receptor 
with the mild acid extract/sepharose resin from calf uterine nuclei. In 
the present study it was observed that the presence (0.25mM) or absence of 
DTT in the eluting buffer had no affect on the observed interaction between 
labelled activated oestrogen receptor and both the 0.1M nuclear
extract and nuclear Fraction C/sepharose resins. These observations 
suggest that sulfhydral groups are not important for the interaction 
between receptor molecules and nuclear components immobilised on the 
sepharose resins. However, previous reports have shown that sulfhydral 
groups on the oestrogen receptor are important in the interaction with 
oestradiol (Jensen et al, 1967).
The presence or absence of EDTA in buffers used to both prepare 
the immature rat uterine cytosol and elute it through both the 0.1M 
nuclear extract and nuclear Fraction C/sepharose resins seemed to have 
little effect on the observed binding activity (Tables 5 and 6 ).
Interestingly EDTA has been reported to inhibit the conversion 
of oestrogen receptor from the 4S-^ 5.3S form when mouse Ieydig tumour
cytosol was heat activated (Sato et al* 1978a). It might be expected that 
inhibition of the activation would result in a decrease in the observed 
binding activity, but no such decrease was observed in the presence of 
EDTA.
Sodium molybdate has also been shown to inhibit the process 
of oestrogen receptor activation as measured by DNA binding activity 
(Pettersson et al., 1982). As can be seen from Table 7, preparation of 
immature rat uterine cytosol in the presence of 20mM sodium molybdate 
does not result in a decrease in the observed binding activity to both 
the 0.1M I^SO^ nuclear extract and nuclear Fraction C/sepharose resins.
This might suggest that the binding site on the receptor molecule 
responsible for the binding to the nuclear fractions is distinct from 
the DNA binding site on the oestrogen receptor molecule. It has been 
reported that approximately 20% of the receptor population in immature 
rat uterine cytosol is insensitive to Inhibition of activation by 
20niM molybdate (Hyder, 1983). It is possible that this small population 
of receptor molecules is responsible for the observed binding, but as no 
decrease whatsoever in the binding is observed in the presence of molybdate 
this explanation seems unlikely. A similar class of oestrogen receptor 
capable of being activated in the presence of molybdate has been reported 
in some breast tumours (Thomas et al., 1983).
Interestingly, Littlefield and Spelsberg (1985) report that 
molybdate stabilised progesterone receptor still binds to oviduct 
chromatin at a level of 407, of that seen with activated, fully functional 
receptor. However the binding to chromatin of this inactive progesterone 
receptor is unsaturable.
The best assay system as defined by the maximum amount of 
observed binding activity comprised oestrogen receptor from immature 
rat uterus interacting with human nuclear components immobilised on
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sepharose. Several lines of evidence suggest that there is similarity 
between the immature rat uterine oestrogen receptor and human oestrogen 
receptor. The first of these concerns the cross reaction of both 
polyclonal and monoclonal antibodies raised against calf uterine 
oestrogen receptor with a variety of oestrogen receptor preparations from 
various sources. These included human breast tumour and uterine oestrogen 
receptor and rat uterine oestrogen receptor.(Greene et al., 1980;
Greene and Jenson, 1982). The cross-reactivity of these antibody 
preparations suggests that the oestrogen receptor molecules with which they 
interact must share a number of common features. The second line of 
evidence is that the oestrogen receptor from human and rat tissues 
interacts with DNA cellulose resin in comparable ways, suggesting that at 
least the DNA binding domain of these different receptors must share some 
common features. From these observations it does not seem unreasonable 
to use immature rat uterine oestrogen receptor to probe the extracts of human 
myometrial nuclei for specific binding sites.
One interesting observation was that only 2 out of 
approximately 20 oestrogen receptor positive breast tumour cytosols were 
capable of inducing binding to the nuclear Fraction C sepharose resin.
The two cytosols which induced binding had reported oestrogen receptor 
levels of 234f.mol/mg protein and 361f.mol/mg protein. There was no 
obvious reason why these samples should have induced such a high level of 
binding except perhaps for a slightly better labelling pattern in the 
initial H and H+C incubations. It is interesting to speculate that the 
other receptor positive tumour cytosols may have contained similar levels 
of oestrogen receptor but also some inhibitory factor which prevented the 
binding of receptor to the nuclear Fraction C sepharose resin (Di Sorbo 
et al., 1980). The presence of such a factor which inhibits the binding 
of oestrogen receptor to DNA has been reported in human breast tumour 
cytosol (Hyder and Leake, 1983).
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Previously Puca et al. (1974) have reported that both crude 
and partially purified calf uterine oestrogen receptor could be used to 
study the acceptor activity extracted from the calf uterine nuclei by 
2M NaCl. In this study crude cytosol was used as a source of oestrogen 
receptor, with no attempt being made to purify the oestrogen receptor 
in any way.
The use of a crude cytosol preparation may complicate the 
assay system if the cytosol contains factors which either promote or 
inhibit the binding of receptor to components of the various nuclear 
extracts (Cake et al., 1978). It would be interesting to carry out 
experiments using purer receptor preparations, and observing any effect 
on the observed binding activity. Littlefield and Spelsberg (1985) 
report that purification of progesterone receptor prior to nuclear 
binding assays destroys specific saturable binding of the receptor 
suggesting that purification may have removed a factor which was essential 
for the previously observed specific, saturable binding.
The use of crude cytosol as a source of oestrogen receptor 
may also introduce complications in that other molecules may become 
labelled with oestradiol. The two types of molecule most likely to become 
labelled with oestradiol are the type II binding sites (Clark and Peck, 
1979) and sec hormone binding globulin (SHBG). Two approaches were used 
to minimise the binding of label to these two classes of molecule. The 
first of these was to label cytosol with a concentration of ligand at 
which only oestrogen receptor molecules ('type I sites) would approach 
saturation. The second involved assessing non-specific binding using 
an excess of cold DES, a synthetic molecule which has a higher affinity 
for the oestrogen receptor than oestradiol. DES does not bind to SHBG, 
hence if competition can be measured in the presence of cold DES, it is 
fairly certain the binding of label alone represents binding to the
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oestrogen receptor and not SHBG.
The observed binding activity appeared to be very dependent
on the presence of activated, labelled oestrogen receptor complex (see
3
Figure 10 and Table 3). When H-oestradiol alone was applied to the
nuclear extract sepharose columns, very little, if any, binding was observed.
This is in agreement with previous reports of Puca et al. (1974),
Mainwaring et al. (1976), and more recently Ota et al; (1984), that when
studying the binding of steroid receptor complexes to nuclear components
in vitro, the ligand alone is incapable of inducing significant levels
of binding. Further support that the presence of the activated,
labelled, oestrogen receptor complex was required for binding came from
the observation that prior elution of cold DES through the nuclear
extract/sepharose columns could not block the binding of activated, labelled
oestrogen receptor. This rules out the possibility of exchange between 
3
H-E2 applied in the cytosol and oestrogen receptor, extracted initially 
from the myometrial nuclei, and covalently coupled to the sepharose resin.
Comparing the levels of binding activity assayed in nuclear 
Fraction C (Tables 3 and 8 ) reveals that later preparations were enriched 
with the ability to bind activated labelled oestrogen receptor when 
compared to earlier ones. This can only be attributed to practice 
and experience in handling and preparing the nuclear fractions and also 
in performing the binding assay itself.
Comparing the binding activity exhibited by the 0.1M 
nuclear extract and nuclear Fraction C/sepharose resins, it appears that 
nuclear Fraction C is enriched in the ability to bind activated labelled 
oestrogen receptor (see Tables 5 and 6 ). This may suggest that the use 
of 2M NaCl is more efficient at solubilising the nuclear components 
responsible for the binding activity. The other obvious possibility 
is that 0.1M is equally efficient at solubilising the appropriate
nuclear components but under these acid conditions a proportion of the 
extracted components are denatured which results in a decrease in the
- 135 -
3.3 Effects of Digestive Enzymes on Binding Activity
Both the 0.1M nuclear extract and nuclear Fraction C/
sepharose resins were digested with various enzymes as described in
Section 2.3.3. The ability of the digested nuclear extract/sepharose
3
resins to bind activated H-E2 labelled oestrogen receptor was then 
determined as described in Section 2.3.4.
The data are presented in Tables 9 and 10.
As can be seen, only the proteolytic enzyme trypsin is capable
of destroying the ability of both the 0.1M l^SO^ nuclear extract and
3
nuclear Fraction C/sepharose resins to bind activated H-E2 labelled 
oestrogen receptor. Digestion of the nuclear extract/sepharose resins 
with either DNase or RNase has no effect on the binding activity. It has 
been reported that nucleic acids must be structurally modified before they 
can be covalently attached to sepharose to any great extent (Poonian 
et al. ,1971). Hence, only low levels of nucleic acid should become 
attached to the sepharose under the coupling conditions. This suggests 
the binding activity present on both nuclear extract/sepharose resins is 
proteinaceous.'
However the. reduction in binding activity caused by trypsin
digestion is not as great as might be expected. To explore this problem
further the nuclear extract/sepharose resins were digested with a variety
3
of proteolytic enzymes and their ability to bind activated H-E2 labelled
oestrogen receptor was determined. The results from these studies are
presented in Tables 11 and 12.
As can be seen in Tables 11 and 12 papain, pronase and trypsin
3
all destroy approximately 50% of the binding sites for activated H-E2 
labelled oestrogen receptor present on both of the nuclear extract/ 
sepharose resins. The proteolytic enzyme protease S.aureus has a far 
less damaging effect on the binding activity.
- 136 -
TABLE 9
Enzyme used to Digest the 
Nuclear Extract/Sepharose Resin
% of Binding Activity Present 
in Control Binding Assay
Control (no digestion) 100%
DNase 92 + 5%
RNase 92 + 8%
Trypsin 55 + 15%
Mean of triplicates + SD
Table 9 - The effect of various digestive enzymes on the ability of the
0.1M nuclear extract/sepharose resin (900pg immobilised protein/
500mg resin) to bind activated labelled oestrogen receptor. Immature rat 
uterine cytosol (l-2mg protein/ml) was used as a source of receptor.
10,000 cpm were added to each experiment. Before incubation the nuclear 
extract/sepharose resin was digested as described in Section 2.3.3. 
lOmg of resin was used for each binding assay.
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TABLE 10
Enzyme used to Digest the 
Nuclear Extract/Sepharose Resin
% of Binding Activity Present 
in Control Binding Assay
Control (no digestion) 1007,
DNase 94 + 47o
RNase 91 + 67o
Trypsin 51 + 137o
Mean of triplicates + SD
Table 10 - The effect of various digestive enzymes on the ability of the 
nuclear Fraction C/sepharose resin (600pg immobilised protein/500mg resin) 
to bind activated labelled oestrogen receptor. Immature rat uterine 
cytosol (l-2mg protein/ml) was used as a source of oestrogen receptor. 
10,000 cpm were added to each experiment. Before incubation the nuclear 
extract/sepharose resin was digested as described in Section 2.3.3. 
lOmg of resin was used for each binding assay.
- 138 -
When compared to the results presented in Tables 9 and 10 it 
can be seen that trypsin destroys a slightly larger percentage of the 
available binding sites present on both nuclear extract/sepharose resins 
(Tables 11 and 12). In these studies the digestion of the nuclear extract/ 
sepharose resins was carried out at pH8.0 compared to pH7.4 in the earlier 
studies. pH8.0 represents the optimum pH of this enzyme and the slight 
increase in the observed potency of trypsin in destroying binding sites 
may reflect the slight difference in the conditions under which the 
digestions were carried out.
Again, the reduction in binding activity caused by these 
proteolytic enzymes does not approach 100%, as might have been expected 
under the conditions present in the digestion incubation (see Section 
2.3.3).
3.3.1 Discussion.
The data presented in this section is again in broad agreement 
with data presented by Puca et al. (1974) and Mainwaring et al. (1976),
who have shown that the binding activity they observe for calf uterine
oestrogen receptor and rat ventral prostate androgen receptor respectively, 
is sensitive to proteolytic enzymes, but is unchanged by DNase or RNase 
digestion, indicating that the nuclear components responsible for the 
binding activity are protein in nature. However, the decrease in binding 
activity caused by proteolytic enzymes is approximately 90%, a figure 
somewhat larger than the figures reported in this study. There are several 
possible explanations for this discrepancy. One problem may be that the 
proteolytic enzymes cannot gain full access to the proteins immobilised on the
sepharose or it may be that the proteins are immobilised on the sepharose 4B
in a conformation which does not allow attack by the proteolytic enzymes.
The observation that papain, pronaseand trypsin reduce the binding activity by
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TABLE 11
Proteolytic Enzyme used to Digest 
the Nuclear Extract/Sepharose Resin
7o of Binding Activity Present 
in Control Binding Assay
Control (no digestion) 100%
Papain 49 + 37o
Trypsin 48 + 47o
Pronase 53 + 27o
Protease S.aureus 75 + 57o
Mean of Quadruplicates + SD
Table 11 - The effects of various proteolytic enzymes on the ability of 
the 0.1M nuclear extract/sepharose resin. (l,000pg immobilised
protein/500mg sepharose resin) to bind activated labelled oestrogen 
receptor. Immature rat uterine cytosol (l-2mg protein/ml) was used 
as a source of oestrogen receptor. 10,000 cpm were added to each 
experiment. Before incubation the nuclear extract/sepharose resin was 
digested as described in Section 2.3.3. lOmg of resin was used for each 
binding assay.
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TABLE 12
Proteolytic Enzyme used to Digest % of Binding Activity Present
the Nuclear Extract/Sepharose Resin in Control Binding Assay
Control (no digestion) 100%
Papain 50 + 6%
Trypsin 4 4 + 3 %
Pronase 57 + 2%
Protease S.aureus 81 + 3%
Mean of quadruplicates _+ SD
Table 12 - The effects of various proteolytic enzymes on the ability of 
the nuclear Fraction C/sepharose resin (800pg immobilised protein/500mg 
sepharose resin) to bind activated labelled oestrogen receptor.
Immature rat uterine cytosol (l-2mg protein/ml) was used as a source of 
oestrogen receptor. 10,000 cpm were added to each experiment. Before 
incubation the nuclear extract/sepharose resin was digested as described 
in Section 2.3.3. lOmg of resin was used for each binding assay.
approximately the same amount, but protease S.aureus reduces the binding 
to a lesser extent is interesting. Apart from pronase the other enzyme 
preparations represent a single enzyme type, all of which have a similar subunit 
molecular weight (20,000-25,000), so the lesser reduction in binding activity 
caused by protease S.aureus cannot be explained because.it is too large to 
gain access to the immobilised proteins.
The digestion of the nuclear extract/sepharose resins by the 
various proteolytic enzymes was carried out as far as possible at the 
optimum pH of the enzyme in question. Comparing digestion of the nuclear 
extract/sepharose resins with trypsin at pH7.4 and 8.0, shows a slightly 
greater decrease in binding activity caused by digestion at pH8.0 which 
is the optimum pH for the enzyme. The effect of varying the pH on the 
three dimensional structure of the immobilised proteins should not be too 
great. The proteins are covalently attached to the sepharose, and as such 
should be held in a fairly rigid manner, which should not be altered to 
any great extent by the changes in pH, introduced during the digestion 
reactions.
One thing that it is important to bear in mind from these 
results is the role that DNA or RNA may play in the nuclear retention of 
steroid receptor complexes in vivo. Using this in vitro system it appears 
that the observed binding activity is protein in nature but it has been 
reported that DNase treatment of uterine nuclei releases bound oestrogen 
receptor (e.g. King and Gordon, 1972) and that RNase treatment of 'HeLa' 
cell nuclei causes a release of glucocorticoid receptor complexes 
(Rossini, 1984). Recent advances in the field of DNA/steroid receptor 
interactions have increased our knowledge of the role of DNA in the 
nuclear retention of steroid receptor complexes but as yet, no specific 
role • for RNA in nuclear binding has become apparent, although Lin and Ohno 
(1983) have reported selective interaction of oestrogen receptor from
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hen oviduct with poly A RNA and a similar interaction of mouse kidney 
androgen receptor with RNA (rnRNA, tRNA and rRNA) (Lin and Ohno, 1981).
Feldman et al. (1981) report that cytosol from MIW9 rat mammary tumour contains 
a high molecular weight inhibitor of oestrogen receptor binding to DNA.
RNase treatment destroys the inhibitory activity, suggesting the involvment 
of an RNA molecule. A similar situation has been reported for the binding 
of both oestrogen and glucocorticoid receptors from MCF7 cells to DNA 
cellulose (Chong and Lippman, 1982). These observations suggest that 
steroid receptor - RNA interactions may play a role in gene regulation.
3.4 Saturation Analysis of the Nuclear Binding Activity
3.4.1 The 0.1M f^SO^ Nuclear Extract.
Initial saturation analysis was carried out by adding increasing 
amounts of labelled,activated oestrogen receptor complex and, in parallel, 
corresponding H+C labelled receptor to a 0.1M nuclear extract/
sepharose column. From the difference the number of specifically bound 
cpm in each case is calculated. A typical saturation curve obtained
from such a set of experiments is shown in Figure 13. This curve
indicates that the binding of H-E2 labelled activated oestrogen receptor 
to the 0 .1M I^SO^ nuclear extract/sepharose resin is saturable.
However this experimental technique was laborious and time 
consuming to perform and as a result, future saturation analyses were 
carried out using suspensions of protein linked sepharose as described in 
Section 2.4. These experiments were carried out using increasing amounts
of ^H-E2 labelled oestrogen receptor in the presence of both HE/0.12M KC1 and 
HE/0.5M KC1 buffers. Binding which occurred in the presence of 0.5M KC1 
was assumed to be non-specific.
The data from such analyses were plotted out in two ways:-
(a) as for conventional saturation analysis and (b) as described by 
Scatchard (1949).
Figure 14 shows a typical saturation curve obtained from such 
an analysis and Figure 15 shows a typical plot of the data when they were 
treated as described by Scatchard (1949). This indicates that specific 
binding of oestrogen receptor to the protein-sepharose matrix reflects 
a single class of high affinity binding sites. The parameters 
calculated from such a plot are shown in Table 13.
The estimated number of binding sites present was 2000 f mol/ 
mg immobilised protein.
The apparent Kd of the interaction of activated, labelled 
oestrogen receptor (see Table 13) indicates that the binding involved is 
very tight.
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Figure 13 - The binding curve obtained when increasing numbers of cpm
(both H and H+C) were applied to a 0.1M nuclear
extract/sepharose column (lOOOpg immobilised protein/500mg 
resin). Immature rat uterine cytosol (l-2mg protein/ml) 
was used as a source of oestrogen receptor as described in 
Sections 2.2.3.2 and 2.2.3.3. Specific binding was 
calculated as described in Section 2.2.4.1.
3.4.2 Nuclear Fraction C.
3
Saturation analysis of the binding of H-E2 labelled, activated 
oestrogen receptor to nuclear Fraction C/sepharose resin was carried out 
as described in Section 2.4, again using both HE/0.12M KC1 and HE/0.5M KC1 
as incubation buffers.
The pattern of binding of labelled, activated oestrogen
receptor to this nuclear extract/sepharose resin was very similar to that
*
shown in Figure 14, again suggesting the binding activity comprised a 
single class of high affinity saturable sites.
The parameters calculated from these experiments are also 
shown in Table 13.
These results when combined, show that both the 0.1M 
nuclear extract and nuclear Fraction C/sepharose resins contain a single 
class of high affinity, saturable binding site for activated, labelled 
oestrogen receptor complex. The binding which is observed in the 
presence of 0.5M KC1 indicates that both nuclear extract/sepharose resins 
contain non-specific binding sites for activated, labelled oestrogen 
receptor complex.
When compared to the saturating levels of binding of 
labelled, activated oestrogen receptor reported in Section 3.6 (Tables 
23 and 24), it can be seen that when the binding assay is carried out 
in "suspension”, the number of available binding sites is increased.
From the studies in this section it appears that both the 0.1M 
nuclear extract and nuclear Fraction C/sepharose resins contain 
comparable numbers of high affinity binding sites. The experiments 
reported in Section 3.6 show that nuclear Fraction C contains a greater 
number of binding sites for labelled, activated oestrogen receptor.
This may suggest that nuclear Fraction C also contains numerous lower 
affinity binding sites not eliminated by the competition procedure used.
Figure 14(a) - The binding curve obtained when an increasing range of
3
cpm (corresponding to an increasing amount of H-E2 
labelled oestrogen receptor) was added to. 20mg amounts 
of the 0.1M nuclear extract/sepharose resin
(850pg immobilised protein/500mg resin). Immature 
rat uterine cytosol (l-2mg protein/ml) was used as a 
source of receptor as described in Sections 2.2.3.2 and 
2.2.3.3. Non-specific binding was assessed in the
presence of 0.5M KC1.
(b) Apparent saturation curve obtained from data in (a).
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Figure 15 - A typical plot obtained ’when the data obtained from the 
saturation studies using the 0.1M I^SO^ nuclear extract/ 
sepharose resin (850pg immobilised protein/500mg resin) 
were analysed as described by Scatchard (1949). Analysis 
was carried out as described in Section 2.4.2.
The binding parameters for the saturable high affinity 
interaction of activated, labelled oestrogen receptor complex with these 
nuclear fractions have been calculated at 4°C, under physiological pH 
conditions and almost physiological ionic strength.
3.4.3 Discussion.
It is now generally accepted that under defined conditions 
of pH and ionic strength, it is possible to observe saturable binding 
of steroid receptor complexes to target cell nuclei, chromatin or isolated 
chromatin components (Spelsberg et al., 1976a).
Saturation analysis provides an insight into the 
characteristics of the binding sites at a concentration of steroid which 
falls within the physiological range. The data presented in Sections
3.4.1 and 3.4.2 show that both the 0.1M nuclear extract and nuclear
Fraction C/sepharose resins contain a limited number of specific, saturable 
binding sites for activated, labelled oestrogen receptor complex.
Saturation analysis was carried out at an ionic strength which is known 
to extensively dissociate receptor complex from intact nuclei i.e.
0.4-0.6MKC1 (Clark and Peck, 1979). It is well accepted that the nuclear 
binding of oestrogen receptor complexes can be divided into a form which 
is salt extractable and a form which is not extracted under these 
conditions (Clark and Peck, 1979). However it is not certain which of 
these two types of nuclear binding is physiologically important i.e. 
which results in specific gene activation. Hence, the assumption that 
the binding observed in the presence of 0.5M KC1 represents non-specific 
binding may not be strictly correct as receptor can still be bound in the 
remaining nucleus under such conditions. However, the binding observed 
under these conditions was never saturable, and was offlower affinity 
than the specific saturable binding observed in 0.12M KC1. An attempt 
to analyse non-specific binding using "H" and nH+C" cytosols as described
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TABLE 13
Nuclear Fraction Coupled to 
Sepharose 4B
Calculated Kd of Interaction with 
H-E2 Labelled Oestrogen Receptor
0.1M t^SO^ Extract
850pg Immobilised Protein/500mg 
sepharose resin
Kd = 39 + 8x10"12M 
12Approximately 1.2x10
Binding sites/mg immobilised protein
(2000 f mol)
Nuclear Fraction C - 2M NaCl 
soluble material Kd = 44 + 9x10 '
400pg Immobilised Protein/500mg 
sepharose resin
11Approximately 1.0x10
Binding sites/mg immobilised protein
(1810 f mol)
Mean of 3 Exps. +_ SD
Table 13 - The apparent dissociation constants for the interaction of
3
activated H-E2 labelled oestrogen receptor complexes with 
the nuclear Fraction C (400pg immobilised protein/500mg 
resin) and the 0.1M l^SO^ nuclear extract (850pg immobilised 
protein/500mg resin)/sepharose resins at 4°C. Analysis was 
carried out as described in Section 2.4.2. Immature rat 
uterine cytosol (l-2mg protein/ml) was used as a source of 
oestrogen receptor.
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in Section 3.2.2, was made. Unfortunately, the results obtained were 
too erratic to enable any significant conclusions to be made. As a 
result, it was assumed that binding observed in the presence of 0.5M KC1 
was non-specific and did not represent binding of activated, labelled 
oestrogen receptor to specific saturable sites on both of the nuclear 
extract/sepharose resins.
The data presented are in broad agreement with those of 
Mainwaring et al. (1976), who show that the 2M NaCl extract from rat 
prostate nuclei binds labelled androgen receptor in a manner which can be 
resolved into two components. However only one of these was saturable. 
These high affinity, low capacity sites were shown to have an apparent 
Kd of 2.5x10 which is comparable with the apparent Kd which can be 
calculated from the data in Figure 15. The second binding component 
observed by Mainwaring et al. (1976) comprised a large number of low 
affinity sites, which could be occupied by receptor complex in buffers 
containing0.5M KC1. In contrast, the high affinity,low capacity sites 
could not be occupied by receptor complex in the presence of 0.5M KC1, 
in agreement with the data reported here.
The data are also in broad agreement with that of Puca et al.
(1974), who show that the 2M NaCl extract from calf uterine nuclei binds
-9 ooestrogen receptor complex with an apparent Kd of 3x10 M at 4 C.
The presence of 0.4M KC1 inhibited or strongly suppressed the observed 
binding activity. Subsequent work (Puca et al., 1975) on the interaction 
of a protein preparation solubilised by mild acid treatment of uterine 
nuclei with oestrogen receptor complex revealed an apparent Kd for the 
interaction at 4°C of 2x10” “^M. Again the presence of 0.4M KC1 strongly
inhibited the specific interaction between the two components. Studies 
which have examined the binding of oestrogen receptor complexes to intact 
nuclei have reported apparent Kd values which are in good agreement with 
those presented in this study. Higgins et al. (1973) report a Kd of
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2-3x10 for the interaction of oestrogen receptor complexes from
immature rat uterus with uterine nuclei and Kon and Spelsberg (1982)
report a Kd of 1.8x10 for the interaction of the oestrogen receptor
from hen oviduct with hen oviduct nuclei. Binding was confined to a
single class of sites with 3000-5000 sites/nucleus. Similarly, De Boer
et al. (1984) report that the binding of calf uterine oestrogen receptor
-9to chicken target cell nuclei occurs with an apparent Kd of 0.4-1.0x10 M, 
which is again in good agreement with the data presented from this study. 
Similar high affinity binding bind sites (Kd=lxl0 ^M) have been reported 
for androgen receptor complexes associated with the nuclear matrix of the 
prostate (Barrack, 1983).
Evidence to support the existence of different subclasses of 
nuclear binding sites for steroid receptor complexes has come mainly from 
work carried out by Spelsberg and his co-workers. Analysis of the 
saturable binding of the progesterone receptor to its '’acceptor” led 
Spelsberg (1976) to conclude that there were in fact several classes of 
nuclear binding sites with differing affinities for the hormone receptor 
complex. The highest affinity class of binding sites display a Kd of 
10’ -12m and were fully saturated before any physiological changes were 
observed. The intermediate class of sites display a Kd of 5x10 
and are probably involved in fine genetic control. Occupation of this 
intermediate class of binding sites by receptor complexes correlated 
with changes in the activities of both RNA polymerases I and II. The 
lowest affinity binding sites display a Kd of 1x10 and will only be 
partially filled by the concentration of steroid in the plasma.
Further evidence supporting the existence of different 
classes of binding sites for steroid receptors in chromatin has come 
from work where the binding of steroid receptor complexes to chromatin 
has been compared before and after the chromatin has been extracted with
a range of concentrations of various chaotrophic agents. Using such
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techniques Ruh et al. (1981) studied the binding of oestrogen receptor 
complex to calf uterine chromatin, and were able to resolve the binding 
of receptor into two components using an increasing range of guanidine 
thiocyanate concentrations (1-6M), and into 3 components using a range of 
guanidine hydrochloride concentrations (1-8M). These techniques rely on 
the ability of the chaotrophic agents to "uncover" binding sites, which 
appear to be "masked" by specific fractions of chromatin proteins, and 
as such gave support to the idea that in target and non-target chromatin, 
the high affinity, specific binding sites are "hidden" to differing extents, 
making them inaccessible to steroid receptor complexes.
A great deal of progress has been made recently regarding the 
interaction of various steroid receptor complexes with specific DNA 
sequences. However, the apparent Kd for the interaction of oestrogen 
receptor complexes with a variety of heterologous DNA molecules is only 
4-6x10 (Buller and O'Malley, 1976). The affinity of the interaction 
reported for steroid receptor complexes with specific DNA sequences is 
only 10-40 times greater than this, which still represents binding of 
insufficient affinity to explain the physiological effects of steroid 
hormones at the very low concentrations at which they occur in vivo.
For the sake of comparison, the lac repressor protein binds to its 
specific DNA sequence in the lac operon region of the E.coli genome 
with an apparent Kd of approximately 10 (Riggs et al., 1970), this 
being a classic example of a protein whose in vivo effects are realised 
through interaction with a specific DNA sequence.
When these observations are considered it seems unlikely that 
the interaction of steroid receptor complexes with specific DNA sequences 
can explain the in vivo effects of steroid hormones, thus it would seem 
likely that other nuclear components are involved in steroid hormone 
receptor recognition and binding. In view of the data presented in this
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study, and data which have previously been published (e.g. Mainwaring 
et al., 1976; Puca et al., 1974; 1975), specific chromosomal proteins, 
such as those involved in the fractions used here, must be involved in 
the acceptor sites in vivo.
For many years Spelsberg has supported the idea that both 
DNA and protein have a role to play in the three dimensional structure 
of "acceptor" sites for steroid hormone receptor complexes in vivo, 
a view that is shared by Leake (1981). The strongest evidence to support 
this proposal so far comes from Spelsberg et al. (1984) who report that 
only a limited number of specific DNA sequences are present in the avian 
genome which can interact with the chromatin protein fraction they have 
previously shown to possess binding activity towards the chick oviduct 
progesterone receptor.
- 154 -
3.5 The Ability of Various Steroid Receptor Complexes
to Bind to the Nuclear Extract/Sepharose Resins
3.5.1 Immature Rat Uterine Cytosol.
In order to probe both the 0.1M nuclear extract and
nuclear Fraction C/sepharose resins for binding sites for various steroid
receptor complexes, immature rat uterine cytosol (l-2mg protein/ml)
was labelled as described in Section 2.5. DCC stripping was carried out
as described in Section 2.2.3.3. The specific activity of the ligand
in question was taken into account when calculating the volume of cytosol
to apply to the column, to ensure that similar amounts of protein bound
ligand were applied in each case. 10,000 cpm of cytosol labelled with 
3
H-E2 was used as reference.
The labelling pattern obtained after the cytosols had been 
- labelled with various ^H-ligands (5x10 M^) is shown in Table 14.
The immature rat uterine cytosol was also labelled with various 
ligands (5x10 M^) plus a 200 fold excess of cold DES . The labelling 
patterns obtained are shown in Table 15.
As can be seen from Table 14, the levels of receptor molecules for 
androgens, glucocorticoids and progestins were much lower in immature rat 
uterine cytosol than the level of oestrogen receptor.
The pattern observed when labelling was carried out in the 
presence of a 200 fold excess of cold DES (see Table 15),indicates that 
these various ligands do not bind to the oestrogen receptor to any 
significant extent, and are presumably bound by the cellular receptor 
protein in question.
Interestingly, the anti-oestrogen tamoxifen, which expresses 
some of its anti-oestrogenic effects via the oestrogen receptor (Taylor 
et al., 1984) does not show the same labelling pattern as that induced by 
E2 (see Table 14). This may be a reflection of the lower affinity that
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TABLE 14
Ligand used to label cytosol
(5x10 M) cpm/lOpl "H" cpm/lOpl "H+C"
e9 1600 + 200 150 + 50z
Dexamethasone 250 + 40 70 + 15
5 U  DHT 180 + 40 80 + 25
Mibolerone 240 + 70 80 + 15
Tamoxifen 670 + 130 300 + 85
ORG 2058 250 + 30 60 + 10
Means of 3 Exps. + SD
TABLE 14 - The pattern of labelling obtained when immature rat uterine
cytosol (l-2mg protein/ml) was labelled with various 
3 _9H-ligands (5x10 M). Competition was measured in the 
presence of a 200 fold excess of the same "cold" ligand 
except for E2 where competition was assessed in the 
presence of a 200 fold excess of DES.
TABLE 15
Ligand used to label cytosol
(5x10 M) cpm/lOpl "H" cpm/lOpl "H"
+ 200 fold excess DES
Eo 1600 + 200 150 + 50z
Corticos terone 200 + 40 185 + 30
Testosterone 100 + 20 95 + 20
Mibolerone 220 + 50 210 + 50
5 oC DHT 190 + 40 185 ± 20
Means of 3 Exps. + SD
TABLE 15 - The pattern of labelling obtained when immature rat uterine
cytosol (l-2mg protein/ml) was labelled with various 
-9ligands (5x10 M) alone or in the presence of a 200 fold 
excess of DES.
tamoxifen displays for the oestrogen receptor molecule, when compared 
to the natural ligand oestradiol (Sutherland and Whybourne, 1981).
The levels of specific binding induced by the various ligands 
to both the 0.1M l^SO^ nuclear extract and nuclear Fraction C/sepharose 
resins are presented in Tables 16 and 17 respectively.
As shown in Tables 16 and 17 the greatest amount of binding 
is induced when the cytosol is labelled with H-E2 , i.e. labelled, activated 
oestrogen receptor is formed and is recognised by some component(s) of 
the nuclear extract/sepharose resins.
The other ligands are capable of inducing lower levels of 
binding, suggesting that there may be binding sites present on the nuclear 
extract/sepharose resins for the various other steroid hormone receptor 
complexes. The labelling pattern shown in Table 15 suggests that binding 
is not the result of the various other ligands interacting with the 
oestrogen receptor which then binds to the nuclear extract/sepharose 
resins.
As can be seen from Tables 16 and 17, nuclear Fraction C 
appears to show a 3 fold enrichment in binding sites for oestrogen 
receptor complexes when compared to the 0.1M l^SO^ nuclear extract.
However, some masking of acceptor sites may occur in the 0.1M 
nuclear extract/sepharose resins since the protein content of the 0.1M
nuclear extract used for these studies was 900pg immobilised protein/ 
500mg resin compared with 400pg immobilised protein/500mg resin for the 
nuclear Fraction C/sepharose resin. Whatever the reasons, the fact that 
the nuclear Fraction C/sepharose resin contains more binding sites/unit 
of protein attached to the resin supports the existence of specific 
binding sites, i.e. the observed binding is not due to non-specific 
protein - protein interaction.
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TABLE 16
3
H-ligand used to label cytosol 
(cpm applied)
f mol specifically bound/mg 
immobilised protein
E2
(1 0,000)
66 + 7
Tamoxifen 10 + 2
(8800)
5 c< DHT 14 ± 2
(10,300)
Mibolerone 13 + 2
(7500)
ORG 2058 20 + 2
(4500)
Dexamethasone 11 ± 2
(7700)
Means of 3 Exps. +_ SD
TABLE 16 - The extent of binding to 0.1M nuclear extract/
sepharose resin (900pg immobilised protein/500mg resin)
after labelling immature rat uterine cytosol (l-2mg
-9protein/ml) with various ligands (5x10 M) alone or in 
the presence of a 200 fold excess of the same cold 
ligand except for E2 where competition was assessed in 
the presence of a 200 fold excess of cold DES. Specific 
binding was calculated as described in Section 2.2.4.1.
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TABLE 17
3
H-Ligand used to label the cytosol 
(cpm applied)
f mol specifically bound/mg 
immobilised protein
E2
207 + 20
(1 0,000)
Dexamethasone 0
(7700)
5 o< DHT 9 + 2
(10,300)
Mibolerone 7 + 2
(7500)
Tamoxifen 30 + 3
(8800)
ORG 2058 0
(4500)
Mean of 3 Exps. +_ SD 
TABLE 17 - The extent of binding to a nuclear Fraction C/sepharose
column (400pg immobilised protein/500mg resin) after
labelling immature rat uterine cytosol (l-2mg protein/ml)
-9with various ligands (5x10 M) alone or in the presence 
of a 200 fold excess of the same cold ligand except for 
E2 where competition was assessed in the presence of a 
200 fold excess of cold DES. Specific binding was 
calculated as described in Section 2.2.4.1.
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The 0.1M T^SO^ nuclear extract/sepharose resin appears to be 
slightly enriched in specific binding sites for androgen receptor 
complexes when compared to nuclear Fraction C/sepharose resin, but the 
levels of specific binding in both cases are markedly lower than those 
induced by labelled activated oestrogen receptor complex.
Specific binding sites for both glucocorticoid receptor complexes 
and progesterone receptor complexes could be detected in low levels using 
the 0.1M nuclear extract/sepharose resin but no such binding sites
could be observed when the nuclear Fraction C/sepharose resin was analysed.
Both the 0.1M f^SO^ nuclear extract and nuclear Fraction C/
sepharose resins displayed specific binding sites for tamoxifen/oestrogen
receptor complexes, with nuclear Fraction C showing a slight enrichment
when compared to the 0.1M nuclear extract. The levels of binding
to both nuclear extract/sepharose resins were much lower, approximately
3
15% of that induced by H-E2 labelled, activated oestrogen receptor complex.
The labelling patterns in Table 14 show that the immature rat 
uterine cytosol is not a particularly good source of either androgen or 
glucocorticoid receptor. As a result further studies using female rat 
liver cytosol as a source of glucocorticoid receptor and ventral prostate 
cytosol as a source of androgen receptor were carried out to ensure that 
the low levels of binding sites for these receptor complexes observed in 
previous experiments were not due to poor receptor preparations.
3.5.2 Female Rat Liver Cytosol.
Female rat liver cytosol was prepared and labelled as described 
in Section 2.5.7.
The labelling pattern obtained is shown in Table 18. As can 
be seen the H+C incubation contains quite a high number of cpm, and this 
may be due to the greater protein concentration and complexity present 
in this cytosol.
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TABLE 18
Source of Cytosol Ligand used as label cpm/lOpl1’H" cpm/lOpl "H+C"
Female Rat Liver 
(30-35mg protein/ml)
Dexamethasone 1800 + 130 1150 + 200
Ventral Prostate 5oC DHT 250 + 50 150 + 30
(5-6mg protein/ml) Mibolerone 280 + 50 150 + 30
Means of 3 Exps. + SD
TABLE 18 - The pattern of labelling obtained when female rat liver
cytosol was labelled with 5x10 M dexamethasone and ventral
_ Q
prostate cytosol was labelled with 5x10 7M 5o( DHT or 
mibolerone. Competition was measured in the presence of a 
200 fold excess of the same cold ligand.
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Cytosol (30-35mg protein/ml) was then applied to nuclear 
Fraction C/sepharose resin (300pg immobilised protein/500mg resin) and 
0.1M nuclear extract/sepharose resin (llOOpg protein/5OOmg resin).
Again the specific activity of the ligand was taken into account when 
calculating the volume of cytosol to apply to the columns.
The levels of specific binding to both the nuclear extract/ 
sepharose resins are presented in Table 19.
As can be seen, using an improved source of glucocorticoid 
receptor enabled the detection of specific binding sites in the nuclear 
Fraction C/sepharose resin which had not been possible when immature rat 
uterus was used as a source or receptor.
Similarly, the use of rat liver cytosol as a source of 
glucocorticoid receptor resulted in an increase in the observed level of 
specific binding to the 0.1M nuclear extract/sepharose resin (see
Table 19).
An interesting observation made during these experiments was 
that although the non-specific binding of dexamethasone to cytosol 
protein was much higher in liver than uterus (compare Tables 14 and 18), 
the non-specific binding to the columns was similarly low in both cases. 
This suggests that the observed specific binding to the nuclear extract/ 
sepharose columns represents binding of labelled, activated glucocorticoid 
receptor and that the label bound in the H+C incubation is bound to numerous 
lower affinity sites which do not bind to the nuclear proteins - again 
confirming the specificity of such interactions.
3.5.3 Ventral Prostate Cytosol.
Ventral prostate cytosol was prepared and labelled as 
described in Section 2.5.8.
TABLE 19
Ligand used to label female 
rat liver cytosol
f mol specifically bound/mg 
immobilised protein
Dexamethasone
Nuclear Fraction C 48 + 7
0.1M nuclear extract 29 + 4
Means of 3 Exps. + SD
TABLE 19 - The extent of binding to a nuclear Fraction C/sepharose
column (300pg immobilised protein/500mg resin) and a
0.1M nuclear extract/sepharose column (llOOpg
immobilised protein/500mg resin) after labelling female
rat liver cytosol (30-35mg protein/ml) with dexamethasone 
-9(5x10 M) alone and in the presence of a 200 fold excess 
of the same cold ligand. Specific binding was calculated 
as described in Section 2.2.4.1. 7700 cpm of both the
H and H+C cytosols were applied in each case. The cytosol 
was prepared as described in Section 2.5.6 .7.
- 164 -
The labelling pattern obtained is shown in Table 18. Virtually
no difference in the labelling pattern could be observed by including
20mM sodium molybdate in the homogenisation buffer. The observed
3
labelling pattern was slightly better when H-mibolerone was used as ligand 
instead of 5oCDHT. The inclusion of ORG 2058 had no effect on the 
observed labelling pattern, indicating that binding to the progesterone 
receptor was not responsible for the enhanced labelling pattern. However, 
the levels of binding present in the ventral prostate cytosol are very 
low,and it was expected that they would be higher. There appears no 
obvious reason for these consistent low binding levels.
Cytosol (5-6mg protein/ml) was then applied to both the 
nuclear Fraction C/sepharose resin (300pg/immobilised protein/500mg 
resin and the 0.1M nuclear extract/sepharose resin (llOOpg
immobilised/500mg resin). As previously, the specific activity of the 
ligand was taken into account before applying cytosols to the columns.
The observed levels of specific binding to both the 0.1M 
nuclear extract and nuclear Fraction C/sepharose resins are 
presented in Tables 20 and 21 respectively.
As can be seen from Table 21 the highest levels of binding to the
3
nuclear Fraction C/sepharose resin are observed when H-mibolerone is used 
as ligand hence %-mibolerone was used as ligand for future experiments.
As can be seen from Tables 20 and 21 the use of ventral 
prostate cytosol as a source of androgen receptor has enabled higher levels 
of binding sites for the androgen receptor complex to be observed in both 
the 0.1M nuclear extract and nuclear Fraction C/sepharose resins
compared to when immature rat uterus was used as a source of androgen 
receptor. Again from Tables 20 and 21 it can be seen that the inclusion 
of 20niM sodium molybdate in the homogenisation buffer has no great effect 
on the observed levels of binding to both the 0.1M nuclear extract
and nuclear Fraction C/sepharose resins. This is a situation similar
- 165 -
TABLE 20
Ligand used to label cytosol f mol specifically bound/mg 
immobilised protein
Mibolerone
HED/0.12M KCl/10% 36 + 5
Glycerol
HED/0.12M KCl/10% Glycerol 38 + 3
20nM molybdate
Means of 3 Exps. _+ SD
TABLE 20 - The extent of binding to a 0.1M i^SO^ extract sepharose 
column (llOOpg immobilised protein/5OOmg resin) after 
labelling rat ventral prostate cytosol (5-6mg protein/ml)
+ 20mM sodium molybdate with mibolerone (5x10 %) alone 
and in the presence of a 200 fold excess of cold 
mibolerone. Specific binding was calculated as described 
in Section 2.2.4.1. 7500 cpm of both the H and H+C cytosols
were applied in each case. Prostate cytosol was prepared 
as described in Section 2.5.7.8 .
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TABLE 21
Ligand used to label cytosol 
(cpm applied)
f mol specifically bound/mg 
immobilised protein
5o< DHT
HED/0.12M KCl/10% Glycerol 
(10,300 cpm)
17 + 4
Mibolerone
HED/0.12M KCl/10%. Glycerol 4 6 + 6
HED/0.12M KCl/10% Glycerol/ 
20niM molybdate 
(7500 cpm)
4 0 + 5
Means of 3 Exps. + SD
TABLE 21 - The extent of binding to a nuclear Fraction C/sepharose 
column (300pg immobilised protein/500mg resin) after 
labelling rat ventral prostate cytosol with either 
mibolerone (5x10 M^) or 5c< DHT (5x10 %) alone or in 
the presence of a 200 fold excess of the same ligand. 
Specific binding was calculated as described in Section 
2.2.4.1. Labelling with mibolerone was carried out 
+ 20mM sodium molybdate. Rat ventral prostate cytosol 
was prepared as described in Section 2.5.7.8 .
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to that reported for the oestrogen receptor from immature rat uterus 
(see Section 3.3.2.3).
3.5.4 Discussion.
The results from this set of experiments show that in addition 
to binding sites for labelled, activated oestrogen receptor both nuclear 
Fraction C and the 0.1M nuclear extract/sepharose resins contain
binding sites for various other steroid receptor complexes.
When immature rat uterine cytosol was used as a source of androgen, 
glucocorticoid and progesterone receptor, only low levels of specific 
binding of each receptor complex to the 0.1M I^SO^ nuclear extract/sepharose 
resin could be detected (Table 16). In the case the nuclear Fraction C/ 
sepharose resin only specific binding sites for androgen receptor complexes 
could be detected (Table 17). The data presented in Table 14 show that 
lower levels of these other steroid receptor proteins are present in 
immature rat uterine cytosol that the level of oestrogen receptor. The 
presence of specific receptor molecules for the various steroids was 
established using a one point assay i.e. measuring competition in the 
presence of an excess of cold competitor - but only at one ligand 
concentration. The cytosol was not subjected to more elaborate analysis. 
However, as shown in Table 15, the distribution of labelled ligand in the 
presence and absence of excess DES indicates that the binding of the various 
ligands does not occur to the oestrogen receptor molecule.
To ensure that the low levels of receptor protein present in the 
, immature rat uterine cytosol were not a limiting factor, female rat liver 
was used as a source of glucocorticoid receptor and rat prostate as a 
source of andrcgen receptor. In rat liver cytosol higher levels of 
labelled glucocorticoid receptor were accompanied by higher levels of 
non-specific binding but this latter class of binding protein was not 
retained by the nuclear protein/resin complexes. The use of glucocorticoid
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receptor from this source enabled detection of specific binding sites 
for this steroid receptor complex on nuclear*Fraction C/sepharose resin 
(Table 19) and a larger number of specific binding sites on the 0.1M
nuclear extract/sepharose resin (Table 19). These results suggest 
that uterine cytosol as a source of receptor was limiting in receptor 
content.
The use of rat prostate cytosol as a source of androgen receptor 
enabled detection of an increased number of specific binding sites on both 
the 0.1M nuclear extract and nuclear Fraction C/sepharose resins
(Tables 20 and 21). The labelling patterns obtained (Table 18), were 
rather low, barely greater than those obtained using immature rat uterine 
cytosol. Mainwaring and Randall (1984) report the inclusion of lOmM 
sodium molybdate in the homogenisation buffer, but the incorporation of 
molybdate into the homogenisation buffer in this study did not improve 
the labelling pattern. Table 21 shows that the androgen receptor labelled
3
with H-mibolerone induced higher levels of binding to the nuclear Fraction 
C/sepharose resin when compared to androgen receptor labelled with 
5 c< DHT. One possible explanation for this is that mibolerone may 
cross-react with progesterone receptor resulting in binding of this receptor 
complex to the nuclear extract/sepharose resin. However, previous 
studies in our laboratory have shown that there is minimal cross-reaction 
of mibolerone with progesterone receptor under similar conditions.
As reported for immature rat uterine oestrogen receptor binding to the 
nuclear Fraction C and 0.1M ^ SO^ nuclear extract/sepharose resins (see 
Section 3.2.2.3), the presence of sodium molybdate in the homogenisation 
buffer did not reduce the binding of labelled androgen receptor complexes 
to either of the nuclear extract/sepharose resins (Tables 20 and 21).
As discussed earlier (Section 3.2.2.6), it is not possible to offer a
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simple explanation for these observations.
In all of the above experiments the effect of the different
protein concentrations in the various cytosols was kept to a minimum by
applying the same amount (f mol) of protein bound ligand in each case.
-9 3
10,000 cpm of immature rat uterine cytosol labelled with 5x10
was used as a reference (approximately 150 f mol). It must also be noted
that these experiments were performed under conditions where the specific
binding sites for activated labelled oestrogen receptor were not
3saturated i.e. 10,000 cpm of H-E2 oestrogen receptor complex is not sufficient 
to occupy all of the available binding sites (see Section 3.4.1). In the 
cases of the other steroid receptor complexes, the proportion which is 
bound, of the cpm applied to the nuclear extract/sepharose resins, may 
suggest that the binding sites for these other receptor complexes are 
approaching saturation. This observation confirms that both the nuclear 
fraction/sepharose resins appear to contain a greater number of binding 
sites for oestrogen receptor complexes than for any of the other steroid 
receptor complexes. However, saturation or further analysis of the 
binding sites for androgen, glucocorticoid and progesterone receptor 
complexes were not carried out.
As suggested in Section 3.2.2.6 nuclear Fraction C appears to be 
enriched over the 01M nuclear extract in specific binding sites for
oestrogen receptor complexes (compare Tables 16 and 17). Possible reasons 
for this enrichment have been discussed previously in Section 3.2.2.6 .
Both nuclear Fraction C and the 0.1M ^ SO^ nuclear extract appear to 
contain roughly equal numbers of binding sites for androgen receptor 
complexes (compare Tables 20 and 21). In the case of binding sites for 
glucocorticoid receptor complexes, nuclear Fraction C appears to show a 
slight enrichment over the 0.1M ^ SO^ nuclear extract. This seems a
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little surprising as intially no binding sites for the glucocorticoid 
receptor complex could be detected in this nuclear fraction. However 
these experiments relied on immature rat uterus as a source of 
glucocorticoid receptor.
The only major difference observed between nuclear Fraction C
and the 0.1M nuclear extract was that nuclear Fraction C was
completely devoid of specific binding sites for the progesterone receptor 
complex. This observation suggests that such binding sites are
preferentially solubilised by 0.1M when compared to 2M NaCl. A
slightly different situation has been reported in hen oviduct chromatin, 
where Ruh and Spelsberg (1983) report that the acceptor activities for 
the oestrogen receptor complex and the progesterone receptor complex 
were "unmasked” by similar concentrations of guanidine hydrochloride.
The binding of tamoxifen-oestrogen receptor complexes to 
both the nuclear Fraction C and 0.1M nuclear extract/sepharose
resins is much less than that observed by the corresponding amount of 
^H-E2 labelled, activated oestrogen receptor (Tables 16 and 17). Nuclear 
Fraction C appears to be enriched in the ability to bind tamoxifen- 
oestrogen receptor complexes when compared to the 0 .1M nuclear
extract. There are several possible explanations for this observation. 
It is widely accepted that the active metabolite 4-hydroxy tamoxifen has 
a similar affinity for the oestrogen receptor to that of oestradiol 
(Borgna and Rochefort, 1981) and can cause activation of the receptor as 
assessed by standard procedures (Mester et al., 1981). However, the 
lower affinity of tamoxifen for the oestrogen receptor and doubt over its 
ability to cause receptor activation may be the reason for the reduced 
level of binding, i.e. the levels of observed binding may be reduced 
because only a fraction of the receptor population has become activated,
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resulting in a smaller number of the same binding sites as those occupied 
3
by H-E2 labelled,activated oestrogen receptor being bound. Undoubtedly,
the answer to this question is to repeat the experiments using tritiated
4-hydroxytamoxifen instead of tritiated tamoxifen.
.The second possibility is that the tamoxifen oestrogen receptor
complex binds to a completely different set of binding sites to those 
3
bound by H-E2 labelled oestrogen receptor complexes. If this is the case, 
the number of binding sites present in the two nuclear extracts for 
anti-oestrogen oestrogen receptor complexes is substantially fewer than 
the number present for E2 labelled oestrogen receptor complexes. The idea 
of non-identical chromatin binding sites for oestrogen and anti-oestrogen 
receptor complexes is not a new one (Baudendistal and Ruh, 1976; Massol 
et al., 1978; Lebeau et al., 1981; Singh et al., 1984) (see Section
1.4.3.10.1).
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3.6 The Measurement of Competition between Various Steroid
Receptor Complexes for Binding Sites o.n the Nuclear 
Extract/Sepharose Resins
3.6.1 Competition between Progesterone Receptor Complex
and Oestrogen Receptor Complex.
These studies could only be carried out using the 0.1M 
I^SO^ nuclear extract/sepharose resin as no specific binding sites for the 
progesterone receptor could be detected on the nuclear Fraction C/ 
sepharose resin (see Section 3.5.1).
Parallel columns of 0.1M nuclear extract/sepharose
resin (800pg protein/500mg sepharose) were used. Immature rat uterine 
cytosol (l-2mg protein/ml) was prepared as described in Section 2.6.
The appropriate volume of cytosol, labelled with either
o 3
~>H-E2 or H-ORG 2058 was eluted through the columns alone or in the 
presence of cytosol labelled with either cold ORG 2058 or cold DES as 
described in Section 2.6. The experiments were carried out under 
conditions where the respective binding sites approach saturation. The 
observed binding in each case is shown in Table 22.
As can be seen, the ability of the 0.1M I^SO^ nuclear extract 
to bind activated labelled oestrogen receptor is greater than its ability 
to bind progesterone receptor complexes, confirming earlier observations 
(see Section 3.5.1).
Eluting labelled oestrogen receptor through the nuclear 
extract/sepharose resin in the presence of unlabel led, occupied progesterone 
receptor reduces the observed binding by approximately 30%. The low level 
of progesterone binding which was observed with the immature rat uterine 
cytosol meant large volumes of cytosol would have been required to obtain 
an excess of progesterone receptor complex in these assays, hence 1ml
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TABLE 22
Sample applied to 0.1M I^SO^ nuclear 
extract/sepharose column
f mol bound/mg immobilised 
protein
3
H-E2 oestrogen receptor alone 298 + 26
H^-E^  oestrogen receptor + cold
ORG 2058 progesterone receptor complex 210 + 10
%-ORG 2058 progesterone receptor complex 
alone 67 + 5
%-ORG 2058 progesterone receptor complex 
+ cold DES oestrogen receptor complex 54 + 10
Means of 3 Exps. + SD
TABLE 22 - Assessment of competition between oestrogen receptor 
complexes and progesterone receptor complexes for 
binding sites present on the 0.1M nuclear extract/
sepharose resin (800yg immobilised protein/500mg resin). 
Immature rat uterine cytosol (l-2mg protein/ml) was 
used as a source of receptor (see Section 2.6).
3
50.000 cpm of H-E2 oestrogen receptor (740 f mol) was 
eluted through the columns alone or in the presence of 
670 f mol (1ml of cytosol) cold progesterone receptor.
20.000 cpm of %-ORG 2058 progesterone receptor (670 f mol) 
was eluted through the columns alone or in the presence of 
800 f mol cold oestrogen receptor. Competition was 
assessed as described in Section 2.6.
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(670 f mol) of cytosol was eluted through the column in the presence of 
the labelled oestrogen receptor. It may have been possible to reduce 
the observed binding further by increasing the amount of competing progesterone 
receptor complex.
Eluting ORG 2058 labelled progesterone receptor through the 
0.1M nuclear extract/sepharose resin in the presence of unlabelled,
occupied oestrogen receptor also reduced the observed binding, in this case 
by approximately 20%. In these experiments it was possible to have a 
slight excess of unlabelled, occupied oestrogen receptor present.
These combined results suggest that the binding sites present 
in the 0.1M nuclear extract for oestrogen receptor complex and
progesterone receptor complex are not exclusive to each receptor and there 
is interaction of both receptors with both of the binding sites. However, 
the data obtained from eluting labelled progesterone receptor complex 
through the nuclear extract/ sepharose resin in the presence of excess 
cold oestrogen receptor suggest that binding sites which are unique to 
each receptor complex are also present.
3.6.2 Competition between Oestrogen and Androgen Receptor
Complexes.
Parallel columns of 0.1M nuclear extract/sepharose
resin (lOOOpg immobilised protein/500mg resin) and nuclear Fraction C/ 
sepharose resin (300pg immobilised protein/500mg resin) were used.
Immature rat uterine cytosol (l-2mg protein/ml) was used 
as a source of oestrogen receptor and ventral prostate cytosol (5-6mg 
protein/ml) was used as a source of androgen receptor. Methodology 
was as described for oestrogen and progesterone receptor antagonism in 
Section 2.6 and Section 3.6.1. The experiments were carried out under 
conditions where the respective binding sites approach saturation.
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TABLE 23
Sample applied to nuclear Fraction C/ 
sepharose column
f mol bound/mg immobilised 
protein
3
H-E2 oestrogen receptor alone 700 + 28
3
H-Ej oestrogen receptor + cold 
miboferone androgen receptor complex 480 + 24
H^-mibolerone, androgen receptor alone 54 + 4
^H-mibolerone androgen receptor + cold 
DES oestrogen receptor complex 37 ± 3
Means of 3 Exps. +_ SD
TABLE 23 - The assessment of competition between oestrogen receptor
complexes and androgen receptor complexes for binding sites 
present on the nuclear Fraction C/sepharose resin (300pg 
immobilised protein/500mg resin). Immature rat uterine 
cytosol (l-2mg protein/ml) was used as a source oestrogen 
receptor. Rat ventral prostate cytosol (5-6mg protein/ml) 
was used as a source of androgen receptor. 50,000 cpm 
of 3H-E2 oestrogen receptor (740 f mol) was eluted through 
the columns alone or in the presence of 300 f mol cold 
androgen receptor. 15,000 cpm (300 f mol) of H-mibolerone
androgen receptor was eluted through the columns alone or 
in the presence of 1000 f mol cold oestrogen receptor. 
Competition was assessed as described in Section 2.6.
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TABLE 24
Sample applied to 0.1M nuclear 
extract/sepharose column
f mol bound/mg immobilised 
protein
3
H-E2 labelled oestrogen receptor alone 315 + 20
3
H-E2 labelled oestrogen receptor + cold 
miboferone androgen receptor complex 189 + 15
3
H-mibolerone labelled androgen receptor 
alone 42 + 6
3
H-mibolerone labelled androgen receptor 
+cold DES labelled oestrogen receptor complex 26 + 4
Means of 3 Exps. + SD
TABLE 24 - The assessment of competition between oestrogen receptor 
and androgen receptor complexes for binding sites present 
on the 0.1M l^SO^ nuclear extract/sepharose resin (llOOpg 
immobilised protein/500mg resin). Immature rat uterine 
cytosol (l-2mg protein/ml) was used as a source of 
oestrogen receptor. Rat ventral prostate cytosol 
(5-6mg protein/ml) was used as a source of androgen 
receptor. 50,000 cpm of H-E2 oestrogen receptor (740 f mol) 
was eluted through the columns alone or in the presence of 
300 f mol cold androgen receptor. 15,000 cpm (300 f mol) 
of ^H-mibolerone androgen receptor was eluted through the 
columns alone or in the presence of 1000 f mol cold 
oestrogen receptor. Competition was assessed as described 
in Section 2.6.
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The observed binding in each case is shown in Tables
23 and 24.
Again as shown in Section 3.5.1, both the nuclear fraction/ 
sepharose resins possess a greater ability to bind the oestrogen receptor comple:
Table 24 shows that the binding of labelled activated oestrogen 
receptor is reduced by approximately 40% in the presence of unlabelled 
androgen receptor (300 f mol), suggesting there is competition between the two 
steroid receptor complexes for binding sites on the 0 .1M t^SO^ nuclear 
extract/sepharose resin.
Table 23 shows that a similar situation occurs with columns 
containing nuclear Fraction C/sepharose resin. In this case the observed 
binding of labelled oestrogen receptor is reduced by approximately 31%.
For the same reasons mentioned in Section 3.6.1 for 
progesterone receptor, it was difficult to add a large amount of unlabelled 
androgen receptor to compete with the oestrogen receptor for binding sites.
When the reciprocal experiment was performed, Table 24 
shows that competition is observed between labelled androgen receptor and 
excess (1000 f mol) cold oestrogen receptor for binding sites on the 0.1M 
I^SO^ nuclear extract/sepharose resin. The presence of an excess of 
cold oestrogen receptor in the binding assay reduces the observed binding 
by approximately 38%.
Table 23 shows that a similar situation occurs when 
competition between unlabelled oestrogen receptor and labelled androgen 
receptor for binding sites on the nuclear Fraction C/sepharose resin was 
assessed. In this case the observed binding was reduced by approximately 
31%.
The results from this set of experiments suggest that there 
is competition between androgen and oestrogen receptor complexes for at 
least some of the sites on both the nuclear extract/sepharose resins.
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3.6.3 Competition between labelled Oestrogen Receptor and
Tamoxifen Labelled Oestrogen Receptor.
Parallel columns of the 0.1M H^SO^ nuclear extract/sepharose 
resin (800pg immobilised protein/500mg resin) and nuclear Fraction C/ 
sepharose resin (300pg immobilised protein/500mg resin) were used.
Immature rat uterine cytosol (l-2mg protein/ml) was used as 
a source of oestrogen receptor.
The methodology was as described for oestrogen and progesterone 
receptor antagonism in Sections 2.6 and 3.6.1. The experiments were 
carried out under conditions where the respective binding sites approach 
saturation. The observed binding in each case is shown in Tables 25 and 
26.
As has been previously observed (Section 3.5.1), the results 
in Tables 25 and 26 show that the tamoxifen-oestrogen receptor complex 
induces lower levels of binding to both the nuclear extract/sepharose 
columns than does ^  labelled oestrogen receptor.
Table 26 shows that the binding of ^  labelled activated 
oestrogen receptor to the 0.1M I^SO^ nuclear extract/sepharose resin is 
reduced by approxiamtely 41% in the presence of unlabelled tamoxifen receptor 
complex (670 f mol).
Table 25 shows that a similar situation occurs with columns 
containing nuclear Fraction C/sepharose resin. In this case the observed 
level of E^ labelled oestrogen receptor binding is reduced by 21%.
When the reciprocal experiment was performed Table 26 shows 
that competition is observed between labelled tamoxifen receptor complex 
and unlabelled E2 receptor complex (1030 f mol) for binding sites on the
0.1M I^SO^ nuclear extract/sepharose resin. The presence of an excess
- 179 -
TABLE 25
Sample applied to nuclear Fraction C/ 
sepharose column
f mol bound/mg immobilised 
protein
%-E2 oestrogen receptor 728 + 25
3
H--E2 oestrogen receptor + cold 
tamoxifen oestrogen receptor 576 + 80
%-tamoxifen oestrogen receptor 190 + 28
3
H-tamoxifen oestrogen receptor + cold 
DES oestrogen receptor 156 + 9
Means of 3 Exps. + SD
TABLE 25 - Assessment of competition between E2 labelled oestrogen receptor 
and tamoxifen labelled oestrogen receptor for binding sites 
present on the nuclear Fraction C/sepharose resin (300pg 
immobilised protein/500mg resin). Immature rat uterine 
cytosol (l-2mg protein/ml) was used as a source of oestrogen 
receptor. 50,000 cpm (740 f mol) of %-E2 oestrogen 
receptor was eluted through the columns alone or in the 
presence of 670 f mol cold tamoxifen oestrogen receptor.
25,000 cpm (420 f mol) of H-tamoxifen oestrogen receptor 
was eluted through the columns alone or in the presence of 
1030 f mol cold DES oestrogen receptor. Competition was 
assessed as described in Section 2.6.
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TABLE 26
Sample applied to 0.1M I^SO^ nuclear 
extract/sepharose column
f mol bound/mg immobilised 
protein
3
H-E2 oestrogen receptor 304 + 30
%-E2 oestrogen receptor + cold 
tamoxifen oestrogen receptor 178 + 6
%-tamoxifen oestrogen receptor 68 + 10
3H-tamoxifen oestrogen receptor + cold 
DES oestrogen receptor 59 + 4
Means of 3 Exps. + SD
TABLE 26 - Assessment of competition between E2 labelled oestrogen
receptor and tamoxifen labelled oestrogen receptor for
binding sites on the 0.1M I^SO^ nuclear extract/sepharose
resin (800pg immobilised protein/5OOmg resin). Immature
rat uterine cytosol (l-2mg protein/ml) was used as a source
3
of oestrogen receptor. 50,000 cpm (740 f mol) H-E2 
oestrogen receptor was eluted through the columns alone 
or in the presence of 670 f mol cold tamoxifen oestrogen 
receptor. 25,000 cpm (420 f mol) of H-tamoxifen oestrogen 
receptor was eluted through the columns alone or in the 
presence of 1030 f mol cold DES oestrogen receptor. 
Competition was assessed as described in Section 2.6.
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of cold DES labelled receptor reduces the observed binding by approximately 
16%.
Table 25 shows that a similar situation occurs when competition 
between labelled tamoxifen receptor and cold DES receptor complexes was 
assessed for binding sites on the nuclear Fraction C/sepharose resin.
In this case the observed binding was reduced by approximately 18%.
The results from these experiments suggest that competition 
between ^  labelled oestrogen receptor and tamoxifen labelled oestrogen 
receptor does occur but the level of competition is not as high as that 
observed between oestrogen receptor complex and androgen receptor complex 
(see Tables 23 and 24).
Again the small reduction in tamoxifen oestrogen receptor 
binding in the presence of excess cold DES oestrogen receptor (sufficient 
to saturate the binding sites) indicates that although there are some 
common binding sites, many seem to be independent.
3.6.4 Discussion.
The results obtained from this set of experiments indicate 
that there is antagonism between labelled, activated oestrogen receptor 
and occupied progesterone receptor for some of the binding sites present 
on the 0.1M nuclear extract/sepharose resin. Nevertheless, the
data obtained on the binding of labelled progesterone receptor complex 
in the presence of excess cold occupied oestrogen receptor (Table 22) 
suggests that there are also binding sites which are unique to each of the 
steroid receptor complexes. It was not possible to assess the relative 
affinities of the oestrogen and progesterone receptor complexes for the 
common binding sites, although the data in Table 22 (lower half) suggest 
that the progesterone receptor complex may have a higher affinity for the 
common binding sites.
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When the binding of oestrogen and androgen receptor complexes 
to both the nuclear Fraction C and 0.1M l^SO^ nuclear extract/sepharose 
resins was examined the situation did not appear to be so simple. Again 
the data suggest there may be common binding sites for both steroid 
receptor complexes and also binding sites which are unique to each steroid
receptor complex (Tables 23 and 24). However, the reduction in binding
of labelled oestrogen receptor complex in the presence of androgen 
receptor complex is far greater than the number of binding sites which are
occupied when labelled androgen receptor complex is eluted through the
nuclear extract/sepharose columns alone. This suggests that not all 
of the competition measured under these conditions represents androgen 
receptor complex competing with oestrogen receptor for common binding sites. 
Some of the competition observed may be due to non-specific protein effects 
which are introduced by the relatively large volume of rat prostate 
cytosol which had to be used for these experiments. Another possibility 
to be considered in both the above sets of experiments is that competition is 
due not to binding of either androgen or progesterone receptor but is due 
to occupied endogenous oestrogen receptor complex present in the uterine 
and prostate cytosols. However, in both cases the low levels of 
endogenous oestradiol would not give rise to sufficiently large amounts 
of occupied oestrogen receptor complex to account for the observed level 
of competition. As such, it‘is difficult to assign the relative affinities 
of the androgen and oestrogen receptor complexes for the common binding 
sites.
These results are in conflict with Ron and Spelsberg (1982) who 
report no antagonism between oestrogen and progesterone receptor complexes 
for binding sites in hen oviduct nuclei. This is surprising since it 
has been shown that the kinetics of induction of conalbumin mRNA by both 
nuclear oestrogen and progesterone receptor complexes is very similar,
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implying that a common binding site may be involved (Mulvihill and Palmiter, 
1977; 1980). Higgins et al. (1973) have reported unique binding sites 
for both glucocorticoid and oestrogen receptor complexes in immature rat 
uterine nuclei. These studies, and those of Kon and Spelsberg (1982) 
examined the binding to intact nuclei, no attempt was made to analyse the 
binding of receptor complexes to nuclear components. The findings 
reported in this thesis when compared to these published observations 
may indicate that the three dimensional structure of the intact acceptor 
site in vivo may only be recognised by a particular class of steroid 
receptor complex. Once this structure has been disrupted during the 
extraction procedures involved in the present studies, a resultant loss 
in the absolute specificity of steroid receptor complex binding may occur.
As discussed in Section 3.7.1, a more likely explanation 
may involve the possibility that specific acceptor sites for steroid 
receptor complexes are normally ''masked'' and can be unmasked when the 
adjacent structural gene is to be activated by the appropriate steroid 
receptor complex. In this case, the question remains of how the unmasking
of specific acceptor sites is initiated and how it is controlled and 
subsequently reversed.
3
The studies on the binding of H-E2 labelled oestrogen 
3
receptor and H-tamoxifen labelled oestrogen receptor to both nuclear
extract/sepharose resins again suggest that some of the binding sites
3
are common to both H-E2 labelled and tamoxifen labelled oestrogen 
receptor complex but that there are binding sites which are unique to each 
receptor complex. Again it was not possible to assess the relative 
affinities of the E2~oestrogen receptor complex and tamoxifen-oestrogen 
receptor complex for the common binding sites.
3.7 Analysis of the ability of Nuclear Fraction C/sepharose
Resins from Various Immature Female Rat Tissues to
3
specifically bind H-Eq labelled oestrogen receptor complex
Nuclei were purified from kidney, liver, spleen and uterus 
essentially as described in Section 2.2.2. Nuclear Fraction C was then 
prepared as described in Section 2.2.2.2 and coupled to CN-Br activated 
sepharose 4B as described in Section 2.2.2.5. The amount of immobilised 
protein was in the range of 400-900pg/500mg of sepharose resin.
Immature rat uterine cytosol (l-2mg protein/ml) was prepared 
as described in Sections 2.2.3.2 and 2.2.3.3 and eluted through the nuclear 
extract sepharose columns as described in Section 2.2.4.
The data are presented in Table 27.
As can be seen, nuclear Fraction C isolated from uterine nuclei
3
has the greatest ability to specifically bind H-dE^  labelled,activated 
oestrogen receptor complexes, although the equivalent nuclear fractions 
isolated from liver, kidney and spleen do possess the ability to specifically
3
bind H-E2 labelled activated, oestrogen receptor complexes to a lesser 
extent. This indicates that the nuclear protein(s) responsible for the 
specific binding activity are not confined to "major" target tissues such as 
the uterus, and can be detected in tissues such as kidney and spleen which 
are considered not to be target tissues.
3.7.1 Discussion.
In order to study any binding activity which may have been present 
in other "non target" tissues of the immature female rat., it was necessary to 
purify nuclei from these various tissues. Generally, the non-target tissues 
which were examined were much "softer" than uterine tissue and hence, nuclear 
purification was easier. The nuclei isolated from spleen and kidney in 
particular, were obtained in very good yields and appeared very "clean" 
under the phase contrast microscope.
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TABLE 27
Immature female rat tissue used 
as a source of nuclear Fraction C
f mol specifically bound/mg 
immobilised protein
Uterus 186 + 17
Liver 127 + 12
Kidney 100 + 19
Spleen 60 + 17
Means of 3 exps. + SD
Table 27 - The extent of specific binding of activated labelled
oestrogen receptor to nuclear Fraction C/sepharose resin 
prepared from various immature female rat tissues.
The range of immobilised protein was 400-900pg/500mg 
resin. Immature rat uterine cytosol (l-2mg protein/ml) 
was used as a source of activated oestrogen receptor.
10,000 cpm of both H and H+C cytosols were applied in 
each case. Competition was calculated as described in 
Section 2.2.4.1.
- 186 -
Table 27 shows that the specific binding activity towards activated, 
labelled oestrogen receptor is present in nuclear Fraction C of all of the 
tissues analysed. However, the greatest amount of binding activity was 
extracted from uterine nuclei, with lesser amounts being extracted from 
liver, kidney and spleen nuclei. The detection of low levels of high 
affinity oestrogen receptor in both the kidney (Li et al., 1974) and liver 
(Aten et al., 1978) makes it possible to designate them as minor target 
tissues. The spleen must be considered as a non-target tissue.
There have been numerous reports that a variety of target cell 
nuclei for a variety of steroids contain markedly more acceptor sites 
than non-target cell nuclei using cell free binding assays (e.g.
Mainwaring and Peterken, 1971; Spelsberg et al., 1972; Puca et al.,
1975; Mainwaring et al., 1976; Pikler et al., 1976; De Boer et al.,
1984). Many such reports did not state that non-target cell nuclei were 
completely devoid of acceptor sites, but that they contained fewer numbers 
of them. As such, the term "tissue specific" nuclear binding may be 
misleading and "enhanced" binding in target tissue nuclei may be more 
appropriate.
In contrast Higgins et al. (1973) report no difference in 
nuclear binding between the chromatin of target and non-target tissues.
It may be possible that these observations are due to some of the methodology 
used during the analysis. Mild protease treatment of chromatin results 
in an increase in the number of nuclear binding sites availale (Spelsberg,
1982). Many of the conditions that enhance proteolysis such as the use 
of crude cytosol, temperatures above 4°C and long periods of incubation 
were used in some of these studies. Hence, the chromatin from non-target 
tissues, which may have no natural steroid receptor binding sites may 
exhibit significant levels of binding when assayed under the above 
conditions.
The assay system used in these studies enables the detection of 
binding sites which are present in the various tissues of the immature 
rat. It does, however, give no idea of the role these binding sites have 
to play in the "non-target” tissues in vivo. It may be that in vivo 
these binding sites are "masked" and therefore concealed from activated 
oestrogen receptor, even if it were present in such cells. It has been 
reported that even in target tissues, masking of some acceptor sites 
occurs (Spelsberg, 1982; Spelsberg et al., 1983). The extraction 
procedure used to isolate nuclear Fraction C will extract the binding sites 
and presumably any masking proteins associated with them. Extraction 
will almost certainly disrupt any interaction which was present between 
them. Hence, in this in vitro system, the binding proteins are available 
for assay.
The question arises as to the biological role of such a masking 
phenomenon. One possible function is that it regulates which genes will 
respond to steroid receptor complex and at what time. If this were the 
case, it would help explain why different target tissues of the same 
organism with presumably the same type of receptor display markedly 
different responses to the same steroid with regard to gene expression,
i.e. different genes seem to be regulated by the same steroid-receptor 
complex in different tissues. Recent evidence indicating that the steroid 
receptors in different tissues from different animals are antigentically 
similar (Greene et al., 1980; Greene and Jensen, 1982), minimises the 
tissue specificity of the receptors themselves. In short, if a gene is 
masked it is not available for activation by steroid receptor complex, 
but if unmasked is available for transcription in the presence of the 
appropriate steroid receptor complex. In non-target tissues which do not 
require the genes that respond to steroids, the acceptor sites of these 
genes will be masked (Spelsberg, 1982). However, since non-target tissues
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are devoid of soluble receptor for the respective steroids, whether or not 
their chromatin contains acceptor sites for the steroid is,biologically 
speaking, of no consequence. During the development of a steroid 
target organ, quantitative and qualitative changes in the masking activity 
might be expected as different cell types appear or change in proportions. 
During oviduct development the number of available acceptor sites but not 
the total number of sites changes throughout the oestrogen induced 
development (Spelsberg, 1982). Thus, the extent of masking changes 
considerably. The masking phenomenon does not appear to be confined to 
the chick oviduct (Spelsberg, 1982) but has been reported for androgens 
in rat prostate (Klyzsejko-Stefanowicz, 1976), oestrogen and progesterone 
in sheep brain (Perry and Lopez, 1978) and oestrogen in rat and bovine 
uterus (Ruh et al., 1981).
3.8 Preliminary Protein Blotting Experiments
3.8.1 Introduction.
Having established that both the 0.1M H^SO^ nuclear extract 
and nuclear Fraction C possess a binding activity which is specific for 
the oestrogen receptor, the next objective should be to characterise the 
protein(s) responsible. Several attempts were made to do this for nuclear 
Fraction C using hydroxylapatite chromatography as described by Puca 
et al. (1974) and ion-exchange chromatography on the cation exchange 
resin Bio-Rex-70 as described by Mainwaring et al. (1976). However, after 
several attempts it proved impossible to recover any binding activity from 
either of these fractionation techniques. These techniques separate 
components on the basis of their overall charge, and thus it was hoped 
to show the nature of the binding components present in nuclear Fraction C 
using these techniques. The fact that the binding activity can be 
solubilised by mild acid treatment of nuclei at low temperature (as shown 
by the 0.1M nuclear extract) suggests that the components involved
in binding are basic, but it would have been more satisfactory to confirm 
this using either or both of the above techniques.
In an alternative approach to characterising the protein(s) 
responsible for the specific nuclear binding activity, the techniques of 
protein blotting were employed.
Using these techniques, a crude extract of proteins is 
separated, usually by some means of electrophoresis. The pattern of 
separated protein is then transferred to a nitrocellulose filter in such 
a manner that the separated pattern is maintained. It is then possible 
to probe the nitrocellulose, in order to "pick out" or identify specific 
proteins which were present in the initial crude extract. This part of 
the technique relies on the availability of an appropriate probe.
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The rationale behind these experiments was the separation
of the nuclear extract using SDS PAGE, transfer of the proteins onto
nitrocellulose filters, then probing the filters using labelled activated
oestrogen receptor to identify proteins capable of binding the probe.
In order to detect such a complex, antiserum against human myometrial
125oestrogen receptor in conjunction with I labelled protein A was used.
1253.8.2 Experiments using I labelled E2 .
Experiments were performed essentially as described in
Section 2.7.
Electrophoresis of nuclear proteins was carried out in
duplicate. One half of the gel was stained as described in Section 2.7.2
to reveal the pattern of separated proteins. The separation obtained
is shown in Figure 6 . The pattern of separated proteins in the other
half of the gel was transferred to nitrocellulose as described in Section 
1252.7.3. I-E2 labelled oestrogen receptor was prepared as described
in Section 2.7.4, such that the cytosol contained between 500,000 and
600,000 cpm, all of which were subsequently applied to the nitrocellulose
filter as described in Section 2.7.5.
The major problem encountered during these experiments was
the amount of non-specific "background” binding which occurred to the
nitrocellulose filter. One possible way in which the background could
have been reduced, would have been the inclusion of 0.5% Tween-20 in the
incubation buffer, but it was considered important to keep the assay
conditions, as similar as possible to those present in previous binding
assays. The resultant high background may have obscured "bands"
125corresponding to the binding of I-E2 labelled activated oestrogen 
receptor to specific protein fractions present on the nitrocellulose.
Thus, it was not possible to observe "bands" corresponding to the binding 
of receptor to discreet areas of the nitrocellulose filters.
3.8.3 Experiments using rabbit antiserum raised against
the human myometrial oestrogen receptor.
These experiments were carried out essentially as described
in Section 2.7.6. Analysis of nuclear Fractions B and C and the
0.1M H^SO^ nuclear extract were carried out.
As described in Section 3.8.2, electrophoresis was carried
out in duplicate. The portion of the polyacrylamide gel which was to
be subjected to the "blotting" procedure was loaded with molecular
weight markers (Pharmacia, low molecular weight range) which had been
125iodinated with Na I as described for protein A in Section 2.7.6.1.
The patterns obtained on electrophoresis of the various nuclear
fractions are shown in Figures 6 and 8 . In an attempt to reduce the
amount of non-specific binding to the nitrocellulose, which results in an 
increased background, the unreacted groups remaining on the nitrocellulose 
filter after transfer of the protein fractions were blocked by using 
BSA as described by Towbin et al. (1979). 3% BSA (w/v) was also included
in buffers used for the various incubations in an attempt to keep the 
non-specific binding to a minimum.
Nuclear Fractions B and C
Previous experiments have shown that, when compared to nuclear 
Fraction B, nuclear Fraction C is greatly enriched in specific binding 
activity towards activated, occupied oestrogen receptor complexes, hence 
it should be interesting to compare both of these nuclear fractions using 
this approach.
Figure 16 shows an autoradiograph of a nitrocellulose filter 
\diich had been probed as described in Section 2.7.6.1. As can be seen 
several prominent bands are present.
m
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Figure 16 - Autoradiograph of nitrocellulose filter probed as described
in Section 2.7.6.1 using rabbit antiserum raised against human
125myometrial oestrogen receptor in conjunction with I-protein
A. Electrophoresis and transfer of proteins to nitrocellulose
were as described in Sections 2.7.2 and 2.7.3 respectively.
125Track 1 I-molecular weight markers as described in Figure 6,
Track 2 50pg nuclear Fraction B, Track 3 50pg nuclear 
Fraction C. Exposure time 5 days.
Fraction B contains bands at molecular weights of greater than 
94,000, a doublet of bands around 67,000 and bands at approximately 55,000, 
approximately 38,000 and approximately 27,500. Fraction C contains 
two bands, one at a molecular weight of approximately 67,000 and another 
much fainter band at a molecular weight of approximately 15,000. The 
identity of these bands is uncertain, but several further experiments can 
be carried out to characterise them further. The bands present in this 
autoradiograph show that it is possible to pick out specific components 
of the initial crude nuclear extracts using this technique.
The next problem which must be tackled concerns the "origins" 
of the detected bands, i.e. do they correspond to proteins extracted 
initially from the myometrial nuclei and recognised by the antiserum, or 
do they correspond to proteins extracted from the myometrial nuclei which 
bind the added activated, occupied oestrogen receptor, which is then 
recognised by the antiserum.
To examine this problem, electrophoresis, transfer of proteins
to nitrocellulose and blocking of unreacted groups using 0.5% Tween-20
was carried out as described in Section 2.7.3. The addition of activated,
occupied receptor was omitted and the nitrocellulose filter probed using 
125antiserum and I-protein A as described in Section 2.7.6 .1. The 
resultant autoradiograph is shown in Figure 17. As can be seen, all of 
the "bands" present in Lane B (Figure 16) are still present, suggesting 
they correspond to proteins extracted from the myometrial nuclei that 
are recognised by the antiserum in the absence of added oestrogen receptor. 
The band at molecular weight 67,000 present in Lane C (Figure 16) is still 
clearly visible, suggesting it too is a protein extracted from the 
myometrial nuclei which is recognised by the antiserum in the absence of 
oestrogen receptor. However the band of molecular weight approximately
15,000 is no longer visible (Figure 17) suggesting it might represent a
Figure 17 - Autoradiograph of a control nitrocellulose filter probed
with anti-oestrogen receptor antiserum in conjunction with 
125I-labelled protein A as described in Section 2.7.6.1.
125Track 1 I-molecular weight markers as described in 
Figure 6. Track 2 50pg nuclear Fraction B, Track 3 50pg 
nuclear Fraction C. Proteins were electrophoresed on a 
12.5% SDS polyacrylamide gel as described in Section 2.7.2 
and transferred to nitrocellulose as described in Section 2.7.3. 
Exposure time was 40 hours. Methodology was the same as 
described in Section 2.7.6.1 without the addition of 
oestrogen receptor.
protein recognised by the added activated, occupied oestrogen receptor
125which is then recognised by the antiserum in conjunction with I 
protein A.
The next possibility to be eliminated is, do the observed
bands correspond to proteins extracted from the myometrial nuclei which
can bind IgG molecules which are present in serum, and are then
125recognised by the I-protein A. To examine this possibility,
antiserum was replaced by normal rabbit serum. All other procedures
were carried out as described in Section 2.7.6.1. The resultant
autoradiograph is shown in Figure 18. As can be seen, only one "band"
is visible, which corresponds to that at a molecular weight of approximately
67,000(Fraction C)which can also be observed in the absence of activated
occupied oestrogen receptor (see Figures 17 and 18). This suggests
this "band" represents a nuclear protein capable of binding IgG molecules
125which are then recognised by the I-protein A, i.e. the "band" is not
induced by specific antibody molecules which recognise the oestrogen
receptor but by IgG molecules in general.
The collective results from this set of experiments enable all
of the observed bands except one (15,000 molecular weight band, Fraction C)
to be explained. No other band involves the specific recognition of
myometrial nuclear proteins, immobilised on the nitrocullulose filter,
by activated, occupied oestrogen receptor, followed by subsequent
identification of this complex by antiserum against the oestrogen receptor
125in conjunction with I-protein A.
The antiserum has been shown to weakly cross-react with 
serum albumin. Preblocking of the antiserum with 3% BSA (see Section
2.7.6.1) should eliminate this problem but the observation that the
67,000 molecular weight std. (BSA) is recognised by the antiserum (see 
Figures 16 and 17) suggests that either the pre-blocking was not fully
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Figure 18 - Autoradiograph of control nitrocellulose filter. Track 1 
125I-molecular weight markers as described in Figure 6.
Track 2 50pg nuclear Fraction B, Track 3 50pg nuclear
Fraction C. Proteins were electrophoresed and transferred
to nitrocellulose as described in Sections 2.7.2 and 2.7.3
respectively. Methodology was as described for standard
blot in Section 2.7.6.1 with antiserum being replaced by
125normal rabbit serum in conjunction with I-protein A. 
Exposure time 40 hours.
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effective or that an artifactual '’band" at 67,000 is generated in the 
presence of antiserum/protein A following sample preparation in 
ft> -mercaptoethanol. The "band" at approximately 55,000 may also be an 
artifact of the sample preparation (Tasheva and Dessev, 1983).
The molecular weight of the mammalian oestrogen receptor has 
been estimated to fall in the range of 65,000-70,000(e.g. Sica and 
Bresciani, 1979; Sakai and Gorski, 1984). Hence the "bands" around
67,000 (Fraction B, Figures 16 and 17) could represent endogenous oestrogen 
receptor since much of this would be expected to be extracted into Fraction
B. The other lower molecular weight bands seen in Fraction B are also 
difficult to explain. There is the possibility they represent proteolytic 
degradation products of the native oestrogen receptor, but this is unlikely 
as lOmM DFP was included in the buffer used for nuclear extraction, 
although proteolytic enzymes not inhibited by this reagent could be 
responsible for the degradation. They might also be physiological 
products of processing which still retain the antigenic site recognised 
by anti-oestrogen receptor antibody.
Overall, these experiments show a low molecular weight band 
(approximately 15,000) present in nuclear Fraction C, which may be capable 
of selectively binding activated, occupied oestrogen receptor. However 
the results are far from conclusive and more work must be carried out to 
substantiate these observations.
0.1M HqSO/^ Nuclear Extract
The results from similar experiments on the 0.1M nuclear
extract were complex as more "bands" could be seen in the control 
experiments than in the test experiment (data not shown).
The results from this set of experiments suggested that the 
presence of immature rat uterine cytosol had a blocking effect on the 
observed binding, as the greatest number of "bands" were observed in the
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complete absence of cytosol. This observation is difficult to explain 
and contrasts with the similar experiments carried out with nuclear 
Fractions B and C. Further, the appearance of a mass of "bands" in a 
position corresponding to the core histone proteins was not observed when 
Fraction C was analysed. (Both the 0.1M I^SO^ nuclear extract and 
nuclear Fraction C contain the core histone proteins -see Figure 9).
One possible explanation is that the two sets of experiments were carried 
out using different batches of antiserum, but the appearance of faint 
bands in the same region of the normal rabbit serum blot (data not shown), 
would tend to rule this out.
From these experiments it was thus not possible to designate any 
of the observed "bands" as being the result of interaction between a 
component of the 0.1M nuclear extract and activated, occupied
oestrogen receptor.
3.8.4 Discussion.
The design of this set of experiments has involved an 
important assumption. This is, that following electrophoresis and transfer 
to a nitrocellulose membrane, the "acceptor" protein is still capable of 
being recognised by the activated, occupied oestrogen receptor complex. 
Preparation of samples for SDS PAGE involves the denaturation of proteins 
under analysis using the detergent SDS. The vast majority of protein 
transfer experiments have been used for the immuno-detection of specific 
antigens. In these experiments, an antiserum raised against the antigen 
in question is subsequently used to localise the antigen. The antibody/ 
antigen complex is then usually identified using radioactive or enzymatic 
means. The great specificity of this procedure enables the antigen to 
be detected in crude homogenates, which contain a vast protein population.
It is fairly well accepted that antibody-antigen interactions 
usually involve a region on the antigen molecule which corresponds to 
only a few amino acid residues. It thus appears that the antibody can often 
recognise this small region of the antigen even after the antigen has been 
denatured by SDS. It seems unlikely that the interaction between 
"acceptor" protein and activated occupied oestrogen receptor involves 
recognition of such a small area of the "acceptor" or receptor molecules.
It may be necessary for larger areas of the "acceptor" protein molecule to 
"renature" before the receptor can interact with it. Several workers
e.g. Sakai and Gorski (1984) have shown that some SDS-denatured 
polypeptides can be renatured on removal of the detergent, an operation 
that can be carried out more conveniently and effectively with blots.
It follows from the preceding statements, that if the site on the "acceptor" 
protein is denatured beyond recognition by the receptor, then this 
technique will not help in the identification of chromatin proteins 
involved in binding activated, occupied oestrogen receptor. However, if 
some degree of renaturation occurs, it may be possible for the interaction 
to occur, but with lower affinity to that observed in vivo.
The results obtained from these studies do not allow any strong 
claims to be made, although they do offer an area to be pursued further.
A very weak signal appears in Figure 16, track 3 (nuclear Fraction C) 
which is not induced in the absence of activated, occupied oestrogen receptor 
or in the presence of antiserum alone. This band may correspond to a 
chromatin protein acceptor activity for occupied oestrogen receptor.
The antiserum used in these studies was raised against human 
myometrial oestrogen receptor and had been shown to cross-react with both 
human and rat oestrogen receptor molecules. However, the experiments 
performed in this section indicate it also reacts with several other protein 
molecules (not necessarily breakdown products of oestrogen receptor)
extracted from human myometrial nuclei (see Figure 17). This meant any 
observed positive "reaction" had to be carefully scrutinised. .
When the anti-oestrogen receptor antiserum was used in protein 
blotting experiments involving the fraction of protein extracted from human 
myometrial nuclei with 0.1M l^SO^ the observed results were very difficult 
to interpret. The mass binding of antiserum in the absence of added 
oestrogen receptor to proteins immobilised on the nitrocellulose was most 
unexpected. The results suggest that extraction of protein with 0.1M 
H^SO^ (e.g. the core histones) has somehow made them immunologically 
reactive towards the anti-oestrogen receptor antiserum. This observation 
was not made when these proteins were extracted with 2M NaCl. The 
observation that immature rat uterine cytosol reduces the observed binding 
is even more difficult to explain, except that it obviously must contain 
some type of inhibitory molecule. No positive conclusions concerning 
the specific interaction of activated,occupied oestrogen receptor with 
nuclear proteins could be made from these experiments.
Protein blotting techniques have been used to study systems where protein- 
protein interactions take place e.g. Bowen et al. (1980) study histone - 
histone interaction using such techniques. Analysing protein ligand 
interactions by using protein blots is expected to develop further and 
provide a powerful means of studying macromolecular assemblies. To do 
so, conditions for more efficient renaturation of the protein should be 
explored e.g. more careful removal of denaturing agents and possibly 
regeneration of disulphide bridges in situ.
It has also been possible to use "blotting" techniques to 
study specific DNA-protein interactions (Bowen et al., 1980). If 
this "blotting" system enabled specific "acceptor" proteins to be 
identified it may then be possible to identify regions of genomic DNA 
which interact specifically with these "acceptor" proteins.
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4. General Discussion
The modulation of gene expression by steroid hormones offers
a number of useful model systems to study how the expression of a gene or set
of genes can be positively regulated at the transcriptional level in 
animal cells.
It is generally thought that the effect of steroid hormones 
is mediated by hormone-specific intracellular proteins that associate with
specific DNA or chromatin sites upon binding the hormone ligand (Mulvihill 
et al., 1982). It is assumed that this receptor-genome interaction is 
the primary event in the induction of transcription of genes which are 
programmed to respond to a given steroid hormone in a given differentiated 
target cell.
Mechanistic schemes for steroid hormone action highlight the 
influence of the nuclear steroid-receptor complex on gene expression, 
a feature common to steroid hormones involved both in cellular homeostasis 
and in growth processes. This concept has, for two decades, been 
considered the key feature of the molecular mechanism of steroid hormone 
action and stems from the rapid accumulation and retention of steroids 
within target cell nuclei after exposure to the steroid in question 
(Clark and Peck, 1979). Circumstantial evidence has thus popularised 
the oestrogen receptor complex (and all other steroid receptor complexes) 
as an intracellular regulator of gene expression. Its selective 
distribution throughout chromatin should be tissue specific, determined 
by "acceptor sites" and should influence expression of the relevant genes.
Steroid-receptor complexes act by interaction with or 
displacement of chromatin associated proteins to reveal initiation sites.
This interaction with chromosomal proteins and/or nucleotide sequences 
is thought to create favourable promotor sites, by assisting in the 
unwinding of DNA, by promoting elongation factors or by inactivating 
termination factors.
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The nature of the acceptor site or region is one of the many 
questions which, if answered, would increase our understanding of the 
mechanism of steroid hormone action at the molecular level. Rapidly 
advancing technology has accelerated certain aspects of our understanding 
of the mehanism of steroid action, but it has tended to occlude some of 
the problems. The nature of acceptor proteins has been abandoned by 
all but a few workers. The majority of work in this area has been carried 
out by Spelsberg and his co-workers (Spelsberg, 1982; Spelsberg et al.,
1983). Many other groups have focussed their attention on the direct 
interaction of steroid-receptor complexes with the DNA of steroid inducible 
genes or the regions of DNA which are adjacent to these genes (e.g.
Compton et al., 1983; Payvar et al., 1983; Cato et al., 1984; Compton 
et al., 1984; Maurer et al., 1985). However, as discussed previously, 
the relative affinity of these regions of DNA for the appropriate steroid- 
receptor complex is insufficient to explain the rapid way in which incoming 
steroid-receptor complexes are trapped within the nucleus. These 
observations support the involvement of other nuclear components in the 
nuclear binding of steroid-receptor complexes.
Data is presented in this thesis which supports the specific 
saturable interaction of oestrogen receptor complexes with nuclear components 
which can be extracted from human myometrial nuclei with either 2M NaCl 
or 0.1M (see Section 3.2). The observation that proteolytic
enzymes can reduce the level of observed interaction suggests that 
chromosomal proteins may be responsible for the binding activity. The 
high affinity binding which is observed (Kd 10 ^) is of the correct order 
of magnitude to be physiologically significant and is certainly higher 
than the affinity of interaction observed between steroid-receptor 
complexes and the DNA from hormonally regulated genes. This data would
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support the involvement of chromatin proteins in acceptor site function 
which has been suggested by several workers previously (Puca et al., 1974; 
1975; Mainwaring et_al., 1976; Spelsberg, 1982; Spelsberg et al., 1983). 
It has also been suggested that chromosomal proteins present at initiation 
sites lower the activation energy required for the opening of the DNA 
helix in forming a stable complex with the RNA polymerase. Such 
proteins would be expected to be major determinants in the location of 
initiation sites and perhaps be composed of a variety of proteins capable 
of destabilising DNA (Thomas and Patel, 1976). It is possible that 
interaction of a steroid hormone-receptor complex with such an area of 
chromatin protein would make the formation of a stable initiation complex 
even more favourable. Naturally, the three dimensional structure of 
"acceptor sites" in vivo will involve both the DNA and the acceptor 
proteins.
Steroid-receptor complexes may function at a number of levels 
to control gene expression. Multiple receptor binding domains of 
varying affinity may be involved. Such binding domains may be involved 
in determining priority effects, in maintenance of an overall structure 
conducive to transcription, more efficient utilisation of promoters or 
influencing DNA-protein interactions to facilitate higher rates of 
elongation within a gene or among genes of differing susceptibility.
This would account for the large number of acceptor sites shown here and 
the spectrum of physiological response relative to numbers of occupied 
sites. However, the techniques used were not sufficiently sensitive to 
allow separation of acceptor sites with minor differences in affinity 
for oestrogen receptor.
The suggestion that the oestrogen receptor may be, at all 
times resident, in the nucleus (King and Greene, 1984; Welshons et al.,
1984) increases the likelihood of binding sites of differing affinity
being present. Unoccupied receptor is readily extracted from the nucleus 
at low salt* concentrations, while high salt is necessary to extract 
activated or transformed receptor. This might suggest that following 
oestrogen binding, the oestrogen-receptor complex may be relocated to an area 
of the genome which has a higher affinity for the receptor complex and is 
responsible for regulation of the expression of oestrogen inducible genes. 
Another possibility is that no relocation occurs, but the receptor is 
located in close proximity to the acceptor site at all times. Binding of 
ligand is necessary to induce expression of the adjacent gene. Of course, 
nuclear localisation of the oestrogen receptor is under debate (Szego and 
Pietras, 1985) and the preceding statements are pure speculation.
A very major problem to be overcome is the characterisation 
of the chromatin proteins which are involved in acceptor site function.
These proteins are inherantly difficult to work with because of their 
hydrophobic nature and general insolubility. The attempts made to 
characterise such proteins so far have involved the use of high 
concentrations of denaturing agents. The use of such harsh regimes 
must risk irreversible loss of biological activity such that assay of the 
isolated proteins for acceptor activity will fail. Several attempts 
have been made to characterise such proteins (Puca et al., 1975;
Mainwaring et al., 1976). However, the greatest efforts to narrowly 
define the chromatin protein fraction which demonstrates acceptor activity 
have been made by Spelsberg and his co-workers (Spelsberg et al., 1983).
If the characterisation of a single protein or narrow group of proteins 
could be achieved in several other systems, it would surely swell support 
for the involvement of chromatin proteins in acceptor function.
In conclusion, the data presented in this thesis support the 
involvement of non-histone chromatin proteins in acceptor site function 
but further work, especially on the characterisation and isolation of the 
protein(s) responsible for the binding activity is required.
| The data presented in this thesis contribute to the general
j
concept of selective acceptor proteins. However, methodological 
problems complicate the final interpretation. These can be discussed as 
follows.
Nuclear Purification
i The purity of a nuclear preparation can be assessed in a number
of different ways. In the present study a combination of the 
DNArProtein ratio of the final nuclear pellet and its appearance under 
the phase contrast microscope were used. Figure 5 shows an example of a 
final nuclear pellet under the phase contrast microscope. Careful 
examination of this figure reveals that the structures present are nuclei 
with prominent nucleoli visible in many of the nuclei. Many of the 
nuclei are also long and thin indicating their probable origin as the 
elongated muscle cells of the myometrium. Previous examination in our 
{laboratory of such nuclei, using scanning and transmission electron 
microscopy, has indicated considerable structural integrity of the 
purified nuclei. For example, any possible contamination by endoplasmic 
reticulum is detected by this method. It is, however, unlikely that 
endoplasmic reticulum contamination will represent a major problem as the 
nuclei have been passed through 0.27, Triton X-100 which will 'strip off' 
both the outer nuclear membrane and the endoplasmic reticulum which is 
attached to it.
The major problem in using the DNA:Protein ratio as an 
indication of nuclear purity is that it is not constant from one tissue 
to another. Although the DNA content of somatic cell nuclei is the
I
same, the amount of non histone chromatin protein they contain is not 
(Allfrey, 1971). Tissues which are metabolically active e.g. liver, ‘ 
'contain greater amounts of non histone chromatin proteins, hence their 
DNArProtein ratios are lower than those of metabolically relatively 
inactive tissues such as myometrium. The typical DNArProtein ratio of
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the final nuclear preparation obtained during these studies was 0.5 - 0.6 
which.is in broad agreement with the value of 0.5 for nuclei purified 
from chick oviduct (Spelsberg, 1976).
Another method by which nuclear purity can be assessed is by the 
determination of various enzyme activities. One approach would be to 
assay the purified nuclei for enzymes which are known to be nuclear in 
origin e.g. RNA polymerase (Widnell and Tata, 1964) but a more 
satisfactory method is the assay of enzyme activities which are known to 
be located elsewhere in the cell. Examples of these include cytochrome 
oxidase and glucose 6-phosphatase (Widnell and Tata, 1964). However, 
enzyme relocation, activation or destruction may modify the results 
obtained and all the systems available have built within them the hazards 
inherent in cell fractionation and differential centrifugation. The 
best idea of nuclear purity and integrity is achieved through the use of 
microscopic techniques in conjunction with some biochemical parameter.
i
Protein Assay
The hydrophobic nature and general insolubility of chromatin
associated proteins poses problems for their analysis. Table 1 shows
the typical protein content of the various nuclear protein fractions as
analysed by the method of Bradford (1976). This method of analysis is
not ideal for all of the protein fractions and must be considered a
compromise, as no one assay method proved ideal for all the nuclear
protein fractions. The presence of a reasonably high concentration of
salt or denaturing agent is required to maintain most fractions in
solution in vitro. Both nuclear fraction C and the 0.1M H.SO.
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nuclear extract represent this class of protein.
Initial protein assays on the various nuclear fractions were 
carried out using the method of Lowry et a 1 . (1951). This method proved 
reliable for nuclear fraction A and B but in the case of fraction C 
.problems arose with precipitation of the Folin reagent in the presence of
the high salt. This problem did not arise on every occasion, but 
frequently enough to make protein estimation by this method unreliable.
As an alternative the method of Bradford (1976) was used. This method 
was unreliable for estimating the protein content of Fraction A as the 
methods required to solubilise the proteins present in this fraction i.e. 
either alkali or detergent subsequently interfered with the assay. The 
Bradford micro-assay was used to estimate the protein content of Fraction 
B and the standard assay procedure was used to assay the protein content 
of Fraction C. No problems of reagent precipitation were encountered 
using this method on Fraction C. The protein content of the 0.1M 
H^SO^ nuclear extract was also assayed using the standard Bradford 
procedure.
However, when compared to the protein content of the intact
nuclei, the recovery of protein into nuclear Fractions A, B and C was
only approximately 407,, suggesting that there may be further problems
with the Bradford protein assay. Figure 6 shows an SDS polyacrylamide
gel of nuclear Fractions B and C. Closer inspection of the gel reveals
that although the calculated amount of protein loaded in each track is
the same (20ug) more protein has actually been loaded in track 3, which
corresponds to nuclear Fraction C. This observation suggests that not
all of the protein present in nuclear Fraction C is being detected using
the Bradford method. It is possible that, on the addition of the
Bradford reagent, the resulting dilution renders some of the protein
insoluble, hence it is not detected. Figure 9 shows, an SDS
polyacrylamide gel of nuclear Fraction C and the 0.1M H^SO^ nuclear
extract. Again the calculated amount of protein loaded in each track is
the same (20ug), but more protein has actually been loaded in track 3
(the 0.1M H„S0. nuclear extract). This suggests the problem < 2 4
j
outlined for Fraction C may be even more pronounced for the H^SO^ 
extract. An additional reason for the apparent low protein recovery may
be that further protein may be trapped and unassayable in Fraction A as 
the material remaining after the nuclei had been exposed to 2M NaCl was 
very 'sticky' and almost impossible to redissolve.
| The above observations indicate the difficulties in accurately
|determining the protein content of nuclear Fractions A and C. In the 
case of nuclear Fraction B, the observation that both the method of Lowry 
et a l . (1951) and that of Bradford (1976) gave comparable results 
indicates that it was possible to determine the protein content of this 
fraction with reasonable accuracy.
The fact that it was not possible to accurately determine the 
total protein content of all of the nuclear fractions also means that the 
actual amount of nuclear protein immobilised on the Sepharose 4B from 
each fraction must be uncertain. Since this is the case, the assignment 
of relative quantitative abilities to the nuclear Fractions A, B and C to 
specifically bind activated labelled oestrogen receptor is difficult as 
these were expressed per mg of immobilised nuclear protein. In the case 
of nuclear Fraction A the general insolubility problems which arose made 
accurate assessment of nuclear binding sites impossible. In the case of 
nuclear Fractions B and C it was possible to maintain the protein in 
solution to enable coupling to the Sepharose 4B to take place. However, 
as discussed previously Fraction C appears to contain more protein than 
the amount assayed. Hence, attempts to couple equal amounts of nuclear 
Fractions B and C to Sepharose (see Table 8) and then assay for binding 
activity towards activated labelled oestrogen receptor are subject to 
error. Nevertheless, Table 8 shows that Fraction B exhibits less than 
10% of the binding activity shown by Fraction C. It seems unlikely that 
the protein content of Fraction C is tenfold greater than that of 
Fraction B (see Figure 6) and as such is probably correct that Fraction C 
is enriched in binding sites when compared to Fraction B. It must also 
be borne in mind that the aims of these investigations were to identify
specific binding sites for activated, labelled oestrogen receptor 
complexes. The data in Table 8 show that both nuclear Fractions B and C 
contain such binding sites. One obvious question is whether the same 
protein molecule(s) are involved in the binding activity shown by the 
different nuclear fractions or does each fraction contain unique 
molecules capable of specifically interacting with the activated, 
labelled oestrogen receptor? Hopefully, further investigation using, 
for example, antibody probes would provide an answer to this question.
In experiments which examined the binding of different steroid 
! receptor complexes to the same batch of nuclear extract/sepharose resin, 
a knowledge of the exact immobilised protein content of the resin was of 
less importance. The main reason for this being that the appropriate 
nuclear extract/sepharose resin (either Fraction C or the 0.1M H^SO^ 
nuclear extract) remained constant throughout these experiments, whilst 
the nature of the steroid receptor complex was varied.
General Discussion
It is generally thought that the effect of steroid hormones is 
mediated by hormone specific intracellular proteins that associate with 
specific DNA or chromatin sites upon binding the hormone ligand 
(Mulvihill et a l ., 1982). It is assumed that this receptor-genome 
interaction is the primary event in the induction of transcription of 
genes which are programmed to respond to a given steroid hormone in a 
given differentiated target cell. This concept has been considered the 
key feature of the molecular mechanism of steroid hormone action and 
stems from the rapid accumulation and retention of steroids within target 
cell nuclei after exposure to the steroid in question (Clark and Peck, 
1979). Circumstantial evidence has thus popularised the oestrogen 
receptor complex (and all other steroid receptor complexes) as an 
intracellular regulator of gene expression. Its selective distribution 
throughout chromatin should be tissue specific, determined by acceptor
sites and should influence expression of the relevant genes. The exact 
mechanism by which steroid receptor complexes alter the expression of 
specific genes is still unclear. Once in the nucleus, the steroid 
receptor complex must rapidly locate the DNA sequence(s) responsible for 
I steroid induced gene activation. The affinity of interaction between 
steroid receptor complexes and DNA is too low to explain the rapid time 
course of these events hence it is likely that a much higher affinity 
interaction with a chromatin protein 'flag' is necessary to attract the 
steroid receptor complex to the correct DNA sequence and thus establish 
initiation sites.
Data is presented in this thesis which shows that the material
extracted from purified human myometrial nuclei with 2M NaCl or 0.1M
H^SO^ is capable of specifically binding activated, labelled
oestrogen receptor from a variety of sources (see Table 2). The data
presented in Figure 11 show that the majority of the observed binding is
due to activated, labelled oestrogen receptor. Other cellular proteins
capable of binding cannot induce the same level of binding to the
nuclear extract sepharose resins. It was possible to observe the
specific binding of activated, labelled oestrogen receptor complex to the
nuclear Fraction C and 0.1M H„SO. nuclear extract/sepharose resins at
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physiological pH and almost physiological ionic strength.
These data are in broad agreement with those of Mainwaring et_ 
al. (1976) and Puca et a l . (1974; 1975) who report a salt-extract binding 
activity for androgen and oestrogen receptor complexes respectively. 
Subsequently Puca et al. (1975) reported that the binding activity could 
also be extracted from target cell nuclei using H^SO^. Their data 
regarding the 0.1M H^SO^ extract of human myometrial nuclei are in 
agreement with those described here.
Sodium molybdate has been shown to inhibit the process of 
oestrogen receptor activation as measured by DNA binding activity
(Pettersson et al., 1982). In this study, oestrogen receptor prepared 
in the presence of 20mM molybdate was still capable of being bound by 
both the nuclear Fraction C and 0.1M H^SO^ nuclear extract/sepharose 
resins. These observations suggest that molybdate does not interfere 
either directly, or via protein conformational changes with the binding 
site on the receptor recognised by both of these nuclear fractions.
These data also suggest that the DNA binding site of the oestrogen 
receptor complex and the binding site which is active in the present 
studies are distinct.
Interestingly, Littlefield and Spelsberg (1985) report that 
molybdate stabilised progesterone receptor still binds to oviduct 
chromatin at a level of 40% of that seen with activated, fully functional 
receptor. However, the binding to chromatin of this inactive 
progesterone receptor is unsaturable - presumably because the subsequent 
interaction with DNA is inhibited.
The chemical nature of the 'acceptor' site, or region, is a 
question which must be answered before we understand the mechanism of 
steroid hormone action at the molecular level. Experiments w ith cloned 
genes, containing only DNA, will not give us the true physiological 
picture. It is generally considered that nuclear associated proteins 
ultimately control the acceptor function in either an active or passive 
way. Supporters of the passive theory (Mainwaring and Peterken, 1971) 
suggest that DNA is the acceptor whereas nuclear proteins restrict the 
binding sites available on DNA. The active theory (Spelsberg et a l ., 
1971) attributes all acceptor activity to the nuclear proteins with 
little, if any, involvement of DNA. However, more recently Spelsberg 
a l . (1984) have shown that in the chick oviduct the acceptor sites for 
progesterone receptor comprise a specific set of chromatin proteins and a 
limited number of specific DNA sequences. Current data suggest that the 
binding of steroid receptor complexes to chromatin protein acceptor sites 
is characterised by specificity, saturability and high affinity
(Mainwaring et a l . , 1976; Puca et al., 1974; 1975). These features are 
not necessarily evident in the binding of receptor complexes to 
immobilised DNA (Puca et a l . , 1974).
Rapidly advancing technology has enabled many groups to focus 
their attention on the direct interaction of steroid receptor complexes 
with the DNA of steroid inducible genes or the regions of DNA which are 
adjacent to these genes (e.g. Compton et al., 1983; Payvar et .al.,
1983). However, as discussed previously, the relative affinity of these 
regions of DNA for the appropriate steroid receptor complex is 
insufficient to explain the rapid way in which incoming steroid receptor 
complexes are trapped within the nucleus. These observations support 
the involvement of other nuclear components in the nuclear binding of 
steroid receptor complexes.
The data presented in Section 3.3 of this thesis show that in 
this in vitro binding system the interaction of activated, labelled 
oestrogen receptor complex with chromatin associated proteins is being 
examined. Only proteolytic enzymes are capable of reducing the observed 
binding activity to any significant extent, DNase and RNase treatment had 
little effect on the observed binding activity (see Tables 9, 10, 11 and 
12). However, it is likely that the environment presented to the 
oestrogen receptor complex in this in vitro binding system is very 
different from that found in vivo, especially in respect to the absence 
of DNA and RNA (Poonian et a l ., 1971). Previous work has shown that 
DNase treatment of uterine nuclei releases bound oestrogen receptor (e.g. 
King and Gordon, 1972) and RNase treatment of 'HeLa' cell nuclei causes a 
release of glucocorticoid receptor (Rossini, 1984). No specific role 
for RNA in nuclear binding has become apparent, although Lin and Ohno 
(1983) have reported selective interaction of oestrogen receptor from hen 
oviduct with poly A RNA and a similar interaction of mouse kidney 
androgen receptor with RNA (mRNA, tRNA and rRNA) (Lin and Ohno, 1981).
Feldman et al. (1981) report that cytosol from MTW9 rat mammary tumour 
contains a high molecular weight inhibitor of oestrogen receptor binding 
to DNA. RNase treatment destroys the inhibitory activity, suggesting 
the involvement of an RNA molecule. A similar situation has been 
reported for the binding of both oestrogen and glucocorticoid receptors 
from MCF7 cells to DNA cellulose (Chong and Lippman, 1982). These 
observations suggest that steroid receptor-RNA interactions may play a 
role in regulation of gene expression by steroid hormones.
By convention, non histone chromatin proteins are generally 
considered to be acidic in nature, although as discussed in Section 
1.5.4.1.2 care must be exercised in the absolute classification of these 
proteins. Reports of both acidic and basic non histone chromatin 
proteins being involved in acceptor activity have been published. Puca 
et a l . (1974; 1985) show that the acceptor activity for oestrogen 
receptor in calf uterine nuclei resides in the basic, but non histone 
chromatin protein fraction as do Mainwaring et a l . (1976) for the 
acceptor activity towards androgen receptor in rat prostate nuclei. 
Conversely, the acceptor activity for progesterone receptor in the chick 
oviduct system has been shown quite clearly to reside in the acidic non 
histone chromatin protein fraction (Spelsberg, 1982; Spelsberg et a l . , 
1983).
The detection of multiple binding sites in vitro suggests that 
more than one protein or protein fraction is involved in nuclear in vivo 
(Ruh et al., 1981). From the data presented in this study it is not 
clear what type of nuclear protein component is involved, although the 
observation that the binding activity can be solubilised with H^SO^, 
as is described by Puca et al. (1975) suggests that the nuclear proteins 
involved may be of basic overall charge.
It has also been suggested that chromosomal proteins present at 
initiation sites lower the activation energy required for the opening of
the DNA double helix in forming a stable complex with the RNA 
polymerase. Such proteins would be expected to be major determinants in 
the location of initiation sites and perhaps be composed of a variety of 
proteins capable of destabilising DNA (Thomas and Patel, 1976). It is 
possible that the interaction of a steroid hormone receptor compelx with 
such an area of chromatin protein would make the formation of a stable 
initiation complex even more favourable. Naturally, the three 
dimensional structure of 'acceptor sites' in vivo will involve both the 
DNA and the acceptor proteins.
Characteristics expected of an acceptor site are, (1) high 
affinity binding, (2) a limited number of binding sites must exist and 
(3) steroid specificity.
It is now generally accepted that under defined conditions of pH 
and ionic strength, it is possible to observe saturable binding of 
steroid receptor complexes to target cell nuclei, chromatin or isolated 
chromatin components in vitro (Spelsberg et a l ., 1976a). However, 
physiological ionic conditions are probably important for specificity.
The data presented in Section 3.4.1 and 3.4.2 show that both the 
0.1M H^SO^ nuclear extract and nuclear fraction C/sepharose resins 
contain a limited number of specific saturable binding sites for 
activated labelled oestrogen receptor complex. Saturation analysis 
provides an insight into the characteristics of the binding sites at a 
concentration of steroid which falls within the physiological range. 
Saturation analysis was also carried out at an ionic strength which is 
known to extensively dissociate receptor complex from intact nuclei i.e. 
0.4 - 0.6M KCl (Clark and Peck, 1979). It is well accepted that nuclear 
binding can be divided into a form which is salt extractable and a form 
which is not extracted under these conditions (Clark and Peck, 1979).
It is not certain which of these two types of nuclear binding is 
physiologically important i.e. which results in specific gene
activation. Hence, the assumption that the binding observed in the 
presence of 0.5M KC1 represents non-specific binding may not be strictly 
correct, as receptor can still be bound in the remaining nucleus under 
such conditions. However, the binding observed under these conditions 
was never saturable and was of lower affinity than the specific saturable 
binding observed in 0.12M KC1.
The apparent dissociation constants for the interaction of 
activated, labelled oestrogen receptor with both nuclear fraction C and 
the 0.1M H^SO^ nuclear extract/sepharose resin (table 13) are in 
reasonable agreement with values published concerning the interaction of 
oestrogen receptor complex with intact nuclei and sub nuclear components 
in vitro (Higgins et a l ., 1973; Puca et al., 1974, 1975; Mainwaring ej^  
al., 1976; Kon and Spelberg, 1982; DeBoer et a l ., 1984). They are of 
the correct order of magnitude to be physiologically significant when 
compared to the low levels of circulating free steroid bound in vivo and 
are certainly higher than the affinity of interaction observed between 
steroid receptor complexes and the free DNA from hormonally regulated 
genes.
A great deal of progress has been made recently regarding the 
interaction of various steroid receptor complexes with specific DNA 
sequences. However, the apparent Kd for the interaction of oestrogen 
receptor complexes with a variety of heterologous DNA molecules is only 
4-6x10 Si (Buller and O'Malley, 1976). The affinity of the 
interaction reported for steroid receptor complexes with specific DNA 
consensus sequences is only 10-40 times greater than this (Chambon e_t 
al., 1984) which still represents binding of insufficient affinity to 
explain the physiological effects of steroid hormones at the very low 
concentrations at which they occur in vivo. For the sake of comparison, 
the lac repressor protein binds to its specific DNA sequence in the lac 
operon region of the E .coli genome with an apparent Kd of approximately
-13
10 M (Riggs et a l . , 1970), this being a classic example of a protein 
whose in vivo effects are realised through interaction with a specific 
DNA sequence.
For many years Spelsberg has supported the idea that both DNA 
and protein have a role to play in the three dimensional structure of 
'acceptor' sites for steroid hormone receptor complexes in vivo, a view 
that is shared by Leake (1981). The strongest evidence to support this 
proposal so far comes from Spelsberg et al♦ (1984) who report that only a 
limited number of specific DNA sequences in the avian genome which can 
interact with the chromatin protein fraction they have previously shown 
to possess binding activity towards the chick oviduct progesterone 
receptor.
Steroid receptor complexes may function at a number of levels to 
control gene expression. Multiple receptor binding domains of varying 
affinity may be involved. Such binding domains may be involved in 
determining priority effects, in maintenance of an overall structure 
conducive to transcription, more efficient utilisation of promoters or 
influencing DNA-protein interactions to facilitate higher rates of 
elongation within a gene or among genes of differing susceptibility.
This would account for the large number of acceptor sites shown here and 
the spectrum of physiological response relative to the numbers of 
occupied sites. However, the techniques used were not sufficiently 
sensitive to allow separation of acceptor sites with minor differences in 
affinity for oestrogen receptor.
The data presented in Section 3.5 show that the protein 
fractions isolated from human myometrial nuclei using 2M NaCl and 0.1M 
H^SO^ contain specific binding activities towards steroid receptor 
complexes other than oestrogen receptor complex. The observation that 
both fractions do not contain specific binding sites for all the steroid 
receptor complexes assayed indicates that there is a selective extraction 
of binding sites by each extraction procedure.
The analysis of competition between steroid receptor complexes
for binding sites on both the nuclear fraction C and 0.1M H_SO,
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nuclear extract/sepharose resins (Section 3.6) suggests that although 
there appear to be unique binding sites for each steroid receptor complex 
there are also many common binding sites. This data is in conflict with 
that of Kon and Spelsberg (1982) who report no antagonism between 
oestrogen and progesterone receptor complexes for binding sites in hen 
oviduct nuclei although the kinetics of conalbumin mRNA induction by both 
nuclear oestrogen and progesterone receptor complexes is very similar 
implying that a common binding site may be involved (Mulvihill and 
Palmiter 1977; 1980). Higgins et al. (1983) have reported unique 
binding sites for both glucocorticoid and oestrogen receptor complexes in 
immature rat uterine nuclei. These studies, and those of Kon and 
Spelsberg (1982) examined the binding to intact nuclei, no attempt was 
made to analyse the binding of receptor complexes to nuclear 
components. The findings in this thesis when compared to those 
published observations may indicate that the three dimensional structure 
of the intact acceptor site in vivo may only be recognised by a 
particular class of steroid receptor complex. Once this structure has 
been disrupted during the extraction procedures involved in the present 
studies, a loss in the absolute specificity of steroid receptor complex 
binding may occur.
Von der Abe et a l . (1985) have shown that there is an 
overlapping pattern of binding of glucocorticoid and progesterone 
receptor complex to the chicken lysozyme promoter, since not all genes 
responsive to glucocorticoid are responsive to progesterone it may be 
that the absolute specificity of steroid hormone induced gene expression 
is provided by the presence of specific acceptor proteins in conjunction 
with a sequence of DNA in the 5' region of the hormonally regulated gene.
The data presented in Section 3.5 shows quite clearly that both
the nuclear fraction C and 0.1M H_S0. nuclear extract/sepharose
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resins possess a greater number of binding sites for activated, labelled 
oestrogen receptor complexes than they do for anti-oestrogen/oestrogen 
receptor complexes. However this may be due to the inability of 
tamoxifen to cause complete activation of the oestrogen receptor 
population (Mester et a l , 1981). To answer this question the 
experiments should be repeated using the activate metabolite 
4-hydroxytamoxifen. The analysis of the antagonism between oestrogen 
receptor complexes and anti-oestrogen receptor complexes for binding 
sites in both the nuclear fraction C and 0.1M H^SO^ nuclear 
extract/sepharose resins again indicates that although there appears to 
be unique binding sites for both forms of the oestrogen receptor complex 
some common binding sites are present. The idea of non-identical 
nuclear binding sites for oestrogen and antioestrogen receptor complexes 
is not a new one (Baudendistal and Rub, 1976; Massol et a l ., 1978;
Lebeau et a l ., 1981; Singh et al♦, 1984) and may be the root of the 
different physiological responses induced by oestrogens and antioestrogen 
in some systems.
The observation that the nuclei isolated from various tissues 
(including non target tissues) of the immature female rat contained 
specific binding sites for activated, labelled oestrogen receptor complex 
indicates that the nuclear protein(s) responsible for the binding are not 
confined to target tissues (see Section 3.7). There have been a variety 
of reports that target cell nuclei for different steroids contain 
markedly more acceptor sites than non target cell nuclei, using cell free 
binding assays (e.g. Mainwaring and Peterken, 1971; Spelsberg et a l ., 
1972; Puca et a l ., 1975; Mainwaring et al, 1976; Pikler et a l ., 1976; 
de Boer et a l ., 1984) and these greatly outnumber reports of no 
differences in nuclear binding between the chromatin of target and non 
target tissues (e.g. Higgins et a l ., 1973). The detection of these 
specific binding sites in non target tissues of the immature female rat 
gives no idea of the role of these binding sites have to play in vivo.
It may be that in vivo these binding sites are 'masked' (Spelsberg,
1982; Spelsberg et a l ., 1983) and therefore concealed from activated 
oestrogen receptor, even if it were present in such non target cells.
The extraction procedure used to isolate nuclear fraction C will extract 
the binding sites and presumably any masking proteins associated with 
them. Extraction will almost certainly disrupt any interaction which 
was present between them and hence in this in vitro system the binding 
proteins are available for assay.
The biological role of such a masking phenomenon is uncertain. 
One possible function is that it regulates which genes will respond to 
steroid receptor complex and at what time. If so, it would help explain 
why different target tissues of the same organism display markedly 
different responses to the same steroid with regard to gene expression. 
Recent evidence indicating that the steroid receptors in different 
tissues from different animals are antigenically similar (Greene et a l . , 
1980; Greene and Jensen, 1982) minimises the tissue specificity of the 
receptors themselves. In short, if a gene is masked it is not available 
for transcription but if unmasked is available for transcription in the 
present of the appropriate steroid receptor complex. The masking 
phenomenon does not appear to be confined to the chick oviduct 
(Spelsberg, 1982) but has been reported for androgens in the rat prostate 
(Klyzsejko-Stefanowicz, 1976) oestrogen and progesterone in the sheep 
brain (Perry and Lopez, 1978) and oestrogen in rat and bovine uterus (Ruh 
et al, 1981).
Without doubt, one of the major problems which still remains is 
; that of isolating and characterising acceptor proteins. Early attempts 
to characterise such proteins lead Puca et a l . (1975) to conclude the 
binding protein for oestrogen receptor complex in calf uterine nuclei was 
of basic overall charge and had a molecular weight of approximately 
85,000, and Mainwaring et a l . (1976) to conclude the binding protein for
androgen receptor in the rat prostate was a basic protein of molecular 
weight approximately 70,000. However, the majority of attempts to 
isolate and characterise acceptor proteins have been made by Spelsberg 
and his co-workers (Spelsberg, 1982; Spelsberg et a l ., 1983). Working 
with the avian oviduct system they conclude that the majority of acceptor 
activity can be assigned to a group of proteins with a molecular weight 
range of 14,000-18,000. Isoelectric focussing has shown that the group 
can be resolved into two major peaks, one of which focussed around pH5.0 
and another which focussed in the range of pH6 to pH7.5. This suggests 
that these proteins belong to the acidic non histone protein fraction. 
Using protein blotting techniques, this study has attempted to identify 
the proteins present in the nuclear fractions which are responsible for 
the observed binding activity towards activated, labelled oestrogen 
receptor (see Section 3.8). Figure 16 shows what may be a very weak 
signal at a molecular weight of approximately 15,000, however, further 
work is required to substantiate these findings. The major problem 
encountered during these studies was that of non-specific background 
binding, which may have obscured other very weak signals.
If it were possible to identify specific 'acceptor' proteins 
using this approach it may then be possible to identify specific regions 
of genomic DNA which interact with the acceptor proteins, to complete the 
three dimensional structure of the acceptor site in vivo. the analysis 
of the specific interactions between the lac repressor protein and DNA 
contain the lac operator has been reported by Bowen et a l . (1980) using 
similar techniques.
In conclusion, the data presented in this thesis support the
involvement of non-histone chromatin proteins in acceptor site function,
f
but further work, especially on the characterisation and isolation of the 
| protein(s) involve is required to increase our understanding of the 
acceptor site - in vivo.
The suggestion that the oestrogen receptor may be, at all times 
resident in the nucleus (King and Green, 1984; Welshons et al., 1984) 
increases the likelihood of binding sites of differing affinity being 
present. Unoccupied receptor is readily extracted from the nucleus at 
low salt concentrations, while high salt is required to extract activated 
receptor. This might suggest that following oestrogen binding, the 
receptor complex may be relocated to an area of the genome which has a 
higher affinity for the receptor complex and is responsible for 
regulation of the expression of oestrogen inducible genes. Another 
possibility is that no relocation occurs but the receptor is located in 
close proximity to the acceptor site at all times. Binding of the 
ligand is necessary to induce expression of the adjacent gene. Of 
course, nuclear localisation of the oestrogen receptor is under debate 
(Szego and Pietras, 1985) and the preceding statements are pure 
speculation.
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